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Single-cell profiling techniques have provided an unprecedented opportunity to study cellular
heterogeneity at the molecular level. This represents a remarkable advance over traditional bulk
sequencing methods, particularly to study lineage diversification and cell fate commitment events in
heterogeneous biological processes. While the large majority of single-cell studies are focused on
quantifying RNA expression, transcriptomic readouts provide only a single dimension of cellular
heterogeneity. Recently, technological advances have enabled multiple biological layers to be probed
in parallel one cell at a time, unveiling a powerful approach for investigating multiple dimensions
of cellular heterogeneity. However, the increasing availability of multi-modal data sets needs to
be accompanied by the development of suitable integrative strategies to fully exploit the data
generated. In this thesis I worked in collaboration with different research groups to introduce
innovative experimental and computational strategies for the integrative study of multi-omics at
single-cell resolution.
The first contribution is the development of scNMT-seq, a protocol for the simultaneous profiling
of RNA expression, DNA methylation and chromatin accessibility in single cells. I demonstrate
how this assay provides a powerful approach for investigating regulatory relationships between the
epigenome and the transcriptome within individual cells.
The second contribution is Multi-Omics Factor Analysis (MOFA), a statistical framework for the
unsupervised integration of multi-omics data sets. MOFA is a Bayesian latent variable model
that can be viewed as a statistically rigorous generalization of Principal Component Analysis to
multi-omics data. The method provides a principled approach to retrieve, in an unsupervised
manner, the underlying sources of sample heterogeneity while at the same time disentangling which
axes of heterogeneity are shared across multiple modalities and which are specific to individual data
modalities.
The third contribution is the generation of a comprehensive molecular roadmap of mouse gastrulation
at single-cell resolution. We employed scNMT-seq to simultaneously profile RNA expression, DNA
methylation and chromatin accessibility for hundreds of cells, spanning multiple time points from
the exit from pluripotency to primary germ layer specification. Using MOFA, and other tools, I
performed an integrative analysis of the multi-modal measurements, revealing novel insights into
the role of the epigenome in regulating this key developmental process.
The fourth contribution is an extended formulation of the MOFA model tailored to the analysis of
large-scale single-cell data with complex experimental designs. I extended the model to incorporate
a flexible regularisation that enables the joint analysis of multiple omics as well as multiple sample
groups (batches and/or experimental conditions). In addition, I implemented a GPU-accelerated
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1.1 Introduction to single-cell sequencing
Next-generation sequencing technologies have revolutionised the study of biological systems by
enabling the genome-wide profiling of molecular layers in an unbiased manner, including the genome
[92] the epigenome [93] and the transcriptome [175, 22, 215, 210]. Traditionally, bulk sequencing
approaches were used to profile a large number of cells at once and report an average molecular
readout. However, these methods are unable to capture differences between individual cells and are
thus of limited use when studying heterogeneous biological processes [99, 223, 227]. The gradual
development of low-input sequencing technologies resulted in an explosion of single-cell sequencing
technologies, most of which focused on profiling the transcriptome. In contrast to bulk protocols,
single-cell technologies provide an unprecedented opportunity to study the molecular variation
associated with cellular heterogeneity, lineage diversification and cell fate commitment [152].
The field of single-cell sequencing has largely been driven by the quantification of the messenger
RNA (mRNA). In less than a decade, the field of single-cell transcriptomics has experienced an
exponential growth of scale in terms of number of cells profiled, driven by incremental optimisations
of reagent volumes, decreases in consumable costs, as well as intelligent innovations in the capture,
separation, and barcoding of cells [294]. The earliest high-throughput single-cell RNA sequencing
(scRNA-seq) technologies were published between 2009 and 2011, yielding a handful of cells. In 2019,
there are studies that have achieved the astonishing milestone of profiling the transcriptome for
more than a million cells in a single experiment [49]. With the development of efficient commercial
platforms, the maturation of scRNA-sequencing technologies has provided major insights on the
study of lineage diversification and cell fate commitment [152, 99, 223, 227]. In 2020, we are at the
stage of a major endeavour to generate transcriptomic atlases for different tissues, embryos and
even entire adult organisms. The most ambitious of all is the Human Cell Atlas, aimed at building
a reference map for all cells in the human body [249].
1.1.1 Single-cell RNA sequencing
scRNA-seq protocols differ extensively in terms of scalability, cost and sensitivity [294, 161]. Broadly
speaking, they can be classified into plate-based and droplet-based methods. In plate-based methods
such as CEL-seq [109] and Smart-seq [244, 231], cells are isolated using micropipettes or flow
cytometry into individual wells of a plate, where the library preparation is performed. Although
plate-based strategies have limitations in terms of throughput and scalability, their main advantage
is the higher quality of libraries and the full length transcript information (in the case of Smart-seq)
1
which enables a more accurate quantification of splicing variants [124], allele-specific expression [73]
and transcription-degradation kinetics [160].
Droplet-based methods are based on the use of droplet microfluidics technology [338]. By capturing
cells in individual droplets, each containing all necessary reagents for library preparation, this
protocol allows the profiling of thousands of cells in a single experiment. This class of methods
include InDrop [150, 344], Drop-seq [191] and the commercial 10x Genomics Chromium platform
[342]. As a trade-off, the increasing throughput of droplet-based approaches comes at the expense
of reduced sensitivity [343, 322, 295].
More recently, a third type of scRNA-seq methodology emerged based on a combinatorial cellular
indexing strategy [47, 258, 49], which has permitted the sequencing of more than a million cells in
a single experiment for a fraction of the cost of other methods, albeit at the cost of much lower
sensitivity.
1.1.2 Single-cell sequencing of the epigenome
While the vast majority of single-cell technologies are focused on quantifying RNA expression,
transcriptomic readouts provide a single dimension of cellular heterogeneity and hence contain
limited information on the molecular determinants of phenotypic variation [254]. Consequently,
gene expression markers have been identified for a myriad of biological systems, but the role of the
accompanying epigenetic changes in driving cell fate decisions remains poorly understood [99, 140,
28]. Significant effort has been placed to obtain epigenetic measurements at single-cell resolution by
adapting bulk methods for small quantities of input material, a strategy thas has been successful
for a variety of molecular layers, including DNA methylation [274], chromatin accessibility [69, 50,
57], histone modifications [157] and chromatin conformation [157].
DNA methylation
DNA methylation is a stable epigenetic modification that is strongly associated with transcriptional
regulation and lineage diversification in both developmental and adult tissues [132, 226, 165, 275].
Its classical roles include the silencing of repetitive elements, inactivation of the X chromosome,
gene imprinting, and repression of gene expression [135]. Consequently, the disruption of the DNA
methylation machinery is associated with multiple dysfunctions, including cancer [26], autoimmune
diseases [178] and neurological disorders [10].
Protocols for profiling DNA methylation in single cells have emerged from their bulk counterparts,
most notably bisulfite sequencing (BS-seq) [274, 102, 98, 90]. The underlying principle of BS-
seq is the treatment of the DNA with sodium bisulfite before DNA sequencing, which converts
unmethylated cytosine (C) residues to uracil (and after PCR amplification, to thymine (T)), leaving
5-methylcytosine residues intact. The resulting C→T transitions can then be detected by DNA
sequencing [93, 60, 58]. Nevertheless, the high degree of DNA degradation caused by the purification
steps and the bisulfite treatment impaired the use of conventional BS-seq with low starting amounts
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of DNA. To address this problem, [274] adapted the post-bisulfite adaptor tagging (PBAT) protocol
by doing multiple rounds of 3’ random primer amplification. In addition, when the bisulfite treatment
is performed before ligation of adaptors, rather than afterwards, loss of adapter-tagged molecules is
minimised, demonstrating the potential to use scBS-seq from low-input material.
Chromatin accessibility
In eukaryotes, the genome is packed into a compact complex of DNA, RNA and proteins called
chromatin. Several layers of chromatin condensation have been identified, the fundamental of which
being the nucleosome, which consists of a string of ≈ 150bp of DNA wrapped around histone proteins,
with ≈ 80bp of DNA connecting them [151, 312]. The positioning of the nucleosomes along the DNA
provide an important layer of gene regulation, mostly by exposing or sheltering transcription factor
binding sites [130]. In general, active regulatory regions tend to have low occupancy of nucleosomes,
whereas inactive regions show a high density of nucleosomes [289]. Thus, the profiling of DNA
accessibility and transcription factor footprints represents an important dimension to understand
the regulation of gene expression.
Traditionally, three main experimental approaches have been used to profile bulk chromatin ac-
cessibility in a genome-wide and high-throughput manner [219] (Figure 1.1): DNase sequencing
(DNase-seq) [279], transposase-accessible chromatin followed by sequencing (ATAC-seq) [41] and
Nucleosome Occupancy and Methylome-sequencing (NOMe-seq) [139].
• DNase-seq: cells are incubated with DNAse I, an enzyme that in low concentrations cuts
nucleosome-free regions, hence releasing accessible sites that are subsequently sequenced
[279]. Although this methodology became one of the gold standards to profile chromatin
accessibility by the ENCODE consortium [62, 302], it has now been reported that DNase
I introduces significant cleavage biases, thus affecting the reliability of transcription factor
footprints inferred from the DNase-seq data [112].
• ATAC-seq: cells are incubated with a hyperactive mutant Tn5 transposase, an enzyme that
inserts artifical sequencing adapters into nucleosome-free regions. Subsequently, the adaptors
are purified, PCR-amplified and sequenced. In the recent years it has displaced DNase-seq as
the de facto method for profiling chromatin accessibility due to its fast and sensitive protocol
[39, 312].
• NOMe-seq: follows a very different strategy than the previous technologies. Cells are
incubated with a GpC methyltransferase (M.CviPI), which labels accessible (or nucleosome
depleted) GpC sites by DNA methylation. In mammalian genomes, cytosine residues in
GpC dinucleotides are methylated at a very low rate [144]. Hence, after M.CviPI treatment,
GpC methylation marks can be interpreted as direct read outs for chromatin accessibility.
[139]. NOMe-seq has a range of appealing properties in comparison with count-based methods
such as ATAC-seq or DNAseq-seq. First, one can obtain simultaneous information of CpG
DNA methylation with little additional cost, permitting the user to effectively measure two
molecular layers for the price of one. Second, the resolution of the method is determined by
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the frequency of GpC sites within the genome (≈ 1 in 16 bp), rather than the size of a library
fragment (usually >100 bp). This allows the quantification of nucleosome positioning and
transcription factor footprints at high resolution [139, 237]. Third, non-sequenced fragments
can be easily discriminated from inaccessible chromatin. This implies that lowly accessible
sites will not suffer from increased technical variation (due to low read counts) compared
to highly accessible sites. The downsides of the approach are the high sequencing depth
requirements and the need to discard read outs from GCG positions (21% of all CG sites) and
CGC positions (27%), as I will discuss later in this thesis.
Figure 1.1: High-level overview of the workflows for the three main chromatin accessibility assays:
NOMe-seq, DNase-seq and ATAC-seq. Reprinted from [219] with minor modifications.
As with DNA methylation, ATAC-seq [40], NOMe-seq [237] and DNase-seq [131] have also been
adapted for single cells. Due to its cost-effective strategy, single-cell ATAC-seq (scATAC-seq) has
become the most popular technique to profile open chromatin [69, 50, 57]. Compared with bulk
ATAC-seq, scATAC-seq libraries are notably sparse. In a saturated library, [69] reported a range of
≈ 500 to ≈ 70,000 mapped reads per cell, with a median of ≈ 2500. As the authors report, this
represents less than 25% of the molecular complexity expected from 500-cell bulk experiments. Yet,
despite the low coverage, the authors showed that cell-type mixtures can be confidently deconvoluted.
Later, in a pioneer effort, [68] generated an atlas of chromatin accessibility for different mouse
tissues, defining the first in vivo landscape of the regulatory genome at single-cell resolution.
1.1.3 Multi-modal single-cell sequencing
Cellular phenotypes result from the combination of multiple levels of cellular regulation. Undoubtedly,
no single "-omics" technology can capture the intricacy of complex molecular mechanisms, but the
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collective information has the potential to draw a more comprehensive picture of biological processes
[110, 254].
The profiling of multi-omic readouts at the bulk level is relatively simple, as the same tissue can be
dissociated into different aliquots, where each assay can be performed independently [254]. This
strategy is also used with single-cell assays, but it has the important downside that the different
molecular layers cannot be unambiguously matched, hence limiting the insights that can be inferred
from the data. Therefore, many single-cell multi-omics technologies are being developed, which seek
to obtain multiple molecular readouts from the same cell. The development of these technologies
will help us understand the fundamental regulatory principles that connect the different molecular
layers. In addition, integrative analyses that simultaneously pool information across multiple data
modalities (-omics) and across multiple studies promise to deliver more comprehensive insights into
the complex variation that underlies different cellular populations.
Notably, the early success and rapid development of single-cell multi-modal methods has led to
their recognition as Method of the year in 2019 by the journal Nature Methods [203]. However,
their development is still in pilot stages and at the time of writing there is no commercial platform
available, limiting its widespread use by the community. As reviewed in [290, 55], multi-modal
measurements can be obtained using three broad strategies:
• Application of a non-destructive assay before a destructive assay: a prominent
example of this is the sorting of cells based on protein surface markers using (multiparameter)
fluorescence-activated cell sorting (FACS) followed by high-throughput sequencing [228].
Although simple and efficient, this approach requires prior knowledge of protein surface
markers, and is limited by the spectral overlap of fluorescence reporters.
• Physical isolation of different cellular fractions followed by high-throughput se-
quencing: this technique was pioneered with the introduction of genome and transcriptome
sequencing (G&T-seq) [189]. After cell lysis, the mRNA fraction is separated from the genomic
DNA fraction using biotinylated or paramagnetic oligo(dT) beads, followed by the independent
sequencing of the mRNA and the DNA. This strategy allows for the simultaneous profiling
of transcriptomic measurements with (epi)-genomic measurements, including DNA sequence,
copy number variation, DNA methylation or chromatin accessibility [189, 122, 12, 123].
• Conversion of different molecular layers to a common format that can be mea-
sured using the same readout: prominent examples of this are the simultaneous measure-
ment of surface proteins and mRNA expression as in Cellular indexing of transcriptomes and
epitopes by sequencing (CITE-seq [288]) and RNA expression and protein sequencing assay
(REAP-seq [230]). The idea is to incubate cells with antibodies tagged with oligonucleotides
that target specific protein surface proteins. This allows both protein surface markers and
mRNA levels to be simultaneously measured using a single sequencing round. Notably, this
strategy is significantly more powerful than FACS, as the DNA barcodes can be resolved at
the sequence level with much higher sensitivity than using fluorescence markers. A second
prominent example is NOMe-seq, described in Section 1.1.2. By labelling accessibile GpC sites
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with DNA methylation marks, one can simultaneously measure endogenous DNA methylation
and chromatin accessibility using a single bisulfite sequencing assay.
Although single-cell multi-modal technologies have proven successful, they still face numerous
difficulties, both on the experimental and the computational front, including limited scalability, low
coverage and high levels of technical noise. These difficulties, which are also inherent to single-cell
uni-modal technologies, generally get exacerbated when doing multi-modal profiling. To quote
Cole Trapnell, one of the pioneers of single-cell data analysis: When you do a multi-omic assay,
you’re combining all the bad things from multiple protocols [81]. A clear example of these challenges
is sci-CAR [48], a combinatorial indexing strategy that combines scRNA-seq and scATAC-seq to
profile gene expression and chromatin accessibility in the same cell. This is a promising approach
that reported, for the first time, the profiling of both modalities in thousands of cells. However, the
chromatin accessibility modality yielded ≈ 10-fold less complexity than previous (already sparse)
uni-modal scATAC-seq experiments.
I envision that in the next few years significant efforts will be made to obtain more scalable and
cheaper multi-modal measurements from single cells. However, as cost and scalability remain a
barrier for high-resolution multi-modal technologies, the development of computational methods
that are capable of uncovering biological signal across multiple data modalities while overcoming
the technical biases and missing information that are inherent to single-cell experiments, will be a
cornerstone of data analysis.
1.2 Single-cell transcriptomics data analysis
From a computational perspective, the rapid development of single-cell technologies has introduced
unprecedented challenges for the statistical community, and novel computational methods need to
be developed (or adapted) for interrogating the data generated [283]. The vast majority of methods
are focused on RNA expression, spanning multiple tasks that include normalisation [159], feature
selection [308], differential expression [143], clustering [146], cell type recognition [1], pseudotime
inference [106], detection of gene regulatory networks [2] and batch correction [105], among others.
Analysis tools have been wrapped into popular platforms such as Seurat [46], the Bioconductor
class SingleCellExperiment [9] and Scanpy [328].
In this section I will provide a brief overview of a typical scRNA-seq analysis pipeline, paying
particular attention to the methods that I have used throughout this thesis.
1.2.1 Read alignment and gene expression quantification
The first step in the computational pipeline is to demultiplex the DNA barcodes in order to identify
reads that originate from the same cell. This is particularly important when multiple experiments
are pooled into a common sequencing library. This task is significantly more complex than in bulk
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data, owing to the large number of cells and the high rates of errors that can introduce nucleotide
missmatches [299].
Subsequently, trimmed reads are aligned to the appropriate reference transcriptome. Gene expression
is represented as an integer matrix of counts, with rows representing genomic features (typically
genes) and the columns representing individual cells.
1.2.2 Quality control
Incomplete cell lysis or failures during library preparation may result in poor quality cells that need
to be removed for a successful downstream analysis. Typical quality control metrics are the total
number of reads detected per cell, the number of genes expressed and the fraction of mitochondrial
genes. Cells that are outliers for some of these metrics are filtered out. Importantly, even though
there is a generic strategy to assess the quality control for scRNA-seq samples, the specific thresholds
vary between datasets and technologies, and care must be taken to always visualise the quality
control metrics [184].
A common source of technical variability in single-cell experiments is the existence of doublets,
which occurs when multiple cells co-locate in the same well or in the same droplet and are thus
assigned the same cell barcode. This results in cells that appear as mixtures of different cellular
populations and can be mistaken for non-existing intermediate populations or transitory states.
Thus, it is important to remove doublets so that they do not compromise the downstream analysis. In
small-scale plate-based technologies, most doublets can be excluded simply by microscope inspection,
but in large-scale droplet-based technologies one needs to adopt data-driven heuristics to exclude
multiplet libraries [198].
1.2.3 Normalisation
The first step of quality control is essential to remove poor quality cells, but the number of detected
molecules and transcripts can vary widely even among cells that pass the quality control. This
variability is not only due to biological heterogeneity but may also be technical. Any of the library
preparation steps may lead to technical variability, such as PCR amplification biases, differences in
RNA capture and reverse transcription efficiency. In addition, the stochasticity of the amplification
process produces dropout events, in which no read counts are observed for genes that are expressed
[315]. There has been considerable debate on how to deal with the high proportion of zero counts,
and multiple statistical frameworks have been devised, including zero-inflated negative binomial
models [253]. However, recent reports suggest that droplet-based scRNA-seq measurements can be
explained by simple Poisson statistics [293, 266].
Regardless of the statistical model, data normalisation steps are necessary to eliminate (or at least
reduce) the technical variation. Methods that were developed for bulk RNA-seq, including TMM
[257] and DEseq2 [181] are not successful for scRNA-seq owing to the large number of zeros that
dominate the gene expression matrix.
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In this thesis I used the methodology implemented in the scran package [159]. Briefly, this
normalisation procedure divides the gene counts by a size factor per cell and subsequently applies a
log transformation with pseudocount on each observation. The essential innovation for single-cell
data is to pool expression values from multiple cells (resulting in fewer zeros) and to subsequently
deconvolve the cell-specific size factors using a linear system of equations.
Recent work has suggested that global size factors do not effectively normalise all genes at the same
time, and different groups of genes require specific size factors in order to remove technical biases
[104]. In this thesis I have not explored this approach, but it showcases how data normalisation is
still an open and debated topic.
1.2.4 Dimensionality reduction
A key principle of biological datasets is that covariation patterns between the features (i.e. genes)
results from differences in underlying processes that can be inferred and interpreted. This key
assumption sets off an entire statistical framework of exploiting the redundancy encoded in the data
set to reduce the dimensionality of the data in an unsupervised fashion.
Principal Component Analysis (PCA) is the most popular technique for dimensionality reduction of
scRNA-seq data [184]. A typical analysis pipeline performs clustering, graph inference and other
downstream analyses on the (denoised) latent PCA space defined by the top N principal components
(where components are ranked by variance explained). Importantly, by maximising the variance
explained, PCA implicitly assumes a normal distribution for each feature. Therefore, it is important
that the data is log transformed, which, as outlined above, converts integer counts into continuous
measurements, before PCA is performed. In addition, the log transformation prevents signal being
driven by a small number of extremely highly-expressed genes (because in the raw counts the
variance of each gene is proportional to its mean expression).
PCA defines a linear transformation from the high-dimensional space to the low-dimensional space
where each component captures an orthogonal source of variation. Capturing the biological signal
in most single-cell datasets require a relatively high number of components. Unfortunately, humans
do not have the ability to make visual representations of more than three dimensions at the same
time, so for the purposes of visualisation further dimensionality reduction is typically applied
using non-linear methods, including t-Distributed Stochastic Neighbor Embedding (t-SNE) [188]
and Uniform Manifold Approximation and Projection (UMAP) [199]. Both methods have been
extensively applied, although UMAP is gaining popularity for larger datasets because it is better at
preserving the global structure than is t-SNE, which is aimed at solely preserving local structure.
1.2.5 Clustering
Unsupervised clustering is arguably one of the most powerful applications of single-cell genomics,
as it underpins the ability to define cell types in a coherent, systematic and unbiased manner.
Although clustering is still largely empirical and no strong consensus exists on the methodology
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and the parameters, it is applied in virtually any single-cell data set [145]. The most popular
clustering algorithm has traditionally been k-means, which iteratively identifies k cluster centroids,
and assigns each cell to the nearest centroid. This method is simple, fast and efficient for medium-
sized datasets. For large-scale datasets, however, the use of community-detection algorithms on
coarse-grained graphs has become more popular [184]. Briefly, the first step of commnity-detection
methods is to build a k-nearest-neigbourhood graph using a cell-to-cell similarity metric, where each
node corresponds to one cell. Then, tighly connected communities are detected by maximising a
modularity score, where the modularity quantifies the assignment of nodes to communities when
contrasted to a random network.
1.2.6 Inference of developmental trajectories
In many biological systems, and particularly during embryonic development, cells display a continuous
spectrum of states and so discrete clustering may be inappropriate. Due to the destructive nature of
single-cell assays, experiments are not capable of measuring the changes individual cells undergo over
time. However, differentiating cells are typically asynchronised and display a continuous spectrum of
molecular states that reflect the underlying trajectory. Computational methods have been developed
to reconstruct this continuity using latent mathematical representations, and are often termed
pseudotime methods [262]. The aim of pseudotime methods is to generate an ordering of cells
according to some metric, which is usually (but not necessarily) some approximation of real time
that is inferred from the data. A myriad of pseudotime methods have been developed, with tailored
assumptions depending on the nature of the input data and the expected topology of the trajectory
(linear, bifurcating, etc.), among other variables [262].
1.3 Integrative analysis of single-cell omics
Despite the explosion of statistical methods for scRNA-seq data analysis, to date only a few methods
have been published with the aim of performing data integration across experiments and data
modalities. This is currently defined as one of the grand challenges in single-cell data science [162].
1.3.1 Defining the common coordinate framework
The first step when performing data integration is to consider which coordinate framework can be
used to anchor the different data modalities. This is generally dictated by the experimental design
itself, and leads to three broad types of data integration strategies (Figure 1.2):
• Cells as the common coordinate (vertical integration): when the different data modalities
are derived from the same cell in matched multi-omic assays. Examples of technologies that
generate such data are single-cell Methylome & Transcriptome (scM&T-seq) [12], Cellular
Indexing of Transcriptomes and Epitopes by sequencing (CITE-seq) [288] and Single-nucleus
chromatin accessibility and RNA expression sequencing (SHARE-seq) [187].
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• Genomic features as the common coordinate framework (horizontal integration): when multiple
data modalities of the same type are profiled in different sets of cells. We call this non-matched
multi-omics and the main advantage is that it is significantly easier and cheaper to obtain
than matched multi-omics, and as a result most of the current datasets to date belong in this
category. An example of this would be performing scRNA-seq on cells from the same tissue
across different groups of donors, where the set of genes represents the anchors.
• No common coordinate framework in the high-dimensional space (diagonal integration): when
both cells and genomic features are different between experiments. An example of horizontal
integration would be the profiling of RNA expression in one set of cells, and chromatin
accessibility in an independent set of cells.
Figure 1.2: Defining the data integration strategy: choosing the common coordinate
framework.
Schematic representation of (a) Horizontal integration, when features act as anchors (b) Vertical
integration, when cells act as anchors (c) Diagonal integration, when no anchors exist.
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1.3.2 Challenges of data integration
The joint analysis of multiple data sources must tackle numerous challenges, some of which are:
• Heterogeneous data modalities: measurements collected using different technologies
generally exhibit heterogeneous statistical properties and have to be modelled under different
statistical assumptions. For example, combining count (i.e. gene expression) and binary traits
(i.e.somatic mutations) under the same statistical framework is not a trivial task. In the
statistics community, this is commonly refered to as the multi-view learning problem [332,
170].
• Overfitting: as the number of molecular layers increases but the number of samples remains
limited, modelling strategies need to account for the risk of overfitting, which can lead to
poor generalisation. For example, scM&T-seq captures the methylation status for potentially
millions of CpG sites, but the experimental designs are typically restricted to only a few
hundred cells. This is a classic case of a large p and small n problem in high-dimensional
statistics.
• Discriminating biological vs technical sources of variation: multi-omics datasets
typically contain undesired sources of heterogeneity, both technical and biological [254].
Prominent examples are batch effects or cell cycle variation, respectively. If not accounted for,
such strong sources of variability can hide the signal of interest [42]. Therefore, understanding
and account for undesired cell-to-cell variation hsa to be performed before other computational
pipelines are applied [202].
• Missing data: a major problem in some single-cell methodologies is the large amounts of
missing information. For example, in a typical single-cell bisulfite experiment less than 10%
of all CpG sites in the genome are measured [274]. This poses important challenges to some
of the conventional statistical methods that do not handle missing information. Furthermore,
assays differ in terms of how missing data is defined. For bisulfite sequencing methods, the
missing values are distinguishable from the observed values. However, for other methods such
as scRNA-seq or scATAC-seq, the absence of a sequencing read does not distinguish between
the event that the genomic feature was not measured from that the readout was indeed zero
[59].
• Scalability: as sequencing costs decrease and technologies improve, we anticipate that multi-
modal datasets will follow a similar trend as scRNA-seq, where in the span of less than ten
years the size of the experiments increased from the order of tens to milions of cells [294].
• Assay noise: because of the small amounts of starting material, single-cell technologies are
inherently noisy and result in large amounts of technical noise [283]. Hence, in most cases,
inspection of individual genes or cells tends to be unreliable. To overcome this challenge,
computational frameworks are required to pool information across cells and/or genes to
delinate the signal from noise and to obtain reliable statistical estimates [314]. Prominent
examples of this are (empirical) Bayesian approaches that are able to borrow information
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across cells and/or genes and propagate uncertainity when doing inference and predictions
[143].
• Principled validation of the model outputs: The assessment of data integration outputs
is one of the most challenging steps. In most cases, no ground truth is available and one has
to assess the model fit by relying on quality control statistics and/or assessing the impact
of the integration on downstream analysis tasks (i.e. differential expression, dimensionality
reduction, clustering, etc.). The evaluation of the model fit is particularly hard for non-linear
methods that can be prone to overfit.
1.3.3 Defining the methodology
Once the common coordinate framework is defined, one needs to choose the data integration strategy.
These can fall into two classes: local and global, a notation inspired from integrative approaches
that have been pursued at the bulk level [254].
Local analyses refer to associations between specific features across different molecular layers, with the
aim of detecting putative interactions between them. Prominent examples are associations between
genetic variants and gene expression (expression quantitative trait loci, eQTL) or correlations
between the epigenetic status of putative regulatory elements and gene expression of nearby genes.
The restriction to a local search space is often necessary, to ensure the problem is computationally
tractable. For example, cis eQTL mapping is most prevalent because by testing only proximal
genetic variants for each gene, the effects of the multiple testing burden is reduced [218]. Since such
association analyses are typically performed per feature (across cells), local analyses generally require
unambiguous matching between the modalities, and therefore require matched multi-modal assays,
and thus belongs to the category of vertical analysis. Methodologically, most local analyses rely on
different flavours of linear regression models, with different modelling assumptions depending on the
nature of the molecular readouts. This can include non-gaussian likelihoods, sparsity assumptions to
prevent overfitting or probabilistic terms to account for random effects. For example, linear mixed
models (LMMs) are a popular framework for performing genetic analyses [208]. In a LMM, a random
effect term is added to account for the population structure and relatedness between individuals,
which may affect both the phenotype and the genotype, thus leading to spurious associations if not
accounted for.
While useful for characterising genetic variants or identifying putative regulatory elements, local
analyses have limited capacity to discover complex maps of molecular heterogeneity that result
from interactions between genomic features. An alternative strategy for data integration is to
exploit the full spectrum of measurements to identify cellular states defined by the coordinated
action of multiple genomic elements. For example, cell cycle phase or pluripotency potential are
cellular properties that are determined by gene regulatory networks and thus cannot be studied
with local analyses. Global integration is typically (but not always) performed using unsupervised
dimensionality reduction approaches that find common modes of variation between molecular
layers. Alternatives have been proposed that perform transformations on each data type before
merging them into a common similarity network, e.g. using kernel or graph-based approaches [163,
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319]. Popular examples of global integration methods that have been adapted from the statistical
literature are derived as different flavours of matrix factorisation: PCA, Canonical Correlation
Analysis (CCA, implemented in Seurat [46]), Group Factor Analysis (MOFA [15, 14], introduced
in this thesis), Projected Least Squares (PLS, implemented in DIABLO [273]) and Non-negative
Matrix factorisation (NMF, implemented in LIGER [325]), among others. Although all of these
methods share important similarities, the assumptions underlying each model are heavily dependent
on the common coordinate framework adopted. As such, the output of each data integration method
is the result of different assumptions and thus has specific challenges and diagnostics that must be
addressed accordingly.
Horizontal integration
Horizontal integration strategies define features as the common anchors in unmatched experiments
of the same type. This task is faced in most large-scale projects where sequencing data is generated
across multiple batches, as uncontrollable differences in the experimental procedure result in
systematic deviations in the observed RNA expression across the different batches. If left unaccounted
for, these sources of technical variation can mask relevant biological variability and thus complicate
the interpretation of the downstream analysis. Horizontal integration is currently the most common
task, and it is typically regarded as a batch correction problem, where the aim is to remove undesired
technical variation across batches while preserving the biological variation contained within each
batch [309]. With the growing availability of reference atlases, epitomised by the Human Cell Atlas
project [249], this is arguably one of the most important steps in a single-cell analysis pipeline.
Linear batch correction methods that were originally developed for bulk datasets such as limma
[255] and ComBat [134]) are not successful for single-cell experiments, mainly because they assume
identical (or at least, known) cell type composition across batches. In practice, however, the
abundance of cellular subpopulations can vary even between biological replicates due to subtle
differences in the library preparation or in the sampling procedures. As a consequence, the majority
of horizontal integration methods developed for single-cell data rely on non-linear (or locally linear)
strategies that account for differences in cell type compositions.
Several integrative methods have been developed and benchmarked. These include MNN [105], Seurat
v3 [46], LIGER [325], Harmony [154], BBKNN [236], scVI [180], Conos [23], among others, which
have been benchmarked in an independent study [185]. Despite sharing similar principles, these each
employ different methodologies. In particular, MNN and Seurat v3 detect mutual nearest neighbors
in a joint low-dimensional space, defined by either principal components (MNN) or canonical
covariates (Seurat v3). LIGER, on the other hand, performs integrative NMF and disentangles
dataset-specific factors versus shared factors, followed by the construction of a neighborhood graph
using the shared factors. Harmony learns a cell-specific linear correction function by successive
rounds of k-means clustering on a principal component space. BBKNN performs correction on a
neighbourhood graph, which results in much faster computations at the expense of losing single-cell
resolution. Finally, scVI is a Bayesian variational autoencoder with a probabilistic formulation
which includes random variables that account for batch-specific variation.
13
Most of these methods also share a common set of challenges. First, a classical problem of non-
linear integration methods is over-correction, which occurs when the batch correction vector is
wrongly estimated and the algorithm forcibly merges non-matching subpopulations of cells [185].
This can occur for example when there are no common axes of biological variation between the
datasets. Second, most methods perform data integration in a denoised latent space, typically
using principal components or canonical covariates. This step undoubtedly improves most batch
correction algorithms, but the high-dimensional observations (i.e. the gene expression counts) can
be severely distorted as a result of the batch alignment, and other downstream gene-based analyses
such as gene marker detection or differential expression analysis can be problematic [105].
Vertical integration
Vertical integration strategies take advantage of the unambiguous assignment between the molecular
profiles in matched multi-modal experiments and thus define cells as anchors between data modalities.
This facilitates the detection of co-variation patterns across features and permits two data integration
strategies: gene-based local analysis and a cell-based global analysis.
Local analysis
In local analyses, the challenge is to distinguish true interactions between features from spurious
associations that can result from global confounding effects. To correct for global confounding effects
(both technical and biological) affecting the expression phenotype in eQTL mapping, methods such
as Principal Component Analysis and PEER [284] are often used to identify factors that capture
global expression trends, which can be added as covariates in the linear (mixed) model framework.
Similarly, the use of a kinship matrix is used to account for global genotype effects that result from
population substructure and individual relatedness. Mapping eQTL using single-cell genomics has
led to the identification of cell type-specific eQTL in rare cell populations, which would have been
masked using bulk assays [327]. Additionally, [67] combined differentiations of iPSCs across multiple
donors and single cell expression profiles to show how eQTL influence expression dynamically along
a differentiation trajectory. Single cell eQTL mapping is growing as a field, and it promises to
provide an extra layer to our understanding of genetic regulation at the molecular level. As methods
to assay various molecular traits at single cell resolution become more established, non-expression
single cell QTL mapping, where genomic variants are associated with changes in DNA methylation,
histone modifications or protein level at single cell resolution may also become routine.
Global analysis
When having a single data modality, PCA is the paradigmatic method for global analysis, and
will be discussed in more detail in Chapter 3. Briefly, PCA infers an orthogonal projection of
the data onto a low-dimensional space such that the variance explained by the projected data is
maximised. The key for the popularity of PCA is its linearity assumption, which ensures that the
resulting principal components are simple and interpretable. PCA has also been applied as an
integrative method for multi-modal data by extracting principal components from each modality and
subsequently comparing them. This approach was attempted in one of the first multi-modal datasets,
where scM&T-seq was used to simultaneously profile RNA expression and DNA methylation on
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61 embryonic stem cells [12]. The authors found that a small number of PCs derived from mRNA
expression displayed significant correlations with PCs derived from DNA methylation, which suggests
that some global sources of variation are preserved across data modalities, but a large fraction of the
variation is uncorrelated. This simple analysis provides the intuition for some of the more advanced
multi-omic integration methods aimed at performing variance decomposition across data modalities.
An alternative strategy has been to apply PCA after concatenation of the datasets, but this has
important limitations when applied to datasets where the features are structured into non-overlapping
views (referred to as multi-view data in the machine learning literature). First, PCA extracts
components that maximise the variance explained, but it is difficult to quantify the contribution
that each component has from each data modality. Second, in its vanilla implementation, PCA does
not handle missing values and hence imputation is required when cells do not have measurements
available in all data modalities. This is a frequent problem in matched assays, as cells might
pass quality control for one data modality but not the other. Third, by maximising the variance
explained, PCA implicitly assumes a normal distribution for each feature, and is not well suited for
the integration of binary and count-based readouts.
Generalisations of PCA for the integration of multi-omics data have been devised by adapting
multi-view learning methods from the statistics literature. Although most of these methods were
originally devised for bulk data, the majority of them remain applicable to single-cell multi-modal
data. This includes MOFA [15], JIVE [179], PLS [273], MCIA [201] and iNMF [325], all of which
use different flavours of matrix factorisation to perform unsupervised dimensionality reduction.
As I will discuss in this thesis, the matrix factorisation framework is very appealing due to its
simplicity, interpretability, scalability and limited overfitting. This framework has also proven to be
an excellent choice for extracting interpretable signatures from sparse and noisy observations such
as single-cell measurements.
Diagonal integration
The third type of data integration problem occurs when no common coordinate framework exists in
the high-dimensional space. This task is faced in unmatched experiments when different molecular
layers are profiled in different subsets of cells, and is arguably the hardest type of integration.
Diagonal integration methods are generally aimed at reconstructing a low-dimensional manifold
that captures co-variation across data modalities. Thus, a critical assumption of this integrative
strategy is the existence of a latent manifold with similar topology between the data modalities.
For example, this could represent cells sampled from a common differentiation trajectory or cells
sampled from a common set of discrete subpopulations.
The simplest strategy that has been employed to solve a diagonal integration task is to transform
it into a simpler horizontal integration task. This can be achieved by summarising molecular
measurements over genomic elements that can be unambiguously linked (i.e. RNA expression
and promoter methylation). Using this strategy, methods such as LIGER [325] and Seurat [291]
have been successful at integrating unmatched epigenetic and transcriptomic experiments from the
same tissue, and even across different species. However, this strategy relies on fragile biological
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assumptions and is prone to fail in scenarios where molecular layers are not strongly correlated. A
good example is early embryonic development where promoter DNA methylation and/or chromatin
accessibility are not as predictive of RNA expression [14] as in terminally differentiated cell types.
Alternatively, a few methods have attempted to solve this problem by reconstructing technology-
invariant integrated latent spaces. The first method to be developed was MATCHER [324], a
gaussian process latent variable model. However, this method relies upon the strong assumption that
biological variation is defined by a unidimensional axis of variation. Some recent methods, including
MMD-MA [176], SCIM [282] and UnionCom [51] have generalised MATCHER to account for
complex multivariate trajectories. However, no independent benchmarking has yet been performed,
and the biological insights extracted from these methods have been relatively limited.
1.4 Thesis overview
In this PhD thesis I sought to develop computational strategies for data integration for single-cell
multi-omics. In particular my research focused on the vertical integration task, where cells are the
common coordinate framework in matched assays.
In Chapter 2 I introduce single-cell nucleosome, methylation and transcription sequencing (scNMT-
seq), an experimental protocol for the genome-wide profiling of RNA expression, DNA methylation
and chromatin accessibility in single cells. While some approaches have reported unbiased genome-
wide measurements of up to two molecular layers, scNMT-seq allows, for the first time, the
simultaneous profiling of three molecular layers at single cell resolution. We validate the assay using
a simple prototype experiment, and we show how scNMT-seq can be used to study coordinated
epigenetic and transcriptomic heterogeneity along a simple differentiation process.
In Chapter 3 I present Multi-Omics Factor Analysis (MOFA), a statistical framework for the
integration of multi-omics datasets. MOFA is a latent variable model that offers a principled
approach to explore, in a completely unsupervised manner, the underlying sources of sample
heterogeneity in multi-omics data. After validating the model features using simulated data, we
applied MOFA to a cohort of chronic lymphocytic leukaemia patients. In a quick unsupervised
analysis, MOFA revealed the most important dimensions of disease heterogeneity, connected to
clinical markers that are commonly used in practice. In a second application we show how MOFA can
cope with noisy single-cell multi-modal data, identifying coordinated transcriptional and epigenetic
changes along a differentiation process.
In Chapter 4 I discuss how we combined scNMT-seq and MOFA to study the role of epigenetic layers
during mouse gastrulation, a critical embryonic stage that spans exit from pluripotency to primary
germ layer specification. In this study we built the first triple-omics roadmap of mouse gastrulation,
which enabled us to perform an integrative study that revealed novel insights on the dynamics of the
epigenome. Notably, we show that cells committed to mesoderm and endoderm undergo widespread
epigenetic rearrangements, driven by demethylation in enhancer marks and by concerted changes
in chromatin accessibility. In contrast, the epigenetic landscape of ectodermal cells remains in a
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default state, resembling earlier stage epiblast cells. This work provides a comprehensive insight
into the molecular logic for a hierarchical emergence of the primary germ layers.
In Chapter 5 I propose an improved formulation of the MOFA framework (MOFA+) aimed at
performing integrative analysis of large-scale (single-cell) datasets with complex experimental designs.
We introduce key methodological developments, including a fast stochastic variational inference
framework and multi-group generalisation in the structure of the prior distributions. All together,
this allows MOFA+ to disentangle heterogeneity across sample groups (i.e. studies or experimental
conditions) and data modalities (i.e. omics) in very large datasets. After benchmarking the new
features using simulated data, we applied it to single-cell datasets of different scales and designs.




Joint profiling of chromatin accessibility
DNA methylation and transcription in sin-
gle cells
In this Chapter I describe scNMT-seq, an experimental protocol for genome-wide profiling of RNA
expression, DNA methylation and chromatin accessibility in single cells. First, I show a validation
of the quality of the molecular readouts, including a comparison with existing technologies. Subse-
quently, I showcase how scNMT-seq can be used to reveal coordinated epigenetic and transcriptomic
heterogeneity along a differentiation process.
The work discussed in this Chapter results from a collaboration with the group of Wolf Reik
(Babraham Institute, Cambridge, UK). It has been peer-reviewed and published in [59]. The
methodology was conceived by Stephen Clark, who performed most of the experiments. Felix
Krueger processed and managed sequencing data. I performed all the computational analysis shown
in this chapter. John C. Marioni, Oliver Stegle and Wolf Reik supervised the project. The article
was jointly written by Stephen Clark and me, with input from all authors.
2.1 Description of the experimental protocol
scNMT-seq builds upon two previous multi-modal protocols: single-cell Methylation and Tran-
scriptome sequencing (scM&T-seq) [12] and Nucleosome Occupancy and Methylation sequencing
(NOMe-seq) [139, 237]. An overview of the protocol is shown in Figure 2.1.
In the first step (the NOMe-seq step), cells are sorted into individual wells and incubated with a
GpC methyltransferase (M.CviPI). This enzyme labels accessible (or nucleosome depleted) GpC sites
via DNA methylation[144, 139]. In mammalian genomes, cytosine residues in GpC dinucleotides
are methylated at a very low rate. Hence, after M.CviPI treatment, GpC methylation marks can
be interpreted as direct read outs for chromatin accessibility, as opposed to the CpG methylation
readouts, which can be interpreted as endogenous DNA methylation[144, 139].
In a second step (the scM&T-seq step), the DNA molecules are separated from the mRNA using
oligo-dT probes pre-annealed to magnetic beads. Subsequently, the DNA fraction undergoes single-
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Figure 2.1: scNMT-seq protocol overview.
In the first step, cells are isolated and lysed. Second, cells are incubated with a GpC methyl-
transferase. Third, the RNA fraction is separated using oligo-dT probes and sequenced using
Smart-seq2. The DNA fraction undergoes scBS-seq library preparation and sequencing. Finally,
CpG Methylation and GpC chromatin accessibility data are separated computationally.
As discussed in Section 1.1.2, NOMe-seq has a range of appealing properties in comparison with
count-based methods such as ATAC-seq or DNAseq-seq. First, the obvious gain of simultaneously
measuring another epigenetic readout such as DNA methylation with little additional cost. Second,
the resolution of the method is determined by the frequency of GpC sites within the genome (≈ 1 in
16 bp), rather than the size of a library fragment (usually >100 bp). This allows the robust inspection
of individual regulatory elements, nucleosome positioning and transcription factor footprints [139,
237, 219]. Third, missing data can be easily discriminated from inaccessible chromatin. Importantly,
this implies that lowly accessible sites will not suffer from increased technical variation (due to low
read counts) compared to highly accessible sites. Finally, the M.CviPI enzyme shows less sequence
motif biases than the DNAse or the Tn5 transposase [219].
The downsides of the approach are the limited scalability associated with plate-based methods, and
the need to discard read outs from (1) GCG positions (21% of all CpG sites), as it is intrinsically
not possible to distinguish endogenous methylation from in vitro methylated bases, and (2) CGC
positions (27%), to mitigate off-target effects of the enzyme [139]. This filtering step reduces the
number of genome-wide cytosines that can be assayed from 22 million to 11 million.
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2.2 Description of the data processing pipeline
After DNA sequencing, reads undergo quality control and trimming using TrimGalore to remove the
flanking 6bp (the random primers), adaptor contamination and poor-quality base calls. Subsequently,
trimmed reads are aligned to the corresponding genome assembly. Here we used Bismark [156] with
the additional –NOMe option, which produces CpG report files containing only ACG and TCG
trinucleotides and GpC report files containing only GCA, GCC and GCT positions.
Following [274], a bernoulli model is assumed for each CpG and GpC site in each cell after removal
of duplicate alignments, which results in binary methylation calls. Notice that the use of a bernoulli
model is an exclusive property of single-cell bisulfite sequencing data, for the vast majority of
sites only one allele is observed per cell (due to data sparsity). This contrasts with bulk bisulfite
sequencing data, where each dinucleotide typically contains multiple reads (originating from different
cells) and thus a binomial model is more appropriate than a bernoulli estimate.
Finally, when quantifying DNA methylation and chromatin accessibility over genomic features (i.e.
promoters or enhancers) a binomial model is assumed for each cell and feature, where the number
of successes is the number of methylated CpGs (or GpCs) and the number of trials is the total
number of CpGs (or GpCs) that are observed within the specific cell and genomic feature.
2.3 Data validation
2.3.1 Coverage
We validated scNMT-seq in 70 EL16 mouse embryonic stem cells (ESCs), together with 3 cells
processed without M.CviPI enzyme treatment (i.e. using scM&T-seq). The use of this relatively
simple and well-studied in vitro system allows us to compare our DNA methylation and chromatin
accessibility statistics to published data [274, 12, 91].
First, we compared the theoretical maximum coverage that could be achieved with the empirical
coverage (Figure 2.2). Despite the reduction in theoretical coverage due to the removal of ambiguous
CCG and GCG sites, we observed, for DNA methylation, a median of ≈ 50% of promoters, ≈ 75%
of gene bodies and ≈ 25% of active enhancers captured by at least 5 CpGs in each cell. Nevertheless,
limited coverage is indeed observed for small genomic contexts such as p300 ChIP-seq peaks (median
of ≈ 200bp).
For chromatin accessibility, coverage was larger than that observed for endogenous methylation due
to the higher frequency of GpC dinucleotides, with a median of ≈ 85% of gene bodies and ≈ 75% of







Theoretical percentage of loci 





Observed percentage of loci 






0 25 50 75 100 0 25 50 75 100
Gene bodies
Figure 2.2: Coverage statistics for CpG DNA methylation and GpC chromatin acces-
sibility.
(a) Fraction of loci with at least 5 CpG (red) or GpC (blue) dinucleotides per genomic context,
after exclusion of the conflicting trinucleotides. The grey bar shows the total number of CpGs
without exclusion of trinucleotides. (b) Empirical coverage per genomic context in a data set of 61
mouse ES cells. The empirical coverage is quantified as the fraction of loci with at least 5 CpG
(red) or GpC (blue) observed. The boxplots summarise the distribution across cells, showing the
median and the 1st and 3rd quartiles.
Next, we compared the DNA methylation coverage with a similar data set profiled by scM&T-seq
[12] (Figure 2.3), where the the conflicting trinucleotides are not excluded.
Despite scNMT-seq yielding less CpG measurements, we find little differences in coverage when
quantifying DNA methylation over genomic contexts, albeit these become evident when down-
sampling the number of reads.
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Figure 2.3: Comparison of the empirical coverage of DNA methylation with scM&T-
seq [12].
The y-axis displays the fraction of loci covered with at least 5 CpG sites. The x-axis displays the
downsampling factor, where the value of 1 corresponds to no downsampling (i.e. the base line). To
facilitate the comparison, we selected two cells that were sequenced at equivalent depth.
2.3.2 Consistency with previous studies
To assess the consistency with previous studies we quantified DNA methylation and chromatin acces-
sibility using a running window throughout the genome. The resulting methylomes were compared
to datasets from the same cell lines profiled with similar technologies, including scM&T-seq[12],
scBS-seq[274] and bulk BS-seq[91]. We find that most of the variation is not attributed to the
technology but to differences in culture condition (Figure 2.4). This result is expected, as cells
grown in 2i media remain in a native pluripotency state that is associated with genome-wide DNA
hypomethylation [91]. Interestingly, the serum-cultured cells processed in this study overlapped
with 2i-cultured cells from previous datasets. suggesting that they remained in a more pluripotent
state. The most likely explanation for this variation is the differences in the cell lines (we used
female EL16 versus male E14 in [12, 274, 91]). Previous studies have shown that female ESCs
tend to show lower levels of mean global methylation, which is consistent with a more pluripotent
phenotype [345].
In terms of accessibility, no NOMe-seq measurements were available for ESCs at the time of the
study, so we compared it to bulk DNase-seq data from the same cell type, yielding good consistency
between datasets (R = 0.74).
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DNA methylation Chromatin accessibility
Figure 2.4: Comparison of unsupervised genome-wide quantifications to published
datasets.
(a) Principal Component Analysis of 1kb running windows. Missing values were imputed using the
average methylation rate per locus.
(b) Scatter plot of chromatin accessibility quantified over 10kb running windows of scNMT-seq data
versus published bulk DNase-seq. For DNase-seq, accessibility is quantified as the log2 reads. The
Pearson correlation was weighted by the GpC coverage in scNMT-seq data.
2.3.3 Quantification of DNA methylation and chromatin accessibil-
ity in known regulatory regions
We pseudobulked the data across all cells and examined DNA methylation and chromatin accessibility
levels at loci with known regulatory roles. We found that in CTCF binding sites and DNaseI
hypersensitivity sites DNA methylation was decreased while chromatin accessibility was increased,
as previously reported [237]. As a control, we observe that cells which did not receive M.CviPI
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Figure 2.5: Accessibility and methylation profiles in regulatory genomic contexts.
First, we pseudobulk the data set by pooling information across all cells. Next, we compute
running averages of the CpG methylation (red) and the GpC accessibility (blue) in consecutive
non-overlapping 50bp windows. Solid line displays the mean across all genomic elements within a
given annotation and the shading displays the corresponding standard deviation.
(a) Profiles for scNMT-seq cells. (b) Profiles for scMT-seq cells
2.3.4 Quantification of the association between molecular layers.
We attempted to reconstruct the expected directional relationships between the transcriptome and
the epigenome, namely the positive association between RNA expression and chromatin accessibility
and the negative association between DNA methylation and RNA expression [302, 12].
To get a measure of the association (or coupling) between two molecular layers, we quantified a
linear association per cell (across genes). Notice that this approach is not exclusive to single-cell
data and can also be computed (more accurately) with bulk measurements. Reassuringly, this
analysis confirmed, even within single cells, the expected positive correlation between chromatin
accessibility and RNA expression, and the negative correlations between RNA expression and DNA
methylation, and between DNA methylation and chromatin accessibility.
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Figure 2.6: Quantification of linear associations between molecular layers.
The top diagram illustrates the computation of an association test per cell (across all loci in a given
genomic context). The left panel shows DNA methylation versus RNA expression. The middle panel
shows DNA methylation versus chromatin accessibility. The right panel shows RNA expression
versus chromatin accessibility. The x-axis displays the Pearson correlation coefficients between
two molecular layers, per genomic context (y-axis). The box plots summarise the distribution
of correlation coefficients across cells. The dots and stars show the linear associations quantified
in pseudo-bulked scNMT-seq data and published bulk data from the same cell types [91, 62],
respectively.
2.4 Application to an embryoid body differentiation data
set
2.4.1 Identification of genomic elements with coordinated variabil-
ity across molecular layers
Having validated the quality of scNMT-seq data with a simple and relatively homogeneous data set,
we next explored its potential to identify coordinated heterogeneity between the transcriptome and
the epigenome.
We generated a second data set of 43 embryonic stem cells (after quality control), where we induced
a differentiation process towards embryoid bodies by removing the LIF media for 3 days.
Dimensionality reduction on the RNA expression data reveals the existence of two subpopulations:
one with high expression of pluripotency markers (Esrrb and Rex1 ) and the other with high



























Figure 2.7: t-SNE representation of the RNA expression profiles for the embryoid
body cells.
The scatter plots show a t-SNE [188] representation of the EB data. Cells are coloured based on
expression of pluripotency factors (top) and differentiation markers (bottom).
Next, we tested for locus-specific associations between pairwise combinations of molecular layers
(correlation across cells, Figure 2.8).
First, considering correlations between DNA methylation and RNA expression, we identified a
majority of negative associations, reflecting the known relationship between these two layers.
In contrast, we obtained largely positive associations between chromatin accessibility and RNA
expression, mainly in promoters, p300 binding sites and super enhancer regions. Finally, we found
mostly negative associations between DNA methylation and chromatin accessibility. This confirms
the expected direction of association between molecular layers, as reported in bulk studies.
As an illustrative example, we display the Esrrb locus, a gene involved in early development and
pluripotency [225]. A previous study [12], identified a super enhancer near the gene that showed a
high degree of correlation between DNA methylation and RNA expression changes. In our study,
we find Esrrb to be expressed primarily in the pluripotent cells, consistent with its role in early
development. When examining the epigenetic dynamics of the corresponding super enhancers,
we observe a strong negative correlation between DNA methylation and RNA expression, thus
replicating previous findings. Additionally, we observe a strong negative relationship between DNA
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Figure 2.8: scNMT-seq enables the discovery of novel associations between transcrip-
tomics and epigenetics at individual loci.
(a) Illustration for the correlation analysis, which results in one association test per locus (across
cells).
(b) Pearson correlation coefficient (x-axis) and log10 p-value (y-axis) from association tests between
different molecular layers, stratified by genomic contexts. Significant associations (FDR<0.1), are
highlighted in red.
(c) Zoom-in view of the Esrrb gene locus. Shown from top to bottom are: Pearson correlation
between each pair of molecular layers. Accessibility (blue) and methylation (red) profiles shown
separately for pluripotent and differentiated sub-populations; mean rates (solid line) and standard
deviation (shade) were calculated using a running window of 10kb with a step size of 1kb. Track
with genomic annotations highlighting the position of regulatory elements.
2.4.2 Exploration of epigenome and transcriptome connections
The use of single-cell technologies has permitted the unbiased study of continuous trajectories by
computationally reconstructing the pseudotemporal dynamics from the molecular profiles [310, 106,
263]. A novel opportunity unveiled by the introduction of single-cell multi-modal technologies is the
study of epigenetic dynamics along trajectories inferred from the transcriptome. To explore this idea,
we applied a diffusion-based pseudotime method [106] to the EB data set, using the RNA expression
of the 500 genes with highest biological overdispersion [186]. The first diffusion component was used











Figure 2.9: Reconstruction of developmental trajectory in embryoid body cells from
the RNA expression data.
Each dot corresponds to one cell. The y-axis displays expression of Esrrb, a canonical pluripotency
marker, and the x-axis shows the position of the cells in the first diffusion component.
Using the pseudotime reconstruction we investigated whether the strength of association between
molecular layers (as calculated in Figure 2.6) are affected along the developmental trajectory. To do
this, we correlated the correlation coefficient across genes between each pair of molecular layers (one
value per cell) versus the pseudotime position (Figure 2.10). Importantly, this analysis is possible by
the continuous nature of single-cell data and by the ability of scNMT-seq to profile three molecular
layers at the same time.
We observe that for DNA methylation and chromatin accessibility, the negative correlation coefficients
decreases in important regulatory genomic contexts (Figure 2.10), such that pluripotent cells have a
notably weaker methylation-chromatin coupling than differentiated cells. This suggests that the
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Figure 2.10: Developmental trajectory is associated changes in methylation-
accessibility coupling.
Shown is the location of each cell in pseudotime (x-axis) and the corresponding Pearson correlation
coefficients between methylation and accessibility (y-axis) in three different genomic contexts with
regulatory roles.
2.5 Conclusions and open perspectives
In this Chapter I have introduced single-cell nucleosome, methylation and transcriptome sequencing
(scNMT-seq), an experimental protocol for the genome-wide profiling of RNA expression, DNA
methylation and chromatin accessibility in single cells. This novel assay is an important step forward
in the field of single-cell multi-modal sequencing. Yet, as with other protocols, the technology is still
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in a very early stage and numerous developments are expected to occur in the next years. Some
lines of research that I believe are important to improve scNMT-seq are the following:
• Scalability: scRNA-seq protocols are reaching the astonishing numbers of millions of cells
per experiment. This contrasts with the limited cell numbers achieved in current multi-modal
assays, including scNMT-seq [49, 50, 101]. As in scRNA-seq, the maturation of multi-modal
techniques will display a trade-off between sensitivity and scalability [55]. scNMT-seq already
provides high-resolution measurements, thus effort should be placed on making the protocol
more scalable, which can be achieved by a series of technical improvements. First, barcodes are
currently added at the end of the protocol, which limits cell numbers to the size of the plate.
As in droplet-based methods or combinatorial indexing methods, adding the barcodes at the
start of the protocol would enable the simultaneous processing of multiple pools of samples
[74, 212]. Second, the physical separation of mRNA from genomic DNA is performed at the
beginning of the protocol, one cell at a time. Given that it is a time-consuming and expensive
process, this step should be performed after pooling [74]. Finally, albeit sequencing costs are
decreasing [294], the sequencing of scNMT-seq libraries remains expensive due to genome-wide
coverage. Hence, I anticipate that efforts to decrease the library size by a pre-selection of
the genetic material will be indispensable. Examples of such strategies are the digestion
by restriction enzymes as in RRBS [102], an initial round of ATAC protocol to select open
chromatin [281] or the pull-down of specific genomic regions using capture probes.
• Imputation of missing epigenetic data: because of the low amounts of starting material,
single-cell methylation protocols are limited by incomplete CpG coverage [11]. This becomes
even more pronounced in scNMT-seq where almost ≈ 50% of CpG dinucleotides are removed
to avoid technical biases (see Section 2.3.1). Nonetheless, as discussed in Section 2.1, an
important advantage of bisulfite approaches is that missing data can be discriminated from
inaccessible chromatin (unlike in scATAC-seq). Therefore, the imputation of DNA methylation
data will likely be a critical step to enable genome-wide analysis. Most of the imputation
methods developed for bulk data are unsuccesful because they do not account for cell-to-cell
variability [11]. A successful single-cell strategy based on deep learning has been proposed
(DeepCpG [11]), but is a complex model that is difficult to train and does not scale to
large datasets. Faster and accurate Bayesian approaches have also been considered (Melissa
[136]), albeit the model is restricted to a small feature set and cannot perform genome-wide
imputation.
• Adding more molecular layers: scNMT-seq can be adapted both experimentally and
computationally to profile additional molecular layers. From the computational side, one
could exploit the sequence information in the libraries to infer copy number variation or
single nucleotide variants [235, 89, 197, 84]. This approach has been successful at delineating
the clonal substructure of somatic tissues and at tracking mutational signatures in cancer
tissues. In addition, the full length transcript information enables the quantification of splice
variants[124], allele-specific fractions [73] and RNA velocity information [160]. From the
experimental side, scNMT-seq could be combined with novel single-cell assays that quantify
protein expression [288], transcription factor binding [211] and histone modifications [137].
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• Long reads: the scNMT-seq libraries that were generated for this study contained short reads
(75bp) that do not provide sufficient information about the regional context of the individual
DNA molecule. By sequencing NOMe-seq libraries with long-read nanopore sequencing
technology [167] showed that one can obtain phased methylation and chromatin accessibility
measurements and structural changes from a single assay. This approach could potentially
unveil a more comprehensive understanding of the epigenome dynamics and its regulatory
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The work described in this Chapter results from a collaboration with Wolfgang Huber’s group at
the EMBL (Heidelberg, Germany). It has been peer-reviewed and published in [15]. The method
was conceived by Florian Buettner, Oliver Stegle and me. I performed most of the mathematical
derivations and implementation, but with significant contributions from Damien Arnol and Britta
Velten. The CLL data application was led by Britta Velten whereas the single-cell application was
led by me, but with joint contributions in either cases. Florian Buettner, Wolfgang Huber and
Oliver Stegle supervised the project.
The article was jointly written by Britta Velten and me, with contributions from all authors.
3.1 Theoretical foundations
Mathematical notation
– Matrices are denoted with bold capital letters: W
– Vectors are denoted with bold non-capital letters: w. If the vector comes from a matrix, we
will use a single index to indicate the row that it comes from. If two indices are used, the first
one corresponds to the row and the second one to the column. The symbol ’:’ denotes the
entire row/column. For instance, wi refers to the ith row from the W matrix, whereas w:,j
refers to the jth column.
– Scalars are denoted with non-bold and non-capital letters: w. If the scalar comes from a
1-dimensional array (a vector), a single subscript will indicate its position in the vector. If the
scalar comes from a 2-dimensional array, two indices will be shown at the bottom: the first
one corresponding to the row and the second one to the column. For instance, wi,j refers to
the value from the ith row and the jth column of the matrix W, and wi to the ith value of
the vector w.
– 0k is a zero vector of length k.
– Ik is the identity matrix with rank k.
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– Eq[x] denotes the expectation of x under the distribution q. When the expectations are taken
with respect to the same distribution many times, we will avoid cluttered notation and we





: x follows a univariate normal distribution with mean µ and variance σ2.
– G (x | a, b): x follows a gamma distribution with shape and rate parameters a and b.
– Beta (x | a, b): x follows a beta distribution with shape and rate parameters a and b.
– Ber(x|θ): x follows a Bernoulli distribution with parameter θ.
– 10: Dirac delta function centered at 0.
– Tr(X): Trace of the matrix X
Graphical notation for probabilistic models
Probabilistic models can be represented in a diagrammatic format (i.e. a graph or a network) that
offers a compact visual representation of complicated systems of probability distributions [31]. In a
graphical model the relationship between the nodes becomes more explicit, namely their conditional
independence properties which allow the joint distribution over all variables to be factorised into
a series of simpler products involving subsets of variables [31]. The basic unit of a network is the
node, which represents the different types of variables, including observed variables, unobserved
probabilistic variables and unobserved parameters. The nodes are connected by unidirectional edges
(arrows) which capture the conditional independence relationship between the variables.
For this thesis we adapted the graphical notations from [76]:
Observed variables Y
Unobserved probabilistic variables θ
Unobserved parameters θ
Repetition of node θn for n ∈ J1;NK
θn
N
Conditional dependency between nodes:
p(Y, θ) = p(Y |θ)p(θ)
θ Y
3.1.1 Probabilistic modelling
A scientific model is a simple theoretical representation of a complex natural phenomenon to allow
the systematic study of its behaviour. The general idea is that if a model is able to explain some
observations, it might be capturing its true underlying laws and can therefore be used to make
future predictions. In particular, statistical models are a powerful abstraction of nature. They
consist of a set of observed variables and a set of (hidden) parameters. The procedure of fitting the
parameters using a set of observations is called inference or learning.
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One of the major challenges of inference when dealing with real datasets is the distinction between
signal and noise. An ideal model should learn only the information relevant to gain explanatory
power while disregarding the noise. However, this is a non-trivial task in most practical situations.
Very complex models will tend to overfit the training data, capturing large amounts of noise and
consequently leading to a bad generalisation performance to independent datasets. On the other
hand, simplistic models will fit the data poorly, resulting in low explanatory power.
The ideas above can be formalised using the framework of probability and statistics.
3.1.2 Maximum likelihood inference
A common approach is to define a statistical model of the data Y with a set of parameters θ that
define a probability distribution p(Y|θ), called the likelihood function. A simple approach to fit a




This process is called maximum likelihood learning [287, 31, 214]. However, in this setting there is
no penalisation for model complexity, making maximum likelihood solutions can overfit when the
data is relatively sparse. Generalisations that account for model complexity have been proposed
that include regularising terms that shrink parameters to small values. However, these are often
particular cases of the more general framework of Bayesian statistics [111, 31, 214].
3.1.3 Bayesian inference
In the Bayesian framework, the parameters themselves are treated as random unobserved variables
and we aim to obtain probability distributions for θ, rather than a single point estimate. To do so,
prior beliefs are introduced into the model by specifying a prior probability distribution p(θ). Then,
using Bayes’ theorem [25], the prior hypothesis is updated based on the observed data Y by means
of the likelihood p(Y|θ) function, which yields a posterior distribution over the parameters:
p(θ|Y) = p(Y|θ)p(θ)
p(Y)
where p(Y) is a constant term called the marginal likelihood, or model evidence [31, 214].
The choice of the prior distribution is a key part of Bayesian inference and captures beliefs about the
distribution of a variable before the data is taken into account. With asymptotically large sample
sizes, the choice of prior has negligible effects on the posterior estimates, but it becomes critical
with sparse data [31, 214, 97].
There are two common considerations when defining the prior distributions. The first relates to the
incorporation of subjective information, or predefined assumptions, into the model. For example,
one could adapt the prior distribution to match the results from previous experiments (i.e. an
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informative prior). Alternatively, if no prior information is available one could set set uninformative
priors by following maximum entropy principles [129].
The second strategy is based on convenient mathematical properties to make inference tractable. If
the likelihood and the prior distributions do not belong to the same family of probability distributions
(they are not conjugate) then inference becomes more problematic [242, 31, 214, 97]. The existence
of conjugate priors is one of the major reasons that justify the widespread use of exponential family
distributions in Bayesian models [97].
Again, the essential point of Bayesian inference is that an entire posterior probability distribution is
obtained for each unobserved variable. This has the clear advantage of naturally handling uncertainity
in the estimation of parameters. For instance, when making predictions, a fully Bayesian approach
attempts to integrate over all possible values of all unobserved varaibles, effectively propagating
uncertainity across multiple layers of the model. Nevertheless, this calculation is sometimes
intractable and one has to resort to point estimates [31, 214, 97]. The simplest approximation to the




This is similar to the maximum likelihood objective function, but with the addition of a term p(θ).
When the prior distribution is well chosen, this term penalises for model complexity. Therefore, in
contrast to standard (non-penalised) maximum likelihood inference, Bayesian approaches naturally
handle the problem of model complexity and overfitting [31, 214, 97]. At the limit of infinite
observations, the influence of the prior to the posterior is negligible and the MAP estimate converges
towards the Maximum likelihood estimate, hence providing a rational link between the two inference
frameworks.
Deterministic approaches for Bayesian inference
The central task in Bayesian inference is the direct evaluation of the posterior distributions and/or
the computation of expectations with respect to the posterior distributions. In sufficiently complex
models, closed-form solutions are not available and one has to resort to approximation schemes,
which broadly fall into two classes: stochastic or deterministic [97, 33].
Stochastic approaches hinge on the generation of samples from the posterior distribution via a
Markov Chain Monte Carlo (MCMC) framework. Such techniques have the appealing property of
generating exact results at the asymptotic limit of infinite computational resources. However, in
practice, sampling approaches are computationally demanding and suffer from limited scalability to
large datasets [33].
In contrast, deterministic approaches are based on analytical approximations to the posterior
distribution, which often lead to biased results. Yet, given the appropriate settings, these approaches
are potentially much faster and scalable to large applications [31, 214, 33].
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3.1.4 Variational inference
Variational inference is a deterministic family of methods that have been receiving widespread
attention due to a positive balance between accuracy, speed, and ease of use [33, 336]. The core
framework is derived below.
In variational inference the true (but intractable) posterior distribution p(X|Y) is approximated by
a simpler (variational) distribution q(X|Θ) where Θ are the corresponding parameters. The param-
eters, which we will omit from the notation, need to be tuned to obtain the closest approximation
to the true posterior.








Note that the KL divergence is not a proper distance metric, as it is not symmetric. In fact,
using the reverse KL divergence KL(q(X)||p(Y|X)) defines a different inference framework called
expectation propagation [204].
If we allow any possible choice of q(X), then the minimum of this function occurs when q(X) equals
the true posterior distribution p(X|Y). Nevertheless, since the true posterior is intractable to
compute, this does not lead to any simplification of the problem. Instead, it is necessary to consider
a restricted family of distributions q(X) that are tractable to compute and subsequently seek the
member of this family for which the KL divergence is minimised.
Doing some calculus it can be shown (see [31, 214]) that the KL divergence KL(q(X)||p(X|Y)) is
the difference between the log of the marginal probability of the observations log(Y) and a term
L(X) that is typically called the Evidence Lower Bound (ELBO):
KL(q(X)||p(X|Y)) = log p(Y)− L(X)











= Eq[log p(X,Y)]− Eq[log q(X)]
(3.1)
The first term is the expectation of the log joint probability distribution with respect to the
variational distribution. The second term is the entropy of the variational distribution. Importantly,
given a simple parametric form of q(X), each of the terms in Equation (3.1) can be computed in
closed form. In some occasions, we will use the following form for the ELBO:
L(X) = Eq[log p(Y|X)] + (Eq[log p(X)]− Eq[log q(X)]) (3.2)
where the first term is the expectation of the log likelihood and the second term is the difference in
the expectations of the p and q distributions of each hidden variable.
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In conclusion, variational learning involves minimising the KL divergence between q(X) and p(X|Y)
by instead maximising L(X) with respect to the distribution q(X).
Figure 3.1: The quantity L(X) provides a lower bound on the true log marginal likelihood
log p(Y), with the difference being given by the Kullback-Leibler divergence KL(q||p) between the
variational distribution q(X) and the true posterior p(X|Y)
There are several approaches to define q(X), the two most commonly used are called (unparametric)
mean-field and (parametric) fixed-form [336, 33].
Mean-field variational inference
The most common type of variational Bayes, known as the mean-field approach, assumes that the





where typically all unobserved variables are assumed to be independent. Importantly, notice that
no parametric assumptions were placed regarding the nature of q(xi).
Evidently, in sufficiently complex models where the unobserved variables have dependencies this
family of distributions do not contain the true posterior (Figure 3.2). Yet, this is a key assumption
















Figure 3.2: Illustrative example of sampling from a true posterior distribution (blue) versus a
fitted mean-field varaitional distribution (red) in a model with two (correlated) unobserved variables.
The mean-field approximation wrongly assumes that the unobserved variables are independent.
Using calculus of variations (derivations can be found in [31, 214]), it follows that the optimal
distribution q(X) that maximises the lower bound L(X) is
log q̂i(xi) = E−i[log p(Y,X)] + const (3.4)
where E−i denotes an expectation with respect to the q distributions over all variables xj except for
xi.




While the form of q̂(xi) is not restricted to a specific parametric form, it can be shown that when
using conjugate priors, the distributions q̂i(xi) have the same functional form as the priors p̂(xi).
Fixed-form variational inference
An alternative straightforward strategy is to directly define a parametric form for the distribution
q(X) with some parameters Θ. Once the choice of q(X) is made, the parameters Θ are optimised




= E[log(q(X))− log(p(X,Y))] (3.6)
Numerically optimising this function requires the evaluation of expectations with respect to q(X).
In closed form, this is only feasable for a limited group of variational distributions. Alternatively,
one can attempt Monte Carlo approximations, but in practice this turns to be slow and leads to
high-variance estimates [36, 245, 36].
39
Typically, one would choose this distribution to factorise over parameters and to be of the same
(exponential) family as the prior p(X). In such case there is a closed form coordinate-ascent scheme
available, and it turns out that the fixed-form formulation is equivalent to the (non-parametric)
mean-field derivation when using conjugate priors.
Unfortunately, for generic models with arbitrary families of distributions, no closed-form variational
distributions exist [336, 33].
However, while the parametric assumption certainly limits the flexibility of variational distributions,
the advantage of this formulation is that it opens the possibility to use fast gradient-based methods
for the inference procedure [119, 245].
3.1.5 Expectation Propagation
Expectation Propagation (EP) is another deterministic strategy with a similar philosophy as the
Variational approach. It is also based on minimising the KL divergence between a variational
distribution q(X) and the true posterior p(X|Y), but while variational inference minimises KL(p||q),
EP maximises the reverse KL-divergence KL(q||p).
Interestingly, this simple difference leads to an inference scheme with strikingly different properties.














In regions of X where the true posterior density p(X|Y) is small, setting a large density for q(X)
has a much stronger penalisation in Equation (3.8) than in Equation (3.7). Hence, EP tends
to avoid areas where the density p(X|Y) is very low, even if it does not correspond to areas of
very high-density in p(X|Y). In contrast, in Equation (3.7) there is a strong penalty for having
low-density q(X) values.
As discussed in [31], the practical consequences of this duality can be observed when the posterior is
multi-modal. In VI, q(X) converges towards areas of high-density in p(X|Y), namely local optima.
In contrast, EP tends to capture as much non-zero density regions from p(X|Y) as possible, thereby
averaging across all optima. In the context of doing predictions, the VI solution is much more
desirable than the EP solution, as the average of two good parameter values is not necessarily a
good value itself.
A detailed mathematical treatment of EP, including derivations for specific examples, can be found





























Figure 3.3: Illustrative comparison of Variational inference and Expectation Propagation. Shown
is the (a) Density and (b) Variance of the true posterior distribution p(X|Y) (grey), the variational
distribution (orange) and the expectation propagation distribution (green).
3.1.6 Conclusions
In this section we have introduced Bayesian modelling and variational inference methods, which
will be used later in this chapter.
More generally, variational inference is growing in popularity for the analysis of big datasets and it
has been applied to a myriad of different problems, including genome-wide association studies [52],
population genetics, [243], network analysis [264] and natural language processing [34].
Yet, despite its increasing success, there is significant room for improvement. First and foremost,
the theoretical guarantees of variational inference are not as developed as in sampling-based
MCMC schemes [33, 336, 216]. As an example, the mean-field setting makes strong independence
assumptions about the parameters. Although it tends to be surprisingly effective, it is not clear
in which applications the dependencies between the parameters are important enough that the
mean-field approximation could potentially break.
More generally, an open research problem is understanding what are the statistical properties of the
variational posterior with respect to the exact posterior [33, 336].
As we shall demonstrate later, alternative strategies have been considered to allow some dependencies
between the variables, resulting in structured mean-field approximations [118, 304]. However, they
often lead to very complex (if not intractable) inference frameworks.
Finally, another area of extensive research is how to extend the applicability of VI to non-conjugate
models. As discussed in Section 3.1.3, the ELBO of non-conjugate models contains intractable
integrals, and setting up an inference scheme requires the use of either stochastic Monte Carlo
approximations or deterministic approximations that introduce additional lower bounds [336, 271,
82]. In this thesis we follow this rationale to derive an inference framework for a model with
non-Gaussian likelihoods.
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3.1.7 Latent variable models for genomics
With the exponential growth in the use of high-throughput genomics, biological datasets are
increasingly high dimensional, both in terms of samples and features. A key principle of biological
datasets is that variation between the features results from differences in underlying, often unobserved,
processes. Such processes, whether driven by biological or technical effects, are manifested by
coordinated changes in multiple features. This key assumption sets off an entire statistical framework
of exploiting the redundancy encoded in the data set to learn the (latent) sources of variation in an
unsupervised fashion. This is the aim of dimensionality reduction techniques, or latent variable
models [153, 285, 168, 238, 164, 286, 202].
Mathematical formulation
Given a dataset Y of N samples and D features, latent variable models attempt to exploit the
dependencies between the features by reducing the dimensionality of the data to a potentially small
set of K latent variables, also called factors. The mapping between the low-dimensional space and
the high-dimensional space is performed via a function f(X|Θ) that depends on some parameters
Θ.
The choice of f(X|Θ) is essentially the field of dimensionality reduction. A trade-off exists between
complexity and interpretation: while non-linear functions such as deep neural networks provide
more explanatory power, this leads to considerable challenges in interpretation [339]. Hence, for
most applications where interpretability is essential, f(X|Θ) is assumed to be linear:
Y = ZWT (3.9)
where Z ∈ RN×K is a matrix that contains the low-dimensional representation for each sample
(i.e. the factors). The matrix W ∈ RD×K contains the weights, which provide the linear mapping
between the features and the factors.
Note that the aim of dimensionality reduction is to exploit the coordinated heterogeneity between
features, and hence features can be assumed to be centered without loss of generality.
The inference procedure consists in learning the values of all unobserved variables, including factors
and weights. As we shall demonstrate, different inference schemes and assumptions on the prior
distributions lead to significantly different model outputs [248].
3.1.8 Principal Component Analysis
Principal Component Analysis (PCA) is the most popular technique for dimensionality reduction
[120, 252].Two formulations of PCA exist [31]: in the maximum variance formulation, the aim
is to infer an orthogonal projection of the data onto a low-dimensional space such that variance
explained by the projected data is maximised. Formally, the aim in PCA is to infer the matrix W
such that the variance of Z (the projected data) is maximised. If we consider a single latent factor,
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The k-th principal component can be found by subtracting from Y the reconstructed data by the
previous k − 1 principal components. If we define zk = wTk Y to be the k-th principal component:






Re-applying Equation (3.10) defines the new optimisation problem.
In its minimum error formulation, the aim is to find an equivalent projection that minimises the mean









where ∥ · ∥2 is the Frobenius norm.
Remarkably, in both cases, solving the optimisation problems via Lagrange multipliers leads to
master eigenvalue-eigenvector equation:
Swk = λkwk (3.11)
where the weight vectors wk can be calculated as the eigenvectors of the covariance matrix S [31].
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Interestingly, the reason why the maximum variance solution and the minimum reconstruction error
solution are the same can be understood by applying Pythagoras theorem to the right triangle
defined by the projection of a sample yn to a weight vector w (Figure 3.4). Assuming again centered
data, the variance of yn is ∥yn∥ = yTnyn. This variance decomposes as the sum of the variance in






















Figure 3.4: In the maximum variance formulation the aim is to maximise the variance of the
projected data (blue line), whereas in the minimum error formulation the aim is to minimise the
residual variance (red line). Given a fixed total variance (black line), both strategies are equivalent
The main strength of PCA relies on its simplicity and closed form solution. Additionally, the linear
mapping has the advantage of yielding interpretable feature weights, so that inspection of wk reveals
which features are jointly affected by the k-th principal component.
However, PCA suffers from serious drawbacks when applying it to real datasets [171]. First, biological
measurements are inherently noisy, and there is no explicit account of noise in PCA. In practice,
high variance components are often asociated with signal whereas low-variance components are
assumed to be noise, but an ideal model should explicitly disentangle the uncoordinated variability
that is attributed to noise from the coordinated variability that is characterised as signal. Second,
in its original formulation, no missing data is allowed [126]. Third, it does not offer a principled
way of modelling prior information about the data.
3.1.9 Probabilistic Principal Component Analysis and Factor Anal-
ysis
A probabilistic version of PCA was initially proposed in [303]. It can be formulated by convert-
ing some (or all) fixed parameters into random variables and adding an explicit noise term to
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Equation (3.9):
Y = ZWT + ϵ (3.12)
where the weights W are assumed to be non-probabilistic parameters, but the noise ϵ and the latent






N (znk | 0, 1)
p(ϵ) = N
(
ϵ | 0, τ−1
)
where τ is the precision (inverse of the variance).
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(3.13)








Figure 3.5: Graphical model for probabilistic PCA. The latent variables are modelled as
random variables, whereas the weights and the noise are modelled as deterministic parameters.
Importantly, the choice of the distribution for ϵ implies that the noise of each feature is independent
but restricted to have the same precision τ . In practice this is a limiting assumption, as different
features are expected to show different degrees of noise, albeit this constraint can be relaxed and
forms the basis of Factor Analysis [260, 31].
The inference procedures involves learning the parameters W, and τ and a posterior probability
distribution for Z. As the model depends on latent variables, inference can be performed using
the iterative Expectation-Maximisation (EM) algorithm [260, 31]. In the expectation step, the
posterior distribution for Z is computed in closed form (due to conjugacy between the likelihood
and the prior), given current estimates for the parameters W, and τ . In the maximisation step,
the parameters are calculated by maximising the expectation of the joint log likelihood under the
posterior distribution of Z found in the E step [303].
Interestingly, the EM solution of probabilistic PCA lies in the same subspace as the traditional
PCA solution [303], but the use of a probabilistic framework brings several benefits. First, model
selection can be performed by comparing likelihoods across different settings of parameters. Second,
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missing data can naturally be accounted for by ignoring the missing observations from the likelihood.
Finally, the probabilistic formulation sets the core framework for a Bayesian treatment of PCA,
enabling a broad range of principled extensions tailored different types of datasets.
3.1.10 Bayesian Principal Component Analysis and Bayesian Fac-
tor Analysis













N (wdk | 0, 1)
p(ϵ) = N
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ϵ | 0, τ−1
)
p(τ) = G (τ | a0, b0)











G (τd | a0, b0)
where a0 and b0 are fixed hyperparameters. As in Equation (3.13), this results in a Normal likelihood:
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Figure 3.6: Graphical model for Bayesian Factor Analysis. All unobserved variables are
modelled as random variables.
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3.1.11 Hierarchical priors
A key advantage of the full Bayesian treatment is that it explicitly captures uncertainity on the
estimation of all unobserved variables, as opposed to the probabilistic PCA model [30, 29]. Yet,
more importantly, the use of (hierarchical) prior distributions allow different modelling assumptions
to be encoded, providing a flexible and principled approach to extend PCA to a myriad of modelling
scenarios, including multi-view generalisations [147, 318, 149, 45, 142, 340].
Automatic relevance determination
As an example, a major challenge in PCA is how to determine the dimensionality of the latent
space (i.e. the number of principal components). As we will show, the use of hierarchical prior
distributions allows the model to introduce sparsity assumptions on the weights in such a way that
the model automatically learns the number of factors.
In the context of Factor Analysis, one of the first sparsity priors to be proposed was the Automatic














G (αk | aα0 , bα0 )
The aim of this prior is two-fold. First, the zero-mean normal distribution specifies that, a priori,
no information is available and all features are inactive. When exposed to some data, the posterior
distribution for W will be estimated by weighting the contribution from the likelihood, potentially
allowing features to escape from the zero-centered prior (Figure 3.7).
Second, performing inference on the variable α = {α1, · · · , αk} enables the model to discard inactive
factors. To understand this, let us assume that only K = 5 true factors exist, but the model is
initialised with K = 20 factors. In such case, inactive factors can be prunned out by driving the
corresponding αk to infinity. In turn, this causes the posterior p(w:,k|Y) to be sharply peaked at
















Figure 3.7: Visualisation of the sparsity-inducing Automatic Relevance Determination prior
Spike-and-slab prior
Sparse extensions of the Bayesian factor analysis model have been proposed as a regularisation
mechanism but also to model inherent assumptions regarding the sparse nature of biological data
[285, 96].
The variability observed in biological data is driven both by technical factors and biological factors.
Technical factors (i.e. batch effects) tend to be relatively strong and alter the expression of a large
proportion of genes, whereas the biological factors are potentially weak effects driven by changes
in small gene regulatory networks [96]. Hence, a practical factor analysis model should be able to
learn factors with different degrees of sparsity.
The ARD prior proposed in Section 3.1.11 allows entire factors to be dropped out from the model,
but it provides a weak degree of regularisation when it comes to inactivating individual weights
within the active factors.
A sparse generalisation of the Factor Analysis model proposed above can be achieved by combining
the ARD prior with a spike-and-slab prior [205, 304]. For every weight wd,k:
p(wd,k | αk, θk) = (1− θk)10(wd,k) + θkN
(





θk | aθ0, bθ0
)
(3.15)
p(αk) = G (αk | aα0 , bα0 ) (3.16)










Figure 3.8: Graphical model for Bayesian sparse Factor Analysis. A double sparsity-
inducing prior is used on the weights: an ARD prior to prune inactive factors and a spike-and-slab
prior to inactive individual features within the active factors.
The spike-and-slab prior is effectively a mixture model where features are sampled from a zero-
inflated Gaussian distribution, where θk ∈ (0, 1) dictates the level of sparsity per factor (i.e. how
many active features). A value of θk close to 0 implies that most of the weights of factor k are
shrunk to 0 (i.e. a sparse factor), whereas a value of θk close to 1 implies that most of the weights
are non-zero (i.e. dense factors). By learning θk from the data, the model naturally accounts for
combinations of sparse and dense factors.
3.1.12 Multi-view factor analysis models
Probabilistic PCA and Factor Analysis perform dimensionality reduction from a single input matrix.
In some occasions data is collected from multiple data sources that exibit heterogeneous statistical
properties, resulting in a structured data set where features are naturally partitioned into views
[332, 170, 335]. A clear biological example is multi-omics data, where, for the same set of samples,
multiple molecular layers are profiled. Each of the data modalities can be analysed separately using
conventional (single-view) methods, but in the ideal strategy a single model should be used to
leverage information across all molecular layers using a flexible and principled approach. This is
referred to as the multi-view learning problem [332, 170].
A tempting approach to circumvent the multi-view learning problem is to simply concatenate all
datasets before applying conventional (single-view) latent variable models [254]. However, this is
prone to fail for several reasons. First, heterogeneous data modalities cannot always be modelled
using the same likelihood function. For example, continuous measurements are often modelled using
a normal distribution, but binary and count-based traits are not appropriately modelled by this
distribution [234]. Second, even if all views are modelled with the same likelihood, differences in the
scale and the magnitude of the variance can lead to some views being overrepresented in the latent
space. Finally, in a multi-view data set we expect multiple sources of variation, some driven by a
single view, whereas others could capture shared variability across multiple views. In other words,
from a structured input space, one can also expect a structured latent representation. Not taking
this behaviour into account can lead to challenges in the interpretability of the latent space.
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A comprehensive review of multi-view machine learning methods can be found in [332] and a more
genomics-oriented perspective in [254]. For the purpose of this thesis, I will describe only the use of
latent variable models for multi-view data integration.
3.1.13 Canonical Correlation Analysis
Canonical Correlation Analysis (CCA) is a simple extension of PCA to find linear components that
capture correlations between two datasets [121, 108].
Given two data matrices Y1 ∈ RN×D1 and Y2 ∈ RN×D2 CCA finds a set of linear combinations
U ∈ RD1×K and V ∈ RD2×K with maximal cross-correlation. For the first pair of canonical
variables, the optimisation problem is:





As in conventional PCA, the linear components are constraint to be orthogonal. Hence, the first
pair of canonical variables u1 and v1 contain the linear combination of variables that have maximal
correlation. Subsequently, the second pair of canonical variables u2 and v2 is found from the
residuals of the first canonical variables.
Given the similarity with PCA, both methods share statistical properties, including the linear
mapping between the low-dimensional space and the high-dimensional space, and the closed-form
solution using singular value decomposition [121, 108].
Because of its simplicity and efficient computation, CCA has widespread use as a dimensionality
reduction technique [108]. Yet, as expected, CCA suffers from the same pitfalls as PCA: difficulties
in selecting the number of components, lack of sparsity in the solutions and absence of probabilistic
formulation. In addition, CCA have been shown to overfit for datasets where D >> N [195,
103]. Hence, probabilistic versions with sparsity assumptions that reduce overfitting and improve
interpretability followed.
Probabilistic Canonical Correlation Analysis
Following the derivation of probabilistic PCA [303], a similar effort enabled a probabilistic formulation
of CCA as a generative model [20].
In this model, the two matrix of observations Y1 and Y2 are decomposed in terms of two weight
matrices W1 and W2 but a joint latent matrix Z:
Y1 = W1Z+ ϵ1
Y2 = W2Z+ ϵ2
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With the following prior probability distributions:
p(znk) = N (znk | 0, 1)
p(ϵ1) = N
(




ϵ2 | 0, τ−12
)
As in [303], the weights and the variance of the noise are assumed to be non-probabilistic parameters,
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Figure 3.9: Graphical model for probabilistic Canonical Correlation Analysis
Notice that the observations for both datasets are generated from the same set of latent variables Z.
This ensures that the model is focused on capturing the variation associated with cross-correlated
groups of features.
Analogously to probabilistic PCA, the expected value of the posterior distribution p(Z|Y1,Y2) span
the same subspace as standard CCA [20]. Nonetheless, one of the many advantage of a probabilistic
formulation is that it enables a broad range of principled extensions into larger graphical models.
51
Bayesian Canonical Correlation Analysis
A fully Bayesian treatment of CCA followed based on exactly the same principle presented in






































G (αk | aα0 , bα0 )
Resulting in the same likelihood model as in Equation (3.17). Yet, notice that an ARD is introduced
per factor, allowing an automatic inference of the dimensionality in the latent subspace. Also, there
is some flexibility in the definition of noise. Whereas an independent noise term can be defined per
view, one can also model correlated noise by introducing a multivariate Gaussian distribution with
full-rank covariance [320, 148].












Figure 3.10: Graphical model for Bayesian Canonical Correlation Analysis
As expected, the sparsity priors yield a more sparse solution than traditional CCA, which is more
appropriate for biological data analysis. However, this solution is still limited to M = 2 views,
which leads us to the next model extension.
52
3.1.14 Group Factor Analysis
Group Factor Analysis (GFA) is the natural generalisation of Bayesian Canonical Correlation
Analysis to an arbitrary number of views. The original idea was originally presented in [318] and a
series of generalisations followed, tailored with specific assumptions for different applications [149,
169, 45, 142, 340, 250]. In this section we will outline the core principle of GFA.
Given a data set of M views Y1, · · · ,YM , the task of GFA is to find K factors that capture the
variability within as well as the variability between views. In other words, we want to capture factors
that not only explain variance that is shared across all views but we also want to capture factors
that explain variance within a single view or between different subsets of views.
The starting point is to generalise the Bayesian CCA model (Section 3.1.13) to M views:
Y1 = W2Z+ ϵ1
Y2 = W2Z+ ϵ2
· · ·
YM = WMZ+ ϵM
Notice that there is a common factor space for all views, but there is a view-specific weight matrix.
The key to disentangle the activity of each factor in each view lies on the sparsity structure imposed
in the weights. Intuitively, if a factor k is not driving any variation in a specific view m we want all
the individual weights to be pushed to zero. As shown before, this behaviour can be achieved using
Automatic Relevance Determination (ARD) priors. However, if we were to use the same approach
as in Bayesian CCA, where the ARD prior for factor k is shared across all views, then factors would
be restricted to have the same activity across all views.


















G (αmk | aα0 , bα0 ) (3.19)
This is effectively setting an ARD prior per factor k and view m. The matrix α ∈ RM×K defines
four types of factors: (1) Inactive factors that do not explain variance in any view, which corresponds
to all values αk being large. (2) Fully shared factors that explain variance across all views, which
corresponds to all values αk being small. (3) Unique factors that explain variance in a single view,
which corresponds to all values αk being large, except for one entry. (4) Partially shared factors
that explain variance in a subsets views, which corresponds to a mixture of small and large values
for αk.










Figure 3.11: Graphical model for Bayesian Group Factor Analysis
Finally, notice that if M = 1 the model reduces to Bayesian PCA (Section 3.1.10), but when M = 2
the model does not reduce to Bayesian CCA because in the GFA setting factors are also allowed
to capture both inter-specific variability (i.e. across views) and intra-specific variability (within a
view). In Bayesian CCA, the views share a common ARD prior per factor to enforce the factors to
explain variation in both views, at the expense of ignoring sources of variability that are specific to
a single view.
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3.2 MOFA Model description
3.2.1 Mathematical formulation
Multi-Omics Factor Analysis (MOFA) is a multi-view generalisation of conventional Factor Analysis
to an arbitrary number of M data modalities (or views). It is inspired from the Group Factor
Analysis framework discussed in Section 3.1.14.
The input data consists of M views Ym ∈ RN×Dm with non-overlapping features. Views, or data
modalities, often represent different assays, but there is flexibility in their definition. Formally, the
input data is factorised as:
Ym = Z(Wm)T + ϵm (3.20)
where Z ∈ RN×K is a matrix that contains the factor values and Wm ∈ RDm×K are a set of M
matrices (one per view) that contain the feature weights. Finally, ϵm ∈ RDm captures the residuals,
or the noise, which is assumed to be normally distributed and heteroskedastic:
p(ϵmd ) = N
(
ϵmd | 0, (τmd )−1
)
(3.21)











ymnd | zTnwmd , (τmd )−1
)
(3.22)
Non-Gaussian noise models can also be defined (see Section 3.2.6), but unless otherwise stated, I
will always assume Gaussian residuals.
Prior distributions for the factors
For the factors, we can define an isotropic Gaussian prior, as commonly done in most factor analysis
models:
p(znk) = N (znk | 0, 1) (3.23)
This effectively assumes (1) a continuous latent space and (2) independence between samples and
factors.
Prior distributions for the weights
The key determinant to ensure that the model is interpretable lies on the regularization structure
imposed on the weights. Here we encode two levels of sparsity on their prior distributions, (1) a
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view- and factor-wise ARD prior [190] and (2) a feature-wise spike-slab prior [205]:
p(wmdk) = (1− θmk )10(wmdk) + θmk N (wmdk | 0, 1/αmk )
The aim of the ARD prior is to disentangle the activity of factors to the different views, such that
the weight vector wm:,k is shrunk to zero if the factor k does not explain any variation in view m. The
spike-and-slab prior encourages zero values within active factors at the level of individual features.
However, the standard formulation of the spike-and-slab prior contains a Dirac delta function, which
is incompatible with the variational inference scheme. To solve this we adopt a re-parametrization
of the weights w as a product of a Gaussian random variable ŵ and a Bernoulli random variable s,









Ber(smdk | θmk ) (3.24)
In this formulation αmk controls the activity of factor k in view m and θ
m
k controls the corresponding
fraction of non-zero weights (i.e. the sparsity levels).
Finally, we define conjugate priors for θ and α:
p(θmk ) = Beta
(
θmk | aθ0, bθ0
)
(3.25)
p(αmk ) = G (αmk | aα0 , bα0 ) (3.26)
with hyper-parameters aθ0, bθ0 = 1 and aα0 , bα0 = 1e−5 to get uninformative priors. Posterior values of
θmk close to 0 implies that most of the weights of factor k in view m are shrunk to 0 (sparse factor).
In contrast, a value of θmk close to 1 implies that most of the weights are non-zero (non-sparse
factor). A small value of αmk implies that factor k is active in view m. In contrast, a large value of
αmk implies that factor k is inactive in view m.
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All together, the joint probability density function of the model is given by













































G (τmd | aτ0 , bτ0) .
(3.27)




















Figure 3.12: Graphical model for MOFA. Grey circles represent the observed variables
whereas white circles represent hidden variables that are infered by the model. Each plate repsents
a dimension of the model: M for the number of views, N for the number of samples, K for the
number of factors and Dm for the number of features in the m-th view. The use of transparency in
the top left nodes is intentional and becomes clear in Chapter 5.
This completes the definition of the MOFA model.
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Inference
To make the model scalable to large datasets we adopt a Variational inference framework with a
structured mean field approximation. A detailed overview is given in Section 3.1.4, and details on
the variational updates for the MOFA model are given in Appendix A. To enable efficient inference
for non-Gaussian likelihoods we employ local bounds [127, 271]. This is described in detail in
Section 3.2.6.
Missing values
The probabilistic formulation naturally accounts for incomplete data matrices, as missing observations
do not intervene in the likelihood. In practice, we implement this using memory-efficient binary
masks Om ∈ RN×Dm for each view m, such that On,d = 1 when feature d is observed for sample n,
0 otherwise.
3.2.2 Downstream analysis
Once trained, the MOFA model can be queried for a set of downstream analysis (Figure 3.13):
• Variance decomposition: calculate the variance explained (R2) by each factor in each view.
This is the first and arguably the most important plot to be inspected once the model is
trained, as it summarises the variation (i.e. the signal) in a complex multi-view data set using
a simple heatmap. With a quick visual inspection, this plot can be used to determine which
factors are shared between multiple data modalities and which ones are exclusive to a single
data modality.
• Visualisation of the samples on the latent space: the samples can be visualised in the
latent space using beeswarm plots for individual factors or scatterplots for combinations of
factors.
• Inspection of weights: the feature weights can be interpreted as an importance score for
each feature on each factor. Inspecting the top weights for a given factor can reveal the
molecular signatures that underlie each factor.
• Association analysis between factors and external covariates: multi-omic datasets
typically consist of a large set of molecular readouts that are used for model training, and a
small set of additionals covariates or response variables such as clinical outcome measurements.
The external covariates are not used for model training but they can be linked to the factors
a posteriori using a simple association analysis.
• Imputation: the latent factors capture a condensed low-dimensional representation of the
data that can be used to generate (denoised) reconstructions of the input data. This can be
valuable for the inspection of very sparse datasets.
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• Feature set enrichment analysis: when a factor is difficult to characterise based only
on the inspection of the top weights, one can compute a statistical test for enrichment of
biological pathways using predefined gene-set annotations.


















Inspection of feature weights











































Figure 3.13: MOFA overview.
(a) The MOFA model takes as input M data matrices (Y1, · · · ,YM ), each one representing a
separate view or data modality. Samples must be co-occurrent but the features are not necessarily
related across data modalities. MOFA performs a multi-view matrix decomposition that results in a
matrix of factors (Z) and M matrices of feature weights, one for each data modality (W1, · · · ,WM ).
(b) The trained MOFA model can be queried for different downstream analyses.
Interpretation of the factors
The interpretation of the factor values is intuitively similar to that of principal components in PCA.
Each factor sorts cells along a one-dimensional axis with a mean of zero. Samples with different
signs indicate opposite effects along this source of variation, with higher absolute value indicating a
stronger effect.
For example, if the k-th factor captures the variability associated with commitment to cell type X,
we could expect cells that belong to cell type X to be at one end of the factor (irrespective of the
sign, only the relative positioning being of importance). In contrast, cells that do not belong to cell
type X are expected to be at the other end of the factor.
Interpretation of the weights
The weights provide a score for each feature on each factor. Features with no association with the
factor are expected to have values close to zero (as specified by the prior distributions). In contrast,
features with strong association with the factor are expected to have large absolute values. The
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sign of the weight indicates the direction of the effect such that a positive weight indicates that the
feature is positively associated with the factor values.
Following the example above, genes that are upregulated cell type X are expected to have large
positive weights, whereas genes that are downregulated in cell type X (or, equivalently, upregulated
in the other cell types) are expected to have large negative weights. Genes that do not change in
expression between the cell types are expected to have a value of zero.
Variance decomposition
The first step in the downstream analysis is to calculate the percentage of variance explained for
each factor k in each view m (R2m,k), which can be visualised using a heatmap (see Figure 3.13b).


















3.2.3 Model selection and consistency across random initilizations
The optimisation problem in MOFA is not convex and the resulting posterior distributions depend
on the initialisation of the model. Thus, when doing random initialisation of the parameters and/or
expectations it becomes mandatory to perform model selection and assess the consistency of the
factors across different trials. The strategy we adopted in this work is to train several MOFA models
under different parameter initialisations, where the expectation of each node is randomly sampled
from its underlying distribution. After fitting, we select the model with the highest ELBO for
downstream analysis. In addition, we evaluate the robustness of the factors by plotting the Pearson













Figure 3.14: Model selection and robustness analysis in MOFA.
The left plot the log ELBO (y-axis) for 25 model instances (x-axis). The arrow indicates the model
with the highest ELBO that would be selected for downstream analysis. The right plot displays the
absolute value of the Pearson correlation coefficient between pairwise combinations of all factors
across the 25 model instances. A block-diagonal matrix indicates that factors are robustly estimated
regardless of the initialisation.
3.2.4 Learning the number of factors
As described in Section 3.1.11, the use of an ARD prior allows factors to be actively pruned by the
model if their variance explained is negligible. In the implementation we control the pruning of
factors by a hyperparameter that defines a threshold on the minimum fraction of variance explained
by a factor (across all views). Additionally, because of the non-convexity of the optimisation problem,
different model instances can potentially yield solutions with different number of active factors.
Thus, the optimal number of factors can be selected by the model selection strategy outlined in
Section 3.2.3.
3.2.5 Monitoring convergence
An attractive property of Variational inference is that the objective function (the ELBO) increases













Figure 3.15: Training curve for two different instances of MOFA with random initial-
isations. The y-axis displays the log of the ELBO, with higher values indicating a better fit. The
x-axis displays the iteration number. The horizontal dash lines mark the value of the ELBO upon
convergence.
Training is stopped when the change in the lower bound becomes smaller than a predefined threshold.
3.2.6 Modelling and inference with non-Gaussian data
Gaussian likelihoods are sufficient to model the residuals of most types of continuous data. Thus,
when possible, we advise the user to apply data transformations (i.e. log transformation for example)
and use the Gaussian likelihood model. However, there are cases where Gaussian likelihoods are
not appropriate, even after data transformations, namely binary and (low) count data. However,
non-Gaussian likelihoods are problematic because they are not conjugated with prior distributions,
and this prevents the use of the efficient variational inference scheme for Gaussian likelihoods (see
Appendix A).
To implement efficient variational inference in conjunction with a non-Gaussian likelihood we adapt
prior work from [271], where the full derivation can be found. The idea is to approximate non-
Gaussian observations by a normally-distributed pseudo-data that is constructed using second-order
Taylor expansions. This defines a lower bound that can be improved by adjusting parameters
at each iteration. Denoting the parameters in the MOFA model as X = (Z,W,α, τ ,θ), recall
that the variational framework approximates the posterior p(X|Y) with a distribution q(X), which
is indirectly optimised by optimising a lower bound of the log model evidence. The resulting











Let’s now assume a general likelihood function p(Y|X) = f(Y|C) with C = ZWT that we can
write as






with fnd(cnd) = − log p(ynd|cnd). For simplicity in the derivation I will assume a single view and
thus drop the index m for clarity.
Extending [271] to our heteroscedastic noise model, we require fnd(cnd) to be twice differentiable
and upper bounded by a constant κd. I do not prove this here, but this property holds true in many
important models as for example the Bernoulli and Poisson likelihoods, as demonstrated in [271].




(cnd − ζnd)2 + f ′(ζnd)(cnd − ζnd) + fnd(ζnd) := qnd(cnd, ζnd),
where ζnd are additional variational parameters that determine the location of the Taylor expansion
and have to be optimised to make the lower bound as tight as possible. Plugging the bounds into







Eq[qnd(cnd, ζnd)] + KL[q(X)||p(X)]
The new objective function has two class of parameters to optimise: the parameters associated with
the local bounds ζ, and the parameters associated with the model (X). The algorithm proposed in
[271] alternates between updates of ζ and q(Θ). The update for ζ is given by
ζ ← E[Z]E[W]T
where the expectations are taken with respect to the corresponding q distributions.
On the other hand, the updates for q(X) are identical to the standard variational Bayesian updates
with Gaussian likelihoods, but with the observed data Y replaced by the pseudo-data Ŷ and where
the precisions τnd (which were treated as random variables) are replaced by the constant terms κd
introduced above. This might seem a minor change, but it is very important. In the Gaussian case
the model infers a variance parameter for each feature which means that MOFA explicitly models
heteroscedastic noise, but when using non-Gaussian likelihoods this is no longer possible.
Finally, the general formula pseudodata is given by (derived in [271]):
ŷnd = ζnd − f ′(ζnd)/κd
where different log likelihood functions f(·) yield different κd values.
In MOFA we implemented a Bernoulli likelihood model for binary data and a Poisson likelihood
model for (low) count data.
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Bernoulli likelihood for binary data




The second derivative of the log likelihood is bounded by:
f ′′(c) = σ(c)σ(−c) ≤ 1/4 := κ
where σ is the sigmoid function f(c) = 1/(1 + e−c).
The pseudodata updates are given by
ŷnd = ζnd − 4 ∗ (σ(ζnd)− ynd)
Poisson likelihood for count data
When observations are natural numbers, such as count data y ∈ N = {0, 1, · · · }, they can be
modelled using a Poisson likelihood:
p(y|c) = λ(c)ye−λ(c)
where λ(c) > 0 is a convex rate function. As done in [271], here we adopt the rate function
λ(c) = log(1 + ec), which yields the following upper bound of the second derivative of the log-
likelihood:
f ′′nd(cnd) ≤ κd = 1/4 + 0.17 ∗max(y:,d).
The pseudodata updates are given by





3.2.7 Theoretical comparison with published methods
A variety of latent variable models exist with the aim of perfoming multi-view data integration, most
of them inspired by the Group Factor Analysis formulation. A summary is provided in the table
below. MOFA is the only method that scales to large datasets (employs Variational Bayes inference
instead of MCMC-based approaches), has a combination of ARD and spike-slab regularisation on



























Virtanen2012 VB ARD None No Gaussian
Homo-
scedastic
Klami2014 VB ARD None No Gaussian
Homo-
scedastic
Bunte2016 Gibbs ARD Spike-Slab No Gaussian
Homo-
scedastic
Hore2016 VB None Spike-Slab Yes Gaussian
Hetero-
scedastic










Leppaaho2017 Gibbs ARD Spike-Slab Yes Gaussian
Homo-
scedastic






Table 3.1: Overview of latent variable methods for multi-view data integration. Ab-
breviations used: VB (variational Bayes inference), Gibbs (Gibbs sampling based inference),
ARD(Automatic Relevance Determination)
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3.3 Model validation with simulated data
We used simulated data from the generative model to systematically test the technical capabilities
of MOFA.
3.3.1 Recovery of simulated factors
First, we tested the ability of MOFA to recover simulated factors under varying number of views,
features, factors and with different amounts of missing values.
For every simulation scenario we initialised a model with a high number of factors (K = 100), and
inactive factors were automatically dropped during model training by the ARD prior. In addition,
to test the robustness under different random initialisations, 10 model instances were trained for
every simulation scenario.
We observe that in most settings the model accurately recovers the correct number of factors
(Figure 3.16). Exceptions occur when the dimensionality of the latent space is too large (more than
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Figure 3.16: Assessing the ability to recover simulated factors.
In all plots the y-axis displays the number of infered factors. (a) x-axis displays the number of true
factors, and boxplots summarise the distribution of inferred factors across 10 model instances. For
(b-d) the true number of factors was set to K = 10 and each bar corresponds to a different model
instance. (b) x-axis displays the number of features, (c) x-axis displays the number of views, (d)
x-axis displays fraction of missing values.
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View-wise sparsity on the weights
One of the essential features of MOFA is the use of an ARD prior aimed at disentangling the activity
of factors across views (see Section 3.1.11 and Section 3.2).
We simulated data from the generative model such that the factors were set to be active or inactive
in specific views by sampling αmk from a discrete distribution with values {1, 1e3}. We compared
the performance with a popular integrative clustering method (iCluster) that is also formulated
as a latent variable model [206]. In iCluster each factor shares the same sparsity constraint across
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Figure 3.17: Evaluating the ability to recover differential factor activity across views.
(a) The true activity pattern, with factors sampled to display differential activity across views. (b)
Percentage of variance explained for each factor in each view, for MOFA and iCluster [206].
Feature-wise sparsity on the weights
In MOFA we implemented a spike-and-slab prior prior to enforce feature-wise sparsity on the weights
with the aim of delivering a more interpretable solution (see Section 3.2.1).
To assess the effect of the spike-and-slab prior we trained a group of models with and without the
spike-and-slab prior. Importantly, both models contain the ARD prior, which should provide some
degree of regularisation. To compare both options to a non-sparse method, we also fit a Principal
Component Analysis on the concatenated data set. As expected, we observe that the spike-and-slab
prior induces more zero-inflated weights, although the ARD prior provided a moderate degree of


















ARD Concatenated PCA Spike and Slab
Figure 3.18: Assessing the sparsity priors on the weights.
The plot shows the empirical cumulative density function of the weights for an arbitrary factor in a
single view. The weights were simulated with a sparsity level of θmk = 0.5 (50% of active features.)
3.3.2 Non-Gaussian likelihoods
A key improvement of MOFA with respect to previous methods is the use of non-Gaussian likeli-
hoods to integrate data modalities with different types of readouts. In particular, as described in
Section 3.2.6, we implemented a Bernoulli likelihood to model binary data and a Poisson likelihood
to model count data.
To validate both likelihood models, we simulated binary and count data using the generative model
and we fit two sets of models for each data type: a group of models with a Gaussian likelihood and
a group of models with a Bernoulli or Poisson likelihood, respectively.
Reassuringly, we observe that although the Gaussian likelihood is also able to recover the true



























































































































Figure 3.19: Validation of the non-Gaussian likelihood models using simulated data.
(a-d) Comparison of Poisson and Gaussian likelihood models applied to count data.
(e-h) Comparison of Bernoulli and Gaussian likelihood models applied to binary data.
(a,e) The y-axis displays the ELBO for each model instance (x-axis). (b,f) The y-axis displays the
mean reconstruction error for each model instance (x-axis). (c,g) The y-axis displays the number
of estimated factrors for each model instance (x-axis). The horizontal dashed line marks the true
number of factors K = 10. (d,h) Distribution of reconstructed data. Plotted are the expected
values of the inferred posterior distributions, not samples from the corresponding posteriors. This
is why reconstructed measurements are continuous and not discrete.
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3.3.3 Scalability
Finally, we evaluated the scalability of the model when varying each of its dimensions independently,
and we compared the speed with an implementation of GFA that uses Gibbs Sampling [169] and the
popular Cluster+[206], which adopts a maximum-likelihood approach with grid search to optimise
the hyperparameters. Overall, we observe that MOFA scales linear with respect to all dimensions































































Number of samples (N) Number of views (M)
Number of factors (K) Number of features (D)
100 200 300 400 500 4 8 12






















Figure 3.20: Evaluation of scalability in MOFA.
Shown is the time required for convergence (y-axis, in minutes). The x-axis displays the value of the
dimension that was tested, either number of factors (K), number of features (D), number of samples
(N) and number of views (M). Baseline parameters were M = 3,K = 10, D = 1000, N = 100.
Each line represents a different model, GFA (red), MOFA (blue) and iCluster (green). Default
convergence criteria where used for all methods. Each dot displays the average time across 10 trials
with error bars denoting the standard deviation. iCluster is only shown for one value as all other
settings required more than 200min for convergence.
As a real application showcase, the training on the CLL cohort that is described below (Figure 3.21)
required 25 minutes using MOFA, 34 hours with GFA and 5-6 days with iCluster.
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3.4 Application to a cohort of Chronic Lymphocytic Leukaemia
patients
Personalised medicine is an attractive field for the use of multi-omics, as dissecting heterogeneity
across patients is a major challenge in complex diseases, and requires data integration from multiple
biological layers [56, 63, 7].
To demonstrate the potential of MOFA, we applied it to a publicly available study of 200 patient
samples of Chronic Lymphocytic Leukaemia (CLL) profiled for somatic mutations, RNA expression,
DNA methylation and ex vivo drug responses [75], all of them at the bulk level. We selected this data
set for three main reasons: (1) The complex missing data structure, with nearly 40% samples having
incomplete assays (Figure 3.21). As described in Section 3.2.1, the inference framework implemented
in MOFA should cope with large amounts of missing values, including missing assays. (2) After
data processing, three assays had continuous observations whereas for the somatic mutations the
observations were binary. As described in Section 3.2.6, MOFA can combine different likelihood
models. (3) The existence of clinical covariates provide an excellent test to evaluate whether the
MOFA factors can capture the molecular variation that underlies clinically-relevant phenotypes.
3.4.1 Data overview and processing
Data processing and normalisation is essential for the model to work and it requires a few consider-
ations. First, in the case of count-based assays such as RNA-seq one needs to remove differences
in library size between samples. If not done correctly, the signal in the data will be dominated
by this (undesired) source of variation, and more subtle heterogeneity will be harder to identify.
Similarly, batch effects and other undesired technical sources of variation should be regressed out a
priori, although this was not the case for this particular data set. Second, feature selection must
be performed by selecting highly variable features. A proper feature selection will increase the
signal-to-noise-ratio, it will simplify model selection and it will speed up the training procedure.
Finally, as discussed above, the total number of features can influence the contribution of a data
modality to the latent space. To mitigate this problem it is recommended to keep the number of
features per view within the same order of magnitude, when possible.
Here we proceed to briefly describe the different data modalities and outline the basic data processing
steps that we performed before applying MOFA:
• RNA expression was profiled using bulk RNA-seq. Genes with low counts were filtered
out and the data was subsequently normalized using DESeq2 [181]. Feature selection was
performed by considering the top 5,000 most variable genes.
• DNA methylation was profiled using Illumina 450K arrays. We converted the beta-values
to M-values, as it has better statistical properties when modelled with a Gaussian distribution
[79]. Feature selection was performed by considering the top 1% most variable CpG sites.
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• Ex vivo Drug response was screened using the ATP-based CellTiter-Glo assay. Briefly,
the asay includes a panel of 62 drugs at 5 different concentrations each, for a total of 310
measurements. The readout is a number proportional to the fraction of viable cells in culture
based on quantitation of the ATP present, which signals the presence of metabolically active
cells.
• Somatic mutations were profiled using a combination of targeted and whole exome sequenc-
ing. Feature selection was performed by considering only mutations that were present in at
least three samples, which resulted in a total of 69 mutations.
3.4.2 Model overview
In this data set, MOFA recovered K = 10 factors, each one explaining a minimum of 3% of variance
in at least one assay. Interestingly, MOFA detected factors which are shared across several data
modalities (Factors 1 and 2, sorted by variance explained). Some factors captured sources of
covariation between two data modalities (Factor 3 and 5, active in the RNA expression and drug
response). In addition, some factors captured variation that is unique to a single data modality
(Factor 4, active in the RNA expression data).
All together, the 10 MOFA factors explained 41% of variance in the drug response data, 38% in the
mRNA expression, 24% in the DNA methylation and 24% in somatic mutations.






















Figure 3.21: Application of MOFA to a study of chronic lymphocytic leukaemia.
Model overview.
(a) Data overview. Assays are shown in different rows (D = number of features) and samples (N)
in columns, with missing samples shown using grey bars. Notice that some samples are missing
entire assays.
(b) Variance explained (%) by each Factor in each assay.
(c) Total variance explained (%) for each assay by all factors.
The first two factors are the most interesting from a molecular perspective, as they capture a
phenotypic effect that is manifested across multiple molecular layers. To annotate Factors 1 and 2
we proceeded to visualise the feature weights, starting by the (binary) somatic mutation data, as it
is the simplest data modality to interpret. Inspection of the top weights revealed that Factor 1 was
associated with the mutation status of the immunoglobulin heavy-chain variable (IGHV) region,
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while Factor 2 was aligned with trisomy of chromosome 12 (Figure 3.22).
Remarkably, in a completely unsupervised fashion, MOFA recovered the two most important clinical
markers in CLL as the two major axes of molecular disease heterogeneity [86, 44, 66].
Next, we visualised the samples in the latent space spanned by Factors 1 and 2. A scatterplot
based on these factors shows a clear separation of patients by their IGHV status on the first
Factor and presence or absence of trisomy 12 on the second Factor (Figure 3.22). Interestingly, 24
patients lacked IGHV status measurements (grey crosses) due to quality control filtering in the DNA
sequencing assay. Nonetheless, MOFA was able to pool information from the other molecular layers





































Figure 3.22: Visualisation of the genetic signature underlying Factor 1 and 2
(a) Weights of the top somatic mutations for Factors 1 and 2. (b) Scatterplots of Factors 1 and
2. Each dot corresponds to one sample and the colours denote the IGHV status of the tumours
samples; symbol shape indicate chromosome 12 trisomy status.
IGHV status is currently the most important prognostic marker in CLL and has routinely been
used to distinguish between two distinct subtypes of the disease[86]. Molecularly, it is a surrogate
of the level of activation of the B-cell receptor, which is in turn related to the differentiation state
of the tumoral cells. Multiple studies have associated mutated IGHV with a better response to
chemotherapy, whereas unmutated IGHV patients have a worse prognosis [86, 44, 66].
In clinical practice, the IGHV status has been considered binary. Our results suggest that this is a
fairly good approximation, but a more complex structure with at least three groups or a potential
underlying continuum is supported (Figures 3.22 and 3.23), as also suggested in [240].
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3.4.3 Molecular characterisation of Factor 1
An important step in the MOFA pipeline is the characterisation of the molecular signatures
underlying each Factor. I will demonstrate this for Factor 1, although a similar strategy can be
applied to Factor 2.
On the RNA expression, inspection of the top weights pinpoint genes that have been previously
associated to IGHV status, some of which have been proposed as clinical markers[316, 209]. Heatmaps
of the RNA expression levels for these genes reveals clear differences between samples when ordered
according to the Factor 1 values.
On the drug response data the weights highlight kinase inhibitors targeting the B-cell receptor
pathway. Splitting the patients into three groups based on k-means clustering shows clear separation





























































































































Figure 3.23: Characterization of MOFA Factor 1 as IGHV status.
(a) Beeswarm plot of Factor 1 values, where each dot corresponds to a patient sample. Colours
denote three groups found by applying 3-means clustering on the Factor values.
(b) Genes with the largest weights (in absolute values) in the mRNA data. Plus or minus symbols
on the right indicate the sign of the weight.
(c) Heatmap of gene expression values for the genes with the largest weights displayed in (b).
(d) Drugs with the largest weights (in absolute values) in the Drug response data, coloured by the
drug’s target category.
(e) Drug response curves for two of the drugs with top weights, stratified by the clusters displayed
in (a).
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3.4.4 Molecular characterisation of other factors
Despite their clinical importance, Factor 1 (IGHV status) and Factor 2 (chr12 trisomy) they explain
less than 20% variability in each data modality, suggesting the existence of more subtle sources of
variation. As an example, we will also characterise Factor 5, which explains 2% of the variance in
the mRNA and 6% of variance in the drug response.
As mentioned in Section 3.2.2, instead of exploring the feature weights individually, factors can be
annotated using gene set annotations. This procedure is particularly appealing for RNA expression
data, as a rich amount of resources exist that have categorised genes into ontologies in terms of
biological pathways, molecular function and cellular components [87, 17].
Briefly, the idea is to aggregate the weights using prior information to obtain a single statistic
for each gene set, which can be tested against a competitive null hypothesis. Inspired from [94],
in MOFA we implemented several scoring schemes and a variety of parametric and unparametric
statistical tests. By default we use the weights as feature statistics and the average difference in the
weight values as the feature set statistic. P-values are then obtained per feature set and factor via a
simple t-test.
Gene Set Enrichment Analysis on the RNA weights using the Reactome annotations [87] reveals
that Factor 2 is strongly enriched for oxidative stress and senescence pathways. Inspection of the
top features highlights the importance of heat shock proteins (HSPs), a group of proteins that are
essential for protein stability which are up-regulated upon stress conditions like high temperatures,
pH shift or oxidative stress. Importantly, HSPs can be elevated in tumour cells and potentially
contribute to prolonged tumour cell survival[72]. In agreement with the findings from the mRNA
view, the drugs with largest weights on Factor 5 belong to clinical categories associated with stress
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Figure 3.24: Characterization of Factor 5 in the CLL cohort as oxidative stress re-
sponse.
(a) Beeswarm plot of Factor 5, where each dot corresponds to a patient sample. Colours represent
the expression of TNF, an inflammatory stress marker that is present among the top mRNA weights.
(b) Gene set enrichment analysis results using Reactome pathways. Displayed are the top pathways
with the strongest enrichment.
(c) Heatmap of mRNA expression values for representative genes among the top weights. Samples
are ordered by their Factor 5 values.
(d) Weights for the top drugs, annotated by target category.
(e) Heatmap of drug response values for the top three drugs. Samples are ordered by their Factor 5
values, as in (c).
3.4.5 Prediction of clinical outcomes
We conjectured that the integration of multiple molecular layers could allow an improved prediction
of the patients’ clinical outcome. To evaluate the utility of the MOFA factors as predictors of
clinical outcomes we fit Cox regression models [64] using the patients’ time to next treatment (TTT)
as a response variable. Two types of analysis were performed: a univariate analysis where each
Factor was independently associated with TTT, and a multivariate analysis where the combination
of all factors were used to predict TTT (Figure 3.25). In the univariate Cox models, we observe
that Factor 1 (IGHV status), Factor 7 (associated with chemo-immunotherapy treatment prior
to sample collection) and Factor 8 (enriched for Wnt signalling) were significant predictors of
TTT. Accordingly, when splitting patients into binary groups based on the corresponding Factor
values, we observe clear differences in the survival curves. In the multivariate Cox model, MOFA
(Harrell’s C-Index C=0.78) outperformed all other input settings, including PCA on single-omic
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Figure 3.25: Association analysis between MOFA factors and clinical putcome.
(a) Association of MOFA factors to time to next treatment using a univariate Cox regression model
Error bars denote 95% confidence intervals. Numbers on the right show p-values for each Factor.
(b) Kaplan-Meier plots for the three MOFA factors that show a significant association with time to
next treatment.
(c) Prediction accuracy of time to treatment using multivariate Cox regression trained with the
first 10 principal components applied to single data modalities, the full data set or the 10 MOFA
factors. Shown are average values of Harrell’s C-index from fivefold cross-validation. Error bars
denote standard error of the mean.
3.4.6 Imputation of missing values
A promising application of MOFA is the imputation of missing values, including the potential to
impute of entire assays.
The principle of imputation in MOFA follows the same logic as simulating from the generative
model: if the factors and weights are known, the input data can be reconstructed by a simple matrix
multiplication:
Ŷ = E[Z]E[W]T
where E[Z] and E[W] denote the expected values of the variational distributions for the factors and
the weights, respectively. Notice that, when using the expectations of the posterior distributions,
the noise ϵ (Equation (5.16)) has a mean of zero and does not contribute to the predictions.
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The equation above results in point estimates, but it ignores the uncertainity on Z and W. Instead
of relying in point estimates, one could adopt a more Bayesian approach and calculate the posterior
predictive distribution by propagating the uncertainity [97]. Nonetheless, due to the nature of
the optimisation problem in variational inference, the variance of the posterior distributions can
be underestimated (see Section 3.1.5). In addition, this would be substantially more complex to
implement and would result in a significant increase in computational complexity, hence we did not
implement this strategy.
To assess the imputation performance, we trained MOFA models using a data set of complete
measurements (a total of N=121 samples) after masking parts of the drug response measurements.
In a first experiment, we masked values at random, and in a second experiment we masked the
entire drug response measurements. We compared the imputation accuracy of MOFA to some
established imputation strategies, including imputation by feature-wise mean, SoftImpute [194], and
a k-nearest neighbour method [311]. For both imputation tasks, MOFA consistently yielded more
accurate predictions, albeit the differences are less pronounced in the imputation of full assays, a
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Figure 3.26: Evaluation of imputation performance in the drug response assay.
The y-axis shows the mean-squared error (MSE) across 15 trials for increasing fractions of missing
data (x-axis). Two experiments were considered: (a) values missing at random and (b) entire assays
missing at random. Each point displays the mean across all trials and the error bars depict the
corresponding standard deviations.
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3.5 Application to single-cell multi-omics
The emergence of single-cell multi-modal techniques has created opportunities for the development
of novel computational strategies [290, 61, 55].
To show case how MOFA can be used to integrate single-cell multi-omics data, we considered
a simple data set that consists of 87 ESCs where RNA expression and DNA methylation were
simultaneously measured using scM&T-seq[12]. Two populations of ESCs were profiled: the first
one contains 16 cells grown in 2i media, which is known to induce a naive pluripotency state
associated with genome-wide DNA hypomethylation [91]. The second population contains 71 cells
grown in serum media, which contain stimuli that trigger a primed pluripotency state poised for
differentiation [307].
3.5.1 Data processing
The RNA expression data was processed using scran[186] to obtain log normalised counts adjusted
by library size. Feature selection was performed by selecting the top 5,000 most overdispersed
genes[159]. A Gaussian likelihod was used for this data modality.
The DNA methylation data was processed as described in Chapter 2. Briefly, for each CpG site, we
calculated a binary methylation rate from the ratio of methylated read counts to total read counts.
Next, CpG sites were classified by overlapping with genomic contexts, namely promoters, CpG
islands and enhancers (distal H3K27ac peaks). Finally, for each annotation we selected the top
5,000 most variable CpG sites with a minimum coverage of 10% across cells. Each of the resulting
matrices was defined as a separate view for MOFA. A Bernoulli likelihod was used for this data
modality.
3.5.2 Model overview
In this data set, MOFA inferred 3 factors with a minimum explained variance of 1% (Figure 3.27).
Factor 1 captured the transition from naive to primed pluripotent states, which MOFA links to
widespread coordinated changes between DNA methylation and RNA expression. Inspection of the
gene weights for Factor 1 pinpoints important pluripotency markers including Rex1/Zpf42 or Essrb
[207]. As previously described both in vitro [12] and in vivo [19], the transition from naive to primed
pluripotency state is concomitant with a genome-wide increase in DNA methylation levels. Factor 2
captured a second dimension of heterogeneity driven by the transition from a primed pluripotency
state to a differentiated state, with RNA weights enriched with canonical differentiation markers
including keratins and annexins [95].
Jointly, the combination of Factors 1 and 2 reconstruct the coordinated changes between the

































































Figure 3.27: MOFA recovers a differentiation process from a single-cell multi-omics
data set.
(a) Overview of the data modalities. Rows indicate number of features (D) and columns indicate
number of samples (N). Grey bars denote missing samples.
(b) Fraction of variance explained per factor (column) and view (row).
(c) Cumulative fraction of variance explained per view (across all factors).
(d) mRNA weights of Factor 1 (bottom) and Factor 2 (top). The genes that are labelled are known
markers of pluripotency (for Factor 1) or differentiation (for Factor 2).
(e) Scatter plot of Factor 1 (x-axis) against Factor 2 (y-axis). Cells are colored based on the culture
condition. Grey arrow illustrates the differentiation trajectory from a naive pluripotency state to a
differentiated state.
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3.6 Limitations and open perspectives
MOFA solves important challenges for the integrative analysis of (single-cell) multi-omics datasets.
Yet, the model is not free of limitations and there are open possibilities for future research:
• Linearity: this is an assumption that is critical for obtaining interpretable feature weights.
Nonetheless, there is a trade-off between explanatory power and interpretability[158]. Non-
linear approaches, including deep neural networks or variational autoencoders have shown
promising results when it comes to dimensionality reduction [173, 77, 180], batch correction[180],
denoising [85] or imputation [174]. Interestingly, very few multi-view factor analysis models
exist that incorporate flexible non-linear assumptions, making it an interesting line of research
to explore.
• Scalability: the size of biological datasets is rapidly increasing, particularly in the field of
single cell sequencing [294, 49]. When comparing the inference framework to previous methods
that make use of sampling-based MCMC approaches, the variatonal framework implemented
in MOFA yields a vast improvement in scalability. Yet, in its vanilla form, variational inference
also becomes prohibitively slow with very large datasets [117, 33, 118]. This has been recently
addressed by a reformulation of the variational inference problem in terms of a gradient descent
optimisation problem, which enables the full machinery of stochastic inference to be applied
in the context of Bayesian inference. This line of research is followed in Chapter 5, with the
development of a stochastic version of the variational inference algorithm.
• Generalisations to multi-group structures: the sparsity assumptions in MOFA are based
on the principle that features are structured into non-overlapping views. As such, the activity
of the latent factors is also expected to be structured, so that different factors explain variability
in different subsets of views (Figure 3.13). Following the same logic, many studies contain
structured samples, as either multiple experiments or conditions. A simple generalisation of
MOFA would be to intuitively break the assumption of independent samples and introduce an
additional prior that captures the group structure at the sample level. This line of research is
followed in Chapter 5.
• Bayesian treatment of predictions: in the current implementation of MOFA, only the
point estimates for the posterior distributions are used in the downstream analysis. While
convienient for most operations, this ignores the uncertainity associated with the point
estimates, which is a major strength of Bayesian modelling. Future extensions could attempt
a more comprehensive Bayesian treatment that propagates uncertainity in the downstream
analyses, mainly when it comes to making predictions and imputation [97].
• Incorporation of prior information: an unsupervised approach is appealing for discovering
the principal axes of variation, but sometimes this can yield challenges in the interpretation of
factors. Future extensions could exploit the rich information encoded in gene set ontologies,
similar to the methodology proposed in [43].
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• View imbalance: a property of MOFA is that the number of features can influence the
contribution of a data modality to the latent space, such that bigger views tend to contribute
more to the factors. This is because the objective function (the evidence lower bound, ELBO)
does not weight the different data modalities according to their number of features. This is not
necessarily a problem, as we have demonstrated in Section 3.4, where we extracted meaningful
signal from small data modalities. In general, however, the signal that can be extracted from
small data modalities will depend on the degree of structure within the dataset, the levels of
noise and on how strong the feature imbalance is between data modalities. In practice we
suggest users to try balance the number of features by subsetting highly variable features in
the larger views. An alternative option would be to weight the contribution of each view on
the ELBO, such that small views have a relatively higher contribution than large views. This
is however a heuristic that does not arise from the Bayesian generative model and there would
be no theoretical guarantees about its behaviour.
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Chapter 4
Multi-omics profiling of mouse gastrula-
tion at single-cell resolution
In this Chapter I will describe a study where we combined scNMT-seq (introduced in Chapter
2) and MOFA (introduced in Chapter 3) to explore the relationship between the transcriptome
and the epigenome during mouse gastrulation. The work discussed results from a collaboration
with the group of Wolf Reik (Babraham Institute, Cambridge, UK). It has been peer-reviewed and
published in [14]. The experiments were carried out by Stephen Clark, Hisham Mohammed and
Carine Stapel, with the help of Wendy Dean and Courtney Hanna for the collection of embryos.
Tim Lohoff prepared the Embryoid Body TET TKO culture. Wei Xie and Yunlong Xiang shared
the ChIP-seq data that was used to define germ layer-specific enhancers. Felix Krueger processed
and managed sequencing data. Christel Krueger processed the ChIP-seq data. I performed the
majority of the computational analysis, but with contributions from some authors. In particular,
Stephen Clark calculated the transcription factor motif enrichment analysis, Carine Stapel explored
the neuroectoderm and pluripotency signatures in ectoderm enhancers, and Ivan Imaz-Rosshandler
performed the mapping to the gastrulation atlas. John C. Marioni and Wolf Reik supervised the
project. The article was jointly written by Stephen Clark, Carine Stapel and me, with input from
all authors.
4.1 Introduction
The human body is composed of a myriad of cell types with specialised structure, organisation and
function; and yet, each cell in the body contains the same genetic information. The modulation
of the genetic code by internal and external factors begin during embryonic development, giving
rise to the formation of specialised molecular patterns that ultimately determines the complexity of
adult organisms [133]. A key phase in mammalian embryonic development is gastrulation, when a
single-layered blastula of pluripotent and relatively homogeneous cells is reorganised to form the
three primordial germ layers: the ectoderm, mesoderm and endoderm [298, 277, 296].
The onset of gastrulation is determined by the formation of the primitive streak, which establishes
the initial bilateral symmetry of the body. Involution of epiblast cells through the primitive streak
gives rise to the mesoderm and endoderm, whereas epiblast cells establish the ectoderm [16, 296,
298, 297]. Although differences exist between species, the morphogenic process of gastrulation
is evolutionary conserved throughout the animal kingdom [277]. In most cases, gastrulation is
characterised by an epithelial to mesenchymal transition that brings mesodermal end endoderm
progenitors beneath the future ectoderm. The epiblast cells that did not migrate through the
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primitive streak differentiate towards ectoderm, which eventually gives rise to the nervous system
(neural ectoderm) and epidermis (surface ectoderm). The embryonic endoderm gives rise to the
interior linings of the digestive tract, the respiratory tract, the urinary bladder and part of the
auditory system. The embryonic mesoderm gives rise to muscles, connective tissues, bone, cartilage,
blood, kidneys, among others.
4.1.1 Transcriptomic studies
Significant research effort has been deployed to understand the molecular changes underlying
gastrulation. Historically, microscopy was used to quantify gene expression at single cell resolution.
However, constraints imposed by fluorophore emission spectra made this approach unsuitable for
transcriptome-wide studies. Only after the breakthrough made by the introduction of single-cell
sequencing technologies has it become possible to generate comprehensive molecular roadmaps
of embryonic development [268, 232, 49, 249]. In a pioneer study, [232] generated the first high-
resolution atlas of gastrulation and early somitogenesis by profiling the RNA expression of 116,312
cells from 411 whole mouse embryos collected between E6.5 and E8.5. This effort completed earlier
attempts of reconstructing the transcriptomic landscape of post-implantation embryos [207, 270,
125, 326]. At the same time, another study employed a more scalable methodology to profile
around 2 million cells from 61 embryos ranging from E9.5 and 13.5 days of gestation, spanning early
organogenesis [49]. By constructing a densely sampled reference data set, both works have laid the
ground for understanding transcriptomic variation during development.
4.1.2 Epigenetic studies
Transcriptomics is a central piece in the puzzle of understanding embryonic development, but still a
single piece. The next step is to connect RNA expression to the accompanying epigenetic changes.
In differentiated cell types, epigenetic marks confer stable characteristic patterns of cell type identity
which have been extensively profiled using bulk sequencing approaches. Nevertheless, because of the
low amounts of input material and the extensive cellular heterogeneity, the study of the epigenetic
landscape during early development remains poorly understood [140].
Pre-implantation: establishment of the pluripotent state
The first efforts to interrogate the epigenetic dynamics of emrbyonic development using (bulk) next
generation sequencing technologies have provided valuable insights for the pre-implantation stage.
Multiple studies have described that, after fertilisation, there is a round of reprogramming that
resets the epigenetic landscape to a ground state [276, 165]. DNA methylation is globally removed
and the chromatin attains its highest levels of accessibility [329]. Consistently, Hi-C experiments
have revealed a flexible chromatin landscape, with lack of topologically associating domains (TADs)
or chromatin compartments [138, 80, 300], providing a plausible explanation for the remarkable
plasticity of pluripotent ESCs.
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In contrast to DNA methylation, the presence of post-translational modifications in histone marks
are abundant at this stage, potentially providing the major mechanism of epigenetic regulation [107,
300]. Several histone modifications have been studied in ESCs, the most prominent being H3K27ac
and H3K4me3, both (generally) activatory marks; and H3K27me3 and H3K9me3, both (generally)
repressive marks [341]. Interestingly, many genes that are silenced in ESCs contain both activatory
(H3K4me3) and repressive (H3K27me3) epigenetic marks. This distinctive signature of ESCs is
thought to establish a bivalent or poised signature for a transcriptionally-ready state for genes that
become expressed after gastrulation [27, 300].
Post-implantation: exit of pluripotency
In post-implantation development, cells exit pluripotency and undergo a set of critical cell fate
decisions that will ultimately give rise to all somatic cell types. While multiple studies have profiled
the epigenetic landscape in pre-implantation embryos, the epigenetic landscape of gastrulation and
early mammalian organogenesis remains largely unexplored.
DNA methylation is one of the few epigenetic marks that has been profiled in a genome-wide
manner in post-implantation embryos using both bulk and single-cell methodologies [19, 336, 70,
261]. All studies found that the hypomethylated state in the preimplantation blastocysts is followed
by a de novo DNA methylation wave upon implantation that leads to a hypermethylation of most
of the genome. The increase in DNA methylation is concomitant with the increased deposition
of repressive histone marks, presumably with the aim of restricting the differentiation potential
of early pluripotent cells [18]. The de novo methyltransferases (DNMT3A and DNMT3B) are
the enzymes responsible for the insertion of DNA methylation marks. Both genes are highly
expressed in early mouse embryos, and catalytically inactive mutants of both enzymes lacked de
novo methylation activity [19, 221]. Interestingly, mouse ESCs remain viable despite complete loss
of DNA methylation, but they are uncapable of undergoing cell fate commitment and escaping from
the pluripotent state [313].
The interplay of histone marks during post-implantation development is complex. H3K4me3 is
detected at transcription start sites after the zygotic genome activation, and remains remarkably
stable even after differentiation [113]. H3K4me3 is thought to facilitate transcription by inducing a
more efficient assembly of the transcriptional machinery [18, 317]. The other conventional activatory
mark, H3K27ac, is deposted in different types of regulatory elements, including promoters and
enhancers. It is significantly more dynamic than H3K4me3 in response to internal and external
stimuli, and is hence a stronger candidate to regulate cell fate transitions [18, 241].
The inhibitory mark H3K27me3 shows a marked increase upon implantation, deposited by the
Polycomb repressive complex 2 (PRC2) around multiple regulatory elements, including CpG-rich
promoters of developmental genes. H3K27me3 is often present in transcriptionally inactive regions
with low levels of DNA methylation, suggesting a potential antagonism between H3K27me and
DNA methylation [38, 18]. Interestingly, inactivating PRC2 components in mouse embryos does
not affect pre-implantation development, but the embryos become unviable after gastrulation [272].
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This suggests that H3K27me3 has a critical role in regulating gene expression during cell fate
commitment after germ layer specification.
Gastrulation: germ layer specification
The post-implantation blastocyst is a relatively homogeneous population of cells and can be
characterised with some accuracy by bulk sequencing approaches. However, germ layer specification
is uniquely heterogeneous and extremely challenging to study without single-cell technologies. Despite
the technical difficulties, some studies attempted to manually dissect each germ layer, followed
by bulk sequencing [337]. This revealed that the relatively homogeneous epigenetic landscape
at the epiblast is succedeed by a more dynamic landscape where regulatory elements become
activate in a lineage-specific manner [337, 166]. Consistent with a role of DNA methylation during
gastrulation, perturbations that target the Ten-eleven translocation (TET) family of dioxygenases
display developmental defects related to germ layer specification, ranging from impaired migration
of primitive streak cells to failed maturation of the mesoderm layer [70].
The recent development of single-cell multi-modal technologies, where epigenomes can be unequivo-
cally assigned to transcriptomes at single-cell resolution, unveils novel opportunities to study the
cell fate commitment events during gastrulation [101, 321, 177].
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4.2 Results
4.2.1 Data set overview
The aim of this project was to generate a multi-omics atlas of post-implantation mouse embryos at
single-cell resolution. We applied scNMT-seq (described in Chapter 2) to jointly profile chromatin
accessibility, DNA methylation and gene expression from 1,105 cells at four developmental stages
(Embryonic Day (E) 4.5, E5.5, E6.5 and E7.5), spanning exit from pluripotency and germ layer
commitment. Additionally, the transcriptomes of 1,419 additional cells from the relevant time points
were also profiled:
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Figure 4.1: scNMT-seq gastrulation atlas. Data set overview.
(a) Dimensionality reduction for chromatin accessibility data (left, in blue), DNA methylation
(middle, in red) and RNA expression (right, in green). For the gene expression data we used UMAP
[199]. For chromatin accessibility and DNA methylation data we used Bayesian Factor Analysis
[15].
(b) Number of observed cytosines in a GpC context (left, in blue) or (b) in a CpG context (right, in
red). Each bar corresponds to a different cell. Cells are sorted by total number of GpC or CpG sites,
respectively. Cells below the dashed line (50,000 CpG sites and 500,000 GpC sites, respectively)
were removed on the basis of poor coverage.
(c) RNA library size (top) and number of expressed genes (bottom) per cell. Cells below the
dashed line (10,000 reads and 500 expressed genes, respectively) were removed on the basis of poor
coverage.
(d) Number of cells that pass quality control for each molecular layer, stratified by stage. Note that
for 1,419 out of 2,524 cells only the RNA expression was sequenced.
(e) Venn Diagram displaying the number of cells that pass quality control for each data modality:
RNA expression (green), DNA methylation (red), chromatin accessibility (blue).
4.2.2 Cell type assignment using the RNA expression data
To define cell type annotations we mapped the RNA expression profiles to the scRNA-seq gastrulation
atlas [232] using a matching mutual nearest neighbours algorithm [105] (Figure 4.2). In short, the
count matrices for both data sets were concatenated and normalised together. Then, Principal
Component Analysis was applied to the joint normalised expression matrix. The resulting latent
space was then used for the construction of a k-nearest neighbours graph. Finally, for each scNMT-
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seq cell, we assigned a cell type using majority voting on the cell type distribution of the top 30
nearest neighbours in the atlas. We validated the cell type assignments by visualising the expression
of known marker genes (Figure 4.3).
E4.5 E5.5 E6.5 E7.5
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Figure 4.2: Cell type assignments using the RNA expression data. For each stage, the


































Figure 4.3: Validation of cell types by visualisation of marker genes.
UMAP projections of the atlas data set (stages E6.5 to E8.0). In the top left plot, cells are coloured
by lineage assignment. In the bottom left plot, the cells coloured in red correspond to the nearest
neighbours that were used to transfer labels to the scNMT-seq data set. The right plots display the
RNA expression levels of marker genes for different cell types.
4.2.3 Validation of DNA methylation data and chromatin accessi-
bility data
To validate the DNA methylation and chromatin accessibility data, we performed dimensionality
reduction separately for both data modalities using two different settings: (1) with cells from all
stages; and (2) separately at each stage. To handle the large amount of missing values that result
from single-cell bisulfite data we adopted a Bayesian Factor Analysis model (i.e. MOFA with one
view, as described in Chapter 3).
Reassuringly, we observe that for both modalities the model with all cells captures a developmental
progression from E4.5 to E7.5 (Figure 4.1). When fitting a separate model for stages E4.5, E5.5 and
E6.5, the largest source of variation (Factor 1) separates cells by embryonic versus extra-embryonic
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origin, as expected (Figure 4.4). At E7.5 extra-embryonic cells were manually removed during the










































































































































DNA methylation Chromatin accessibility
Figure 4.4: Dimensionality reduction of (a) DNA methylation and (b) chromatin
accessibility data. Shown are scatter plots of the first two latent factors (sorted by variance
explained) that result from applying Bayesian Factor Analysis. From E4.5 to E6.5 cells are coloured
by embryonic or extra-embryonic origin. At E7.5, cells are coloured by their primary germ layer.
4.2.4 Exit from pluripotency is concomitant with the establishment
of a repressive epigenetic landscape
First, we explored the dynamics of DNA methylation and chromatin accessibility associated with
each stage transition. At the global level, CpG methylation levels increase from ≈ 25% to ≈ 75% in
the embryonic tissue and ≈ 50% in the extra-embryonic tissue. This is consistent with previous
studies that described a de novo methylation wave from E4.5 to E5.5 that preferentially targets
CpG-poor genomic loci [19, 336] (Figure 4.5 and Figure 4.6). In contrast to the sharp increase in
DNA methylation, we observed a more gradual decline in global chromatin accessibility from ≈ 38%
at E4.5 to ≈ 29% at E7.5, with no significant differences between embryonic and extra-embryonic
tissues (t-test, Figure 4.6). Similar to the DNA methylation changes, CpG-rich regions remain more
accessible than CpG-poor regions of the genome, as expected.
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Figure 4.5: DNA methylation and chromatin accessibility levels per stage and genomic
context.






























































































p = 0.0041 p < 2.22e−16p < 2.22e−16
p = 0.41p = 0.25p = 0.06
Figure 4.6: Global DNA methylation and chromatin accessibility levels per stage and
lineage.
Box plots display the distribution of global (a) CpG methylation or (b) GpC accessibility per stage
and lineage. Each dot represents a single cell.
Next we attempted to characterise the relationship between the transcriptome and the epigenome
along differentiation. For simplicity we focused on gene promoters (defined as 2kb up and down-
stream from the transcription start site), as RNA expression and epigenetic readouts can be matched
unambiguously. We calculated, for each gene, the correlation coefficient between RNA expression
and the corresponding DNA methylation or chromatin accessibility levels. As a filtering criterion,
we required a minimum number of 1 CpG (methylation) or 3 GpC (accessibility) measurements in
at least 50 cells for each genomic feature. In addition, we restricted the analysis to the top 5,000
most variable genes, according to the rationale of independent filtering [35].
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We identified 125 genes whose expression shows significant correlation with promoter DNA methyla-
tion and 52 that show a significant correlation with chromatin accessibility. Among the top hits
that display significant associations for both comparisons we identified early pluripotency and germ
cell markers, including Dppa4, Dppa5a, Rex1, Tex19.1 and Pou3f1 (Figure 4.7). Reassuringly, all of
them have a negative association between RNA expression and DNA methylation and a positive as-
sociation between RNA expression and chromatin accessibility. Inspection of the transcriptomic and
epigenetic dynamics reveals that the repression of these early pluripotency markers are concomitant










































Figure 4.7: Genome-wide association analysis between RNA expression and the cor-
responding epigenetic status in gene promoters.
(a) Scatter plot of Pearson correlation coefficients between promoter DNA methylation versus RNA
expression (x-axis); and promoter accessibility versus RNA expression (y-axis). Significant associa-
tions for both correlation modes (FDR<10%) are coloured in red. Examples of early pluripotency
and germ cell markers among the significant hits are labeled in red.
(b) Illustrative example of epigenetic repression of the gene Dppa4. Box and violin plots display
the distribution of RNA expression (log2 counts, green), DNA methylation (% levels, red) and
chromatin accessibility (% levels, blue) per stage. Each dot corresponds to one cell.
4.2.5 MOFA reveals coordinated variability between the transcrip-
tome and the epigenome during germ layer formation
In the previous section we demonstrated that exit from pluripotency is concomitant with the
establishment of a repressive epigenetic landscape that is characterised by increasing levels of
DNA methylation and decreasing levels of chromatin accessibility. Next, we sought to investigate
the coordinated changes between RNA expression and epigenetic status that define germ layer
commitment at the E7.5 stage. We performed an unsupervised integrative analysis using Multi-
Omics Factor Anaysis (MOFA, introduced in Chapter 3). As a reminder for the reader, MOFA
takes as input multiple data modalities and it exploits the covariation patterns between the features
within and between modalities to learn a low-dimensional representation of the data in terms of a
small number of latent factors (Figure 3.13). Each Factor captures a different source of cell-to-cell
heterogeneity, and the corresponding weight vectors (one per data modality) provide a measure
of feature importance. Importantly, MOFA relies on multi-modal measurements from the same
cell to identify whether factors are unique to a single data modality or shared across multiple data
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modalities, thereby providing a principled approach to reveal the extent of covariation between
different data modalities.
Data preprocessing
As input to MOFA we used the RNA expression data quantified over genes and the DNA methylation
and chromatin accessibility data quantified over putative regulatory elements. For this analysis, we
selected distal H3K27ac sites (enhancers) and H3K4me3 (active transcription start sites). Both
annotations were defined using an independently generated ChIP-seq data set, where each germ
layer at E7.5 was manually dissected out prior to ChIP-seq [331]. An overview on the numbers and























Figure 4.8: Venn diagrams showing overlap of peak calls for each lineage-specific histone mark,
for distal H3K27ac (left) and all H3K4me3 (right). The figure shows that distal H3K27ac peaks
(putative enhancer [65]) have moderate levels of overlap between the three germ layers. In contrast,
H3K4me3 peaks (active transcription start sites [172]) are similar between the three germ layers.
Additionally, we quantified DNA methylation and chromatin accessibility in gene promoters, again
defined as 2kb upstream and downstream of the transcription start sites.
To reduce computational complexity and to increase the signal-to-noise ratio we performed feature
selection. First, we required for genomic features to have a minimum of 1 CpG (methylation) or 5
GpC (accessibility) observed in at least 25% of cells. Genes were required to be expressed in at least
25% of cells. Second, we subset the epigenetic modalities to the top 1,000 most variable features
and the RNA expression to the top 2,500 most variable genes.
Summary of the MOFA output
MOFA identified 6 Factors capturing at least 1% of variance in the RNA expression data (Figure 4.9).
The first two Factors (sorted by variance explained) captured the the emergence of the three germ
layers, indicating that germ layer commitment is the largest source of variation across all molecular
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layers at E7.5. Notably, for these two Factors, MOFA links the variation at the gene expression level
to concerted DNA methylation and chromatin accessibility changes at lineage-specific enhancer marks.
Surprisingly, these two Factors capture very small amounts of the variation in DNA methylation
and chromatin accessibility at promoters. This suggests that epigenetic changes in promoters may
not be linked to germ layer commitment, with distal regulatory elements (i.e. enhancers) playing a
more prominent role. Yet, we cannot rule out important variation in other epigenetic layers such as



























































Figure 4.9: MOFA reveals coordinated epigenetic and transcriptomic variation at
enhancer elements associated with germ layer commitment.
(a) Percentage of variance explained by each MOFA factor (rows) across data modalities (columns).
Considered data modalities were RNA expression (green); DNA methylation (red) and chromatin
accessibility (blue) quantified on promoters, lineage-specific H3K4me3-marked sites and distal
H3K27ac-marked sites (putative enhancers). Factors are sorted by their total variance explained
across all data modalities.
(b) Scatter plot of Factors 1 and 2. Cells are coloured according to their lineage assignment.
The four remaining factors correspond to mostly transcriptional signatures related to anterior-
posterior axial patterning (Factor 3), lineaging events such as notochord formation (Factor 4) and
mesoderm patterning (Factor 5); and cell cycle (Factor 6). Their characterisation is shown in
Appendix B.
4.2.6 Differential DNA methylation and chromatin accessibility anal-
ysis
The MOFA analysis in the previous section reveals interesting genome-wide trends. We next
attempted to pinpoint individual genomic elements that could be representative of the global
patterns. This could be done by inspecting the feature weights in the MOFA model, but given that
we can accurately classify cells into the three (discrete) germ layers, here we decided to adopt a more
intuitive supervised approach. For each genomic element (with sufficient coverage), we calculated
differential DNA methylation and chromatin accessibility between each germ layer versus the other
two using a Fisher exact test for binomial proportions (Figures 4.10 and 4.11).
In general we observe that, consistent with the MOFA results, only enhancers display substantial
amounts of epigenetic variation between the germ layers (Figure 4.10). As expected, endoderm
enhancers seem to be more associated with endoderm commitment (more open and unmethylated in
the endoderm cells) whereas mesoderm enhancers are more associated with mesoderm commitment
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(again, more open and unmethylated in the mesoderm cells). Notably, for both endoderm and
mesoderm commitment events, the effect sizes associated with regions that display differential
demethylation and chromatin accessibility are moderate (less than≈30% change in levels, Figure 4.11)
but coordinated across multiple enhancers (between ≈10% and ≈25% of the distal H3K27ac peaks,
Figure 4.10).
Intriguingly, ectoderm enhancers display less associations than their meso- and endoderm coun-
terparts, even for ectoderm commitment. This indicates a potential asymmetric contribution of
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Figure 4.10: Differential DNA methylation and chromatin accessibility analysis be-
tween germ layers at E7.5
Bar plots display (a) the fraction and (b) the total number of differentially methylated (red) or
accessible (blue) loci (FDR<10%, Fisher exact test for binomial proportions, y-axis) per genomic
context (x-axis). Each panel corresponds to the comparison of cells from one germ layer (group
A) against cells comprising the other two germ layers (Group B). For (b), positive values indicate
increase in DNA methylation or chromatin accessibility in group A, whereas negative values indicate
decrease in DNA methylation or chromatin accessibility.
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Figure 4.11: Differential DNA methylation and chromatin accessibility between germ
layers at E7.5
Scatter plots display differential DNA methylation (%, x-axis) and chromatin accessibility (%,
y-axis) at (a) lineage-defining enhancers and (b) promoters. Comparisons are ectoderm versus
non-ectoderm cells (left), endoderm versus non-endoderm cells (middle) and mesoderm versus
non-mesoderm cells (right). Black dots depict gene-enhancer or gene-promoter pairs with significant
changes in RNA expression and DNA methylation or chromatin accessibility (FDR<10%). Genes
were linked to enhancers by overlapping genomic coordinates with a maximum distance of 50kb.
Characterisation of individual enhancers
The results above suggest that the establishment of lineage-specific epigenetic profiles results from the
coordinated action of multiple elements located all across the genome, and hence the identification
of individual putative regulatory elements is not trivial and probably requires a much larger data
set than the one we profiled. Nevertheless, when linking enhancers to genes by a maximum genomic
distance of 25kb we identified some interesting gene-enhancer associations linked to key germ layer
markers including Snai1 and Mesp2 for mesoderm, Bmp2 and Hnf1b for endoderm, Bcl11a and













































































































































































































































































































































































































































Figure 4.12: Illustrative examples of putative epigenetic regulation in enhancer ele-
ments during germ layer commitment.
Box and violin plots show the distribution of RNA expression (log normalised counts, green), DNA
methylation (%, red) and chromatin accessibility (%, blue) levels per stage and lineage. Each dot
corresponds to a cell. The enhancer region that is used to quantify DNA methylation and chromatin
accessibility levels is represented with a star and highlighted in yellow in the genomic track above
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4.2.7 Transcription factor motif enrichment analysis
To identify transcription factors (TFs) that could drive the epigenetic variation in lineage-defining
enhancers during germ layer commitment, we integrated the chromatin accessibility and RNA
information as follows. For every TF with an associated motif in the Jaspar core 95 vertebrates data
base we extracted its position-specific weight matrix and we tested for enrichment in differentially
accessible distal H3K27ac sites using a background of all distal H3K27ac sites. To assess statistical
significance we used a Fisher exact test, as implemented in the meme suite (v4.10.1) [21]. This
information was then integrated with differential RNA expression between germ layers for the same
TFs, quantified using the gene-wise negative binomial generalised linear model with quasi-likelihood
implemented in edgeR [196]. Reassuringly, this analysis revealed that lineage-defining enhancers are
enriched for key developmental TFs, including POU3F1, SOX2, SP8 for ectoderm; SOX17, HNF1B,
FOXA2 for endoderm; and GATA4, HAND1, TWIST1, for mesoderm (Figure 4.13).
Although this analysis serves as a good quality control for our results, it is important to keep in
mind that using sequence information is only a proxy for true TF binding, and some essential TFs
to not target specific motifs, including EOMES or BRACHYURY [305].



















































Differential RNA expression Differential RNA expression Differential RNA expression
Figure 4.13: Transcription Factor motif enrichment analysis at lineage-defining distal
H3K27ac sites. Shown is motif enrichment (-log10 q-value, y-axis) plotted against differential RNA
expression (log fold change, x-axis) of the corresponding TF. The analysis is performed separately
for each set of lineage-defining enhancers: ectoderm (left), endoderm (middle) and mesoderm (right).
TFs with significant motif enrichment (FDR<1%) and differential RNA expression (FDR<1% and
log-fold change higher than 2) are coloured and labelled.
4.2.8 Time resolution of the enhancer epigenome
In the previous section we have shown that distal regions marked with H3K27ac (i.e. putative
enhancers) are the elements that drive or respond to germ layer specification at E7.5.
Next, we sought to explore how these epigenetic patterns are established. We visualised DNA
methylation and chromatin accessibility levels at lineage-defining enhancers from E4.5 to E7.5 (Fig-
ure 4.14). Importantly, to interpret the visualisation, DNA methylation and chromatin accessibility
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Figure 4.14: DNA methylation and chromatin accessibility dynamics at lineage-
defining enhancers visualised at pseudobulk resolution.
DNA methylation (red) and chromatin accessibility (blue) levels at lineage-defining enhancers
quantified over different lineages across development. Shown are running averages in consecutive
50bp windows around the center of the ChIP-seq peaks (1kb upstream and downstream). Solid lines
display the mean across cells and shading displays the corresponding standard deviation. Dashed
horizontal lines represent genome-wide background levels for DNA methylation (red) and chromatin
accessibility (blue).
The DNA methylation and chromatin accessibility dynamics can also be visualised at the single-cell
level (Figure 4.15).
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Figure 4.15: DNA methylation and chromatin accessibility dynamics at lineage-
defining enhancers, visualised at single-cell resolution.
UMAP projection based on the MOFA factors inferred using all cells. In the left plot the cells are
coloured according to their lineage assignment. In the right plots cells are coloured by average
DNA methylation (top) or chromatin accessibility (bottom) at lineage-defining enhancers. For cells
with only RNA expression data, the MOFA factors were used to impute the DNA methylation and
chromatin accessibility values.
For clarity, the epigenetic dynamics for mesoderm and endoderm enhancers will be described first,
followed by the ectoderm enhancers.
Mesoderm and endoderm enhancers undergo concerted demethylation and chro-
matin opening upon lineage specification
From E4.5 to E6.5, mesoderm and endoderm enhancers closely follow the genome-wide trend and
undergo a dramatic increase in DNA methylation from an average of ≈25% to ≈80%. Consistently,
the chromatin accessibility decreases from ≈35% to ≈ 25% (Figure 4.14 and Figure 4.15).
Upon germ layer specification at E7.5, mesoderm and endoderm enhancers undergo concerted
demethylation from ≈ 80% to ≈50% in a lineage-specific manner (i.e. mesoderm enhancers demethy-
late in mesoderm cells, whereas endoderm enhancers demethylate in endoderm cells). Consistently,
chromatin accessibility sharply increases from ≈ 25% to ≈45% upon lineage specification.
Ectoderm enhancers are primed in the early epiblast
In striking contrast to the mesoderm and endoderm enhancers, the ectoderm enhancers are open
and demethylated as early as the E4.5 epiblast. Interestingly, the ectoderm cells share the same
epigenetic profile (in enhancer elements) as the epiblast, characterised by demethylated and open
ectoderm enhancers; and methylated and closed mesoderm and endoderm enhancers (Figure 4.14
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and Figure 4.15). Upon commitment to mesoderm and endoderm, ectoderm enhancers become
partially repressed.
Two hypotheses could explain this observation. The first hypothesis is that ectoderm enhancers are
a mixture of pluripotency and proper ectoderm signatures, and hence the pluripotency signatures
are driving the demethylation and chromatin opening in early stage, whereas the proper ectoderm
signatures are driving the demethylation and chromatin opening upon commitment to ectoderm.
The second hypothesis is that the ectoderm fate is epigenetically primed in the early epiblast (i.e.
ectoderm is the default lineage), and hence the ectoderm enhancers remain demethylated and open
all along from the epiblast to the ectoderm.
To investigate this, the first step is to disentangle the pluripotency and ectoderm signatures that
may be confounded within the ectoderm enhancers. We selected the set of E7.5 ectoderm enhancers
(n=2,039) and, at each element, we quantified the H3K27ac levels in ESCs and E10.5 midbrain,
a tissue largely derived from the (neuro-)ectoderm layer. Both annotations were derived from
the ENCODE project [333]. Remarkably, we observe that the E7.5 ectoderm enhancers consist
of an almost exclusive mixture of pluripotent and neuroectoderm signatures, as indicated by the
negative correlation between H3K27ac levels in ESCs versus E10.5 midbrain (Figure 4.16). This
result supports the first hypothesis, but does not rule out the second hypothesis.
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Figure 4.16: E7.5 ectoderm enhancers contain a mixture of pluripotency and neural
signatures.
(a) Scatter plot of ectoderm enhancers’ H3K27ac levels quantified in ESCs (pluripotency enhancers,
x-axis) and E10.5 midbrain (neuroectoderm enhancers, y-axis). Each dot corresponds to an ectoderm
enhancer (Figure 4.8). Highlighted are the top 250 ectoderm enhancers that show the strongest
differential H3K27ac levels between E10.5 midbrain and ESCs (blue for neuroectoderm enhancers
and grey for pluripotency enhancers).
(b) Density plots of H3K27ac levels quantified in ESCs (x-axis) versus E10.5 midbrain (y-axis), for
ectoderm enhancers (left) and endoderm enhancers (right). Endoderm enhancers were included as
a control to show that the negative association is exclusive to ectoderm enhancers.
Next, among the E7.5 ectoderm enhancers we defined a set of 250 neuroectoderm enhancers (high
H3K27ac levels in E10.5 midbrain) and a separate set of 250 pluripotency enhancers (high H3K27ac
levels in ESCs) (blue and grey dots in Figure 4.16). Additionally, we also considered endoderm
enhancers as a negative control.
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For each class of enhancers, we quantified and visualised the DNA methylation and chromatin
accessibility dynamics along the epiblast-ectoderm trajectory Figure 4.17). We plotted absolute
levels in (a) and normalised levels to the genome-wide background in (b). We remind the reader
that to interpret the plot below, it is critical to compare the absolute levels to the genome-wide
background levels.
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Figure 4.17: Pluripotency and neurectoderm enhancers display different DNA methy-
lation and chromatin accessibility dynamics.
(a) Profiles of DNA methylation (red) and chromatin accessibility (blue) quantified along the
epiblast-ectoderm trajectory. Each panel corresponds to a different genomic context. Profiles are
quantified using running averages of 50-bp windows around the centre of the ChIP-seq peak for
a total of 2 kb upstream and downstream. Solid lines display the mean across cells and shading
displays the corresponding standard deviation. Dashed horizontal lines represent genome-wide
background levels for DNA methylation (red) and chromatin accessibility (blue).
(b) Box plots of DNA methylation (top) and chromatin accessibility (bottom) levels quantified
along the epiblast-ectoderm trajectory). Levels are scaled to the genome-wide background for each
stage.
The three types of enhancers display very different epigenetic dynamics:
• Endoderm enhancers simply follow the genome-wide repressive dynamics, driven by a global
increase in DNA methylation and a decrease in chromatin accessibility. Consistently, the
relative levels for both measurements are close to ≈ 1.
• Pluripotency enhancers display an increase in DNA methylation from ≈ 15% at E4.5 to ≈ 60%
at E7.5 and a decrease in chromatin accessibility from ≈ 50% at E4.5 to ≈ 35% at E7.5. This
is similar to our previous result on the promoters dynamics of pluripotency genes (Figure 4.7).
The relative levels show a steady decrease of DNA methylation and a moderate decrease in
chromatin accessibility, consistent again with the global repressive dynamics.
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• Neuroectoderm enhancers remain at ≈ 40% DNA methylation and ≈ 40% chromatin accessi-
bility from E5.5 to E7.5. This is significantly higher methylation levels and lower chromatin
accessibility levels than the genome-wide background. In addition, when looking at the relative
values, neuroectoderm enhancers undergo steady decrease in DNA methylation and an increase
in chromatin accessibility.
To our surprise, the results indicate that both hypotheses are correct. Ectoderm enhancers at
E7.5 contain a mixture of pluripotency and neuroectoderm signatures, but both signatures display
different epigenetic dynamics. Whereas pluripotency enhancers become repressed alongside the
global repressive dynamics, neuroectoderm enhancers display a signature of active chromatin in the
early epiblast.
We conclude that the epigenetic profile of neuroectoderm fate is primed as early as in the E4.5
epiblast. This finding supports the existence of a default pathway in the Waddington landscape of
development, with the ectoderm being the default germ layer in the embryo. As we will discuss
below, this model provides a potential explanation for the phenomenon of default differentiation of
neuroectodermal tissue from ESCs in vitro [213, 114].









Figure 4.18: Schematic illustration of the hierarchical model for the epigenetic dynam-
ics of germ layer commitment. Illustration designed by Veronique Juvin from SciArtWork.
Silencing of ectoderm enhancers precedes mesoderm and endoderm commitment
At E6.5, TGF-β and Wnt signalling in the posterior side of the embryo promote exit from pluripotency
and induce the formation of the primitive streak, which is characterised by the expression of T-box
factors such as Eomes and Brachyury [306]. This transient programme, also called the mesendoderm
state, eventually gives rise to the embryonic endoderm and mesoderm lineages.
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The triple-omics nature of scNMT-seq measurements prompted us to explore whether differences
exist in the timing of onset of molecular events at the mesendoderm state. In particular, we explored
whether the lineage-specific epigenetic profiles are remodelled prior or after the transcriptomic
programme is activated.
Following recent successes in reconstructing trajectories from scRNA-seq data, we used the RNA
expression profiles to order cells by their developmental state to generate two trajectories, corre-
sponding to mesoderm and endoderm commitment (Figure 4.19a). Reassuringly, both pseudotime
trajectories captured the transitiom from epiblast to either mesoderm or endoderm fates, with the
primitive streak as a transient state. Subsequently, we plotted, for each cell, the average DNA
methylation and chromatin accessibility for each class of lineage-defining enhancers (Figure 4.19b).
We find that, as cells begin to display a primitive streak phenotype, ectoderm-defining enhancers
progressively decrease in accessibility and gain methylation, a process that continues as cells differ-
entiate into the mesoderm and endoderm. In contrast, mesoderm and endoderm-defining enhancers
simultaneously become hypomethylated and accessible only after commitment to these cell fates. In
both cases, changes in DNA methylation and chromatin accessibility co-occur, suggesting a tight
regulation of the two epigenetic layers.
In conclusion, we observe a sequential process where the inactivation of ectoderm enhancers precedes
the activation of the mesendoderm enhancers. Interestingly, this resembles reprogramming of induced
pluripotent stem cells, where the differentiated programme is repressed prior to the activation of
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Figure 4.19: Silencing of ectoderm enhancers precedes activation of mesoderm and
endoderm enhancers.
(a) Reconstructed mesoderm (top) and endoderm (bottom) commitment trajectories using a
diffusion pseudotime method applied to the RNA expression data. Shown are scatter plots of the
first two diffusion components, with cells coloured according to their lineage assignment. (b) DNA
methylation (red) and chromatin accessibility (blue) dynamics of lineage-defining enhancers along
the mesoderm (top) and endoderm (bottom) trajectories. Each dot denotes a single cell and black
curves represent non-parametric loess regression fit. In addition, for each setting we fit a piece-wise
linear regression model (vertical dashed lines indicate the thresholds used). For each model fit, the
slope (r) and its significance level is displayed in the top (- for non-significant, ∗ for 0.01 < p < 0.1
and ∗∗ for p < 0.01).
4.2.9 TET enzymes are required for efficient demethylation of lineage-
defining enhancers in embryoid bodies
For a long time it was thought that DNA methylation was an irreversible epigenetic event, until
a family of enzymes called ten eleven translocation proteins (TET)s were shown to erase DNA
methylation marks via a succession of oxidative events [247]. This discovery fundamentally changed
our understanding of DNA methylation, suggesting that it is not as static as previously assumed.
In the context of development, TET enzymes have been implicated in enhancer demethylation,
and loss-of-function experiments both in vitro and in vivo suggest that TET enzymes are vital for
gastrulation [70, 265, 247, 170].
In our study, to test whether TET enzymes drive the lineage-specific demethylation events, we used
an in vitro system where embryoid bodies were differentiated in serum conditions using both wild
type (WT) mouse ESCs and cells that were deficient for all three TET enzymes (TET TKO). The
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embryoid bodies were dissociated and subjected to scNMT-seq at days 2, 4-5, and 6-7 following the
onset of differentiation.
Cell type assignment using the RNA expression
As in Figure 4.2, cell types were assigned by mapping the RNA expression profiles to the in vivo
gastrulation atlas using a mutual nearest neighbours matching algorithm [105].
Notably, the WT cells from the EB differentiation protocol recapitulate the in vivo dynamics with
remarkably accuracy (Figure 4.20). At day 2, most cells are in the pluripotent epiblast stage, which
roughly corresponds to embryonic stages E4.5 to E5.5. At days 4-5, EBs begin the formation of
primitive streak cells, as in embryonic stages E6.5 to E7.0. At days 6-7 of differentiation the primitive
streak cells eventually commit to mesoderm (mostly) or endoderm fate, as in embryonic stages
E7.0 to E8.0. In addition, at days 6-7 we observe the emergence of mature mesoderm structures
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Figure 4.20: Cell type assignment for the Embryoid Body differentiation experiment.
(a) UMAP projection of the 10x atlas data set (stages E6.5 to E8.5, no extra-embryonic cells),
where cells are coloured by lineage assignment.
(b) Same UMAP projection as in (a), but in this case, for each day of EB differentiation, cells are
coloured by the the nearest neighbours that were used to assign cell type labels to the query cells.
Cells from a WT genotype are shown in red and cells from a TET TKO genotype are shown in
blue.
(c) Bar plots display the cell type numbers for each day of EB differentiation, grouped by WT or
TET TKO genotype.
To validate the mapping results, we inspected the expression of marker genes for the different lineages.



















































Figure 4.21: Embryoid bodies recapitulate the transcriptional heterogeneity of the
mouse embryo.
(a) UMAP projection for the embryoid body dataset, where cells are coloured by lineage assignment
and shaped by genotype (WT or TET TKO).
(b) UMAP projection of the atlas data set (stages E6.5 to E8.5, no extra-embryonic cells). Cells
coloured correspond to the nearest neighbours that were used to assign cell type labels to the EB
dataset, red for WT and blue for TET TKO.
(c) UMAP projection of embryoid body cells, as in (a), coloured by the relative RNA expression of
marker genes.
Validation of epigenetic measurements
After validating the reproducibility of the EB system to capture the transcriptomics of post-
implantation and early gastrulation, we proceed to validate the epigenetic measurements. At the
global level, DNA methylation increases in WT cells from ≈55% at day 2 to ≈75% at day 7, whereas
chromatin accessibility decreases from ≈20% at day 2 to ≈16% at day 7 (Figure 4.22).
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Figure 4.22: Global DNA methylation and chromatin accessibility levels during em-
bryoid body differentiation (in WT cells).
(a) Box plots showing the distribution of genome-wide CpG methylation (left) or GpC accessibility
levels (right) per stage and lineage. Each dot represents a single cell.
(b) Heatmap of DNA methylation (left) or chromatin accessibility (right) levels per stage and
genomic context.
Critically, ectoderm-defining enhancers are protected from the global repressive dynamics in the
epiblast-like cells. Upon mesoderm commitment, mesoderm-defining enhancers demethylate from
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Figure 4.23: Profiles of DNA methylation (red) and chromatin accessibility (blue) at
lineage-defining enhancers quantified along EB differentiation using WT cells.
Shown are running averages in consecutive 50bp windows around the centre of the ChIP-seq peaks
(1kb upstream and downstream). Solid lines display the mean across cells and shading displays
the corresponding standard deviation. Dashed horizontal lines represent genome-wide background
levels for DNA methylation (red) and chromatin accessibility (blue).
In conclusion, although the absolute numbers differ with the in vivo data, the relative changes in
DNA methylation and chromatin accessibility in WT EBs substantially mirror the in vivo results.
Characterisation of the TET TKO phenotype
Having validated the EB system from a transcriptomic and epigenetic perspective, we proceed to
compare the WT and the TET TKO cells. At the epigenetic level, TET TKO epiblast-like cells
(day 2) display higher levels of DNA methylation in ectoderm enhancers, but no differences in
mesoderm or endoderm enhancers (Figure 4.24). No significant differences are observed between
WT and TET TKO for chromatin accessibility. Interestingly, the TET TKO cells also display an
increased proportion of cells undergoing mesendoderm transition (days 4-5, 95% versus 51% in the
WT). This is suggestive of an early induction of gastrulation.
After the mesendoderm transition (days 4-5), mesoderm-committed TET TKO cells (days 6-7)
failed to properly demethylate mesoderm-specific enhancers (Figure 4.24). This indicates that (1)
enhancer demethylation is not required for early mesoderm commitment, and (2) demethylation of
lineage-defining enhancers results from an active process that is at least partially driven by TET
proteins.
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Figure 4.24: Distribution of DNA methylation (top) or chromatin accessibility values
for lineage-defining enhancers in the epiblast-like cells at day 2 and the mesoderm-like
cells at days 6-7 of EB differentiation.
The y-axis shows the DNA methylation or chromatin accessibility levels (%) scaled to the genome-
wide levels. P-values resulting from comparisons of group means (t-test) are displayed above each
pair of box plots. Asterisks denote significant differences at a significance threshold of 1% FDR.
Finally, at days 6-7 we observe a systematic loss of hematopoietic cell types in the TET TKO
(Figure 4.20). This suggests that TET-mediated demethylation events, although not crucial for early
mesendoderm commitment, seem to be important for subsequent cell fate decisions. Notably, our
observations are concordant with findings from previous studies in vivo [70], which demonstrated
that TET TKO embryos are able to initiate gastrulation, but by E8.5 they display defective
mesoderm migration with no recognisable mature mesoderm structures.
4.3 Conclusions, limitations and future perspectives
In this work we have employed scNMT-seq to generate a multi-omics atlas of mouse gastrulation at
single-cell resolution. We find that the initial exit from pluripotency coincides with the establishment
of a repressive epigenetic landscape, characterised by increasing levels of DNA methylation and
decreasing levels of chromatin accessibility. This gradual lock-down of the genome is followed by the
emergence of distal regulatory elements that become unmethylated and accessible upon germ layer
commitment. Most notably, when tracing back the epigenetic dynamics for the lineage-defining
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enhancers to the early epiblast stage, we observe that post-implantation cells display epigenetic
priming for an ectoderm fate. This finding supports the existence of a default path in the Waddington
landscape of development, with the ectoderm being the default germ layer in the embryo. In contrast,
commitment to endoderm and mesoderm fates occurs by an active diversion from the default path
likely driven by signalling cues in the primitive streak transient state.
Experimental evidence exist to support this hypothesis. Several groups have shown that, in the
absence of external stimuli, ESCs differentiate to neurons [213, 114], a phenomenon that still remains
largely unexplained. We believe that the epigenetic priming of neuroectoderm enhancers that we
identified in this study could provide the molecular logic for a hierarchical emergence of the primary
germ layers.
Our study is not free of limitations that we hope to address in the future:
• Scalability: in its current form, scNMT-seq is a laborious and expensive protocol, unsuitable for
the profiling of large numbers of cells. In this study, we had to rely on pseudobulk approaches
to obtain sufficient statistical power for some of our results. Also, it is likely that we have been
underpowered to detect subtle yet important epigenetic variation. As discussed in Chapter 2,
some optimisations can be implemented to make the assay more high-throughput, with the
eventual goal of applying it to study organogenesis.
• Coverage: single-cell bisulfite sequencing technologies yield very sparse measurements, partic-
ularly for small regulatory elements. Hence, it is very likely that we have missed important
regulatory elements in our analysis.
• Further experimental support for the default pathway: the default pathway hypothesis is
appealing and supported by independent experiments. Nonetheless, further investigation is
required to understand how it works. How are ectoderm enhancers epigenetically primed (i.e.
what protects them from DNA methylation in the pluripotent stages)? How could we perturb
the default pathway? Is there a way to artifically methylate ectoderm enhancers by precise
genome targeting?
• Further experimental validation for the role of TET TKO in lineage commitment: our
experiments using EBs have yielded promising insights, but as a next step we should verify
whether this can be reproduced in an in vivo setting. However, obtaining knock out mice is
challenging and time-consuming, and more importantly, the phenotypic effects of the mutation
can be masked by gross developmental defects or embryo lethality. For this reason, we are
going to explore the usage of chimeric embryos by injecting fluorescence-labelled ESCs cells
with a TET TKO background into wild-type blastocysts. If the injection is successful, the
adult will contain a mixture of WT and TET TKO cells that can be separated by FACS and
studied independently [232]. A major benefit of this experimental system is that any function
impaired in the TET TKO cells should be compensated by the WT cells and, in contrast a
full knock out, the embryo can develop (almost) normally.
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Chapter 5
MOFA+: a statistical framework for the
integration of large-scale structured datasets
In Chapter 3 we developed Multi-Omics Factor Analysis (MOFA), a statistical framework for the
unsupervised integration of multi-omics data. MOFA addresses key challenges in data integration,
including overfitting, noise reduction, handling of missing values and improved interpretation of the
model output. However, when applied to increasingly-large single-cell genomics datasets, the varia-
tional inference scheme offers limited scalability. In addition, the increased experimental throughput
has facilitated the simultaneous study of multiple conditions within the same experimental design
[251]. However, MOFA makes strong independence assumptions about the dependencies across
samples and it provides no principled strategy to model datasets where the samples are structured
into multiple groups (i.e. batches, donors or even independent studies). In this Chapter we improve
the model formulation with the aim of performing integrative analysis of large-scale datasets where
the features are structured into multiple data modalities (views) and the samples (or cells) are
structured into different groups.
The work discussed in this Chapter has been peer-reviewed and published in [13]. The project was
conceived by Damien Arnol and me. The mathematical derivations and the implementation of the
stochastic variational inference scheme were done together by Damien Arnol, Yonatan Deloro and
me. I implemented the downstream analysis package, but with significant contributions from Danila
Bredikhin. I generated most figures and I wrote the manuscript with feedback from all authors.
John C. Marioni and Oliver Stegle supervised the project.
5.1 Theoretical foundations
5.1.1 Exponential family distributions
Exponential family distributions are a parametric class of probability distributions that have
characteristic mathematical properties which make them amenable for probabilistic modelling.
The majority of probability distributions that are commonly used in statistics belong to the
exponential family, including the normal or Gaussian, Gamma, Poisson, Bernoulli, Exponential, etc.
Formally, exponential family distributions can be represented in the following form:
p(x|θ) = h(x) exp{η(θ)T (x)−A(θ)} (5.1)
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where x is a multivariate random variable and θ are the distribution’s parameters. Each term has a
common notation: T(x): sufficient statistics; η(θ): natural parameters; h(x): base measure; A(η):
the log-partition function (or the normaliser).
The exponential family form for the probability distributions that are frequently used in this thesis
are shown below:
Univariate normal distribution:




















A(θ) = −0.25ηT1 η2−1η1 − 0.5 log(∥ − 2η2∥)
Gamma distribution:
η = [α− 1;−β]
T (x) = [log x;x]
h(x) = 1
A(θ) = log(Γ(η1 + 1))− (η1 + 1) log(−η2)
Beta distribution:
η = [α;β]




A(θ) = log(Γ(η1)) + log(Γ(η2))− log(Γ(η1 + η2))
In the context of Bayesian inference, the main property that make exponential family distributions
indispensable is that they have conjugate priors. That is, the combination of likelihood and prior
distributions ensure a closed-form posterior distribution which is of the same form as the prior. As
we have discussed in Chapter 3, this property is essential for enabling efficient statistical inference,
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otherwise posterior distributions must be computed using expensive and approximate numerical
methods.
5.1.2 Gradient ascent
Gradient ascent is a first-order optimization algorithm for finding the maximum of a function [31,
214]. Formally, for a differentiable function F (x), the iterative scheme of gradient ascent is:
x(t+1) = x(t) + ρ(t)∇F (x(t)) (5.2)
In short, the algorithm works by taking steps proportional to the gradient ∇F evaluated at each







(t))2 <∞. F is guaranteed to converge to
the global maximum if the objective function is convex [256]. If F is not convex, the algorithm is
sensitive to the initialisation xt=0 and can converge to local optima.
Stochastic gradient ascent
Gradient ascent becomes prohibitively slow with large datasets, mainly because of the computational
cost involved in the iterative calculation of gradients [280].
A simple strategy to speed up gradient ascent is to replace ∇F by an estimate ∇̂F using a random
subset of the data (minibatch). The iterative scheme is then defined in the same way as in standard
gradient ascent:
x(t+1) = x(t) + ρ(t)∇̂F (x(t)) (5.3)
Natural gradient ascent
Gradient ascent becomes problematic when applied to probabilistic models. To give the intuition,
consider a probabilistic model with a hidden variable x and corresponding parameter θ, with a
general objective function L(θ). From the definition of a derivative:
∇L(θ) = lim
||h||→0
L(θ + h)− L(θ)
||h||
where h represents an infinitesimally small positive step in the space of θ.
To find the direction of steepest ascent, one would need to search over all possible directions d in an







L(θ + d)− L(θ)
Importantly, this operation requires a distance metric to quantify what a small distance h means. In
standard gradient ascent, this is measured using the Euclidean norm, and the direction of steepest
ascent is hence dependent on the Euclidean geometry of the θ space. This problematic when doing
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probabilistic modelling because it does not consider the uncertainty that underlies probability
distributions. When θ is a random variable with an underlying probability distribution, a small
step from θ(t) to θ(t+1) does not guarantee an equivalently small change from L(θ(t)) to L(θ(t+1)).
To illustrate this, consider the following example of four random variables:
N (ψ1 | 0, 5)
N (ψ2 | 10, 5)
N (ψ3 | 0, 1)
N (ψ4 | 10, 1)
(5.4)
Using the Euclidean metric, the distance between ψ1 and ψ2 is the same as the distance between ψ3
and ψ4. However, the distance in distribution space (measured for example by the KL divergence)





















Figure 5.1: Illustration of the problem of using the Euclidean norm as a distance
measure between parameters of probability distributions.
In both plots, the red and blue distributions are separated by the same Euclidean distance of 100.
Yet, the distance in probability space between the two distributions is higher in the right.
This basic simulation suggests that replacing the Euclidean distance by the KL divergence as a







L(θ + d)− L(θ)
The direction of steepest ascent measured by the KL divergence is called the natural gradient [8,
192]. To find the optimal d̂KL, one needs to solve the following optimisation problem:
argmin
d
L(θ + d) subject to KL[pθ||pθ+d] < c
where c is an arbitrary constant. Previous works have shown that this can be solved by introducing
Lagrange multipliers and Taylor expansions [8, 155]. The solution corresponds to the standard
(Euclidean) gradient pre-multiplied by the inverse of the Fisher Information Matrix of q(x|θ):
d̂KL ∝ F−1(θ)∇θL(θ) (5.5)
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where F(θ) is defined as
F(θ) = Eq(x|θ)[(∇θ log q(x|θ))(∇θ log q(x|θ))T ]
In conclusion, while the standard gradient points to the direction of steepest ascent in Euclidean
space, the natural gradient points to the direction of steepest ascent in a space where distances are
defined by the KL divergence [155, 8, 119].
5.1.3 Stochastic variational inference
In this section I will demonstrate how to derive a stochastic variational inference algorithm for general
Bayesian models. This work is inspired and adapted from [119]. A comprehensive mathematical
derivation of the algorithm is not sought in this Chapter, instead I will describe a modified and
simplified derivation that captures the gist of the original. For a complete mathematical derivation
I refer the reader to [119].
This section builds upon three theoretical foundations that have been introduced before: Variational
inference (Section 3.1.4), exponential family distributions (Section 5.1.1) and (natural) gradient
ascent (Section 5.1.2).
Model definition
Consider a probabilistic model with a set of unobserved random variables, observations and (non-
random) parameters. We begin by classifying the variables of the model into four different categories:
• observations (Y): N different vectors yn, each one containing the observed variables for the
n-th sample.
• local (hidden) variables (Z): N different vectors zn, each one containing K hidden variables
associated with the n-th sample.
• global (hidden) variables (β): one vector that contains B hidden variables not indexed by n.
• parameters (non-random) for the global variables (αβ).
• parameters (non-random) for the local variables (αz).












Figure 5.2: Graphical model for a general probabilistic model where unobserved vari-
ables are classified as global and local.
The dashed line indicates that the connection between global and local variables is optional, not
used in the MOFA model.
Notice that the difference between local and global variables lies on the conditional dependency
assumptions. The local variables for the n-th sample zn are conditionally independent from any
other observation yj or local variable zj (where j ̸= n), given that the global variables β are
observed:
p(yn, zn|yj , znj ,β,αzn ,αzj ) = p(yn, zn|β,αzn)
To relate this formulation to the MOFA model, the local variables would contain the factors whereas
the global variables would contain the feature weights.
For simplicity in the derivation, we will assume the existence of a single global variable β, a single
parameter αβ for the global variables and a single parameter αznk for each local variable.
The first assumption in the model is that the prior distributions of the local and global variables are
members of the exponential family (see Equation (5.1))
p(β|αβ) = h(β) exp{ηg(αβ)t(β)− ag(αβ)}
p(znk|αz) = h(znk) exp{ηl(αz)t(znk)− al(αz)}
(5.7)
The second assumption is that the complete conditionals of the unobserved variables are also
members of the exponential family:
p(β|Y,Z,α) = h(β) exp{ηg(Y,Z,α)T t(β)− ag(ηg(Y,Z,α))}
p(zn|ynj , znj , β) = h(zn) exp{ηl(ynj , znj , β)T t(zn)− al(ηl(ynj , znj , β))}
(5.8)
Setting up the inference problem
First, we set up the variational distributions for both the local variables and the global variables.
Here we are going to assume that all unobserved variables are independent (mean-field assumption)







and belong to the same exponential family as the corresponding prior distribution:
q(β|λ) = h(β) exp{ηg(λ)t(β)− ag(λ)} (5.9)
q(znk|ϕnk) = h(znk) exp{ηl(ϕn)t(znk)− al(znk)} (5.10)
where λ are the parameters governing the variational distribution for the global variables and ϕnk
are the parameters governing the variational distribution for the k-th local variable and the n-th
sample.
From the assumptions above, the ELBO (the objective function in variational inference, introduced
in Chapter 3) factorises as:









Eq(znk)[log q(znk)]− Eq(β)[log q(β)]
(5.11)
Notice that the objective decomposes into global terms (not involving N) and local terms (involving
N). Importantly, the local terms can be approximated using estimates of the gradient by subsampling












Eq(znk)[log q(znk)]− Eq(β)[log q(β)]
If the samples are independent then the expectation of this noisy gradient is equal to the true
gradient. This is the main principle of stochastic optimisation. The next step is to derive an iterative
algorithm to find the values of the variational parameters that maximise the ELBO.
Calculating the gradient for the global parameters
To derive the updates for the global parameters we first write the ELBO in terms of λ:
L(λ) = Eq(z,β)[log p(β|Y,Z)]− Eq(β)[log q(β)] + const.
where the constant term captures all quantities that do not depend on λ. Then, from the assumption
that the complete conditionals and the variational distributions belong to the exponential family
(Equations (5.8) to (5.9)):
L(λ) = Eq(z,β)[ηg(Y,Z,α)T t(β)]− Eq(β)[λT t(β)− ag(λ)] + const.
= Eq(z)[ηg(Y,Z,α)T ]∇a(λ)− λT∇ag(λ)− ag(λ) + const.
where we have used the exponential family identity Eq(β)[t(β)] = ∇ag(λ).
Taking the gradient with respect to λ:
∇λL(λ) = ∇2λag(λ)(Eq(z)[ηg(Y,Z,α)]− λ) (5.12)
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and setting it to zero leads to the solution:
λ = Eq(z)[ηg(Y,Z,α)] (5.13)
Calculating the gradient for the local parameters
Turning to the local parameters, as a function of ϕnk the ELBO becomes:
L(ϕnk) = Eq(β,znj)[log p(znj |yn, znj , β)]− Eq(znk)[log q(znk)] + const.
Again, from the assumption that the complete conditionals and the variational distributions belong
to the exponential family (Equations (5.8) to (5.9)):
L(ϕnk) = Eq(β,znj)[ηl(yn, znj , β)
T t(znj)]− Eq(znk)[ϕnkt(znk)− al(ϕnk)] + const.
= Eq(β,znj)[ηl(yn, znj , β)]
T∇al(ϕnk)− ϕnk∇al(ϕnk)− al(ϕnk) + const.
Taking the gradient with respect to ϕnk:
∇ϕL(ϕnk) = ∇2ϕal(ϕnk)(Eq(β,znj)[ηl(yn, znj , β)]− ϕnk) (5.14)
and setting it to zero leads to the following solution:
ϕnk = Eq(β,znj)[ηl(yn, znj , β)] (5.15)
Coordinate ascent variational inference algorithm
Now that we have the gradients for both the local and the global parameters, we can define a
gradient ascent algorithm to optimise the model:
Algorithm 1 Coordinate ascent variational inference algorithm
1: Initialise the global parameters λ(t=0)
2: repeat
3: for each local variational parameter ϕnk do
4: ϕ
(t+1)
nk ← Eq(β,znj)t [ηl(yn, znj ,β)]
5: end for
6: for each global variational parameter λ do
7: λ(t+1) = Eq(z)t [ηg(Y,Z,α)]
8: end for
9: until Convergence
However, as discussed in Section 5.1.2, the use of Euclidean-based gradients ignores important
information about the geometry of the distribution and is thus not optimal for the optimisation of
probabilistic models. Next, we will derive a similar coordinate ascent algorithm but using instead
the natural gradient.
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Deriving the natural gradients for the global variational parameters
From Equation (5.12), the gradient of the ELBO with respect to the global parameters λ is:
∇λL(λ) = ∇2λag(λ)(Eq(z)[ηg(Y,Z,α)]− λ)
Premultiplying by F(β)−1 = ∇2λag(λ) gives the natural gradient for the global parameters:
∇̂λL(λ) = Eq(z)[ηg(Y,Z,α)]− λ
Deriving the natural gradients for the local variational parameters
From Equation (5.14), the gradient of the ELBO with respect to the local parameters ϕ is:
∇ϕL(ϕnk) = ∇2ϕal(ϕnk)(Eq(β,znj)[ηl(yn, znj , β)]− ϕnk)
Premultiplying by F(znk)−1 = ∇2ϕal(ϕnk) gives the natural gradient for the global parameters:
∇̂ϕL(ϕnk) = Eq(β,znj)[ηl(yn, znj , β)]− ϕnk
Remarkably, the natural gradient for both the local and global variational parameters is simply the
standard gradient subtracting the current value of the parameters. Thus, the Fisher Information
matrix does not need to be explicitly computed at each iteration, which leads to a considerable
simplification of the problem.
Stochastic variational inference algorithm using natural gradients
After replacing the Euclidean gradient with the natural gradients, the model can be trained using the
following stochastic algorithm based on gradient descent (Algorithm 2). Notice that the stochastic
variational inference algorithm introduces additional hyperparameters:
• Batch size: controls the number of samples that are used to compute the gradients at each
iteration. A trade off exists where large batch sizes lead to a more expensive computation of
the gradient but yield a less noisy estimate.
• Learning rate: The learning rate p(t) controls the step size in the direction of the natural
gradient, with high learning rates leading to higher steps. In the natural gradient setting, the
learning rate also controls how much memory from previous iterations is translated to the
current updates. The particular case of a constant learning rate of 1 yields no memory from
previous iterations (thus simplifies to standard gradient ascent). To ensure proper convergence,
the learning rate has to be decayed during training. Several strategies exist [246], here we
used the simple function ρ(t) = ρ0
(1+κt)3/4
, which introduces two extra hyperparameters: (1)
The forgetting rate κ, which controls the decay of the learning rate, and ρ0 which determines
the initial learning rate.
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Algorithm 2 Stochastic variational inference algorithm using natural gradients
1: Initialise the global parameters λ(t=0).
2: Initialise step size ρ(t=0)
3: repeat
4: sample B a mini-batch of samples of size S




nk = Eq(t)(β,znj)[ηl(yn, znj ,β)]
7: end for
8: for each global variational parameter λ do
9:
λ(t+1) = (1− ρ(t))λ(t) + ρ(t)∇̂λLS(λ)











In MOFA+ we introduce two key novelties, both in the model aspect and in the inference scheme.
In the model side we introduce a principled approach for modelling multi-omic data set where the
samples are structured into non-overlapping groups, where groups typically correspond to batches,
donors or experimental conditions. In the inference side we implement a stochastic inference
algorithm to improve scalability and enable inference with large single-cell datasets.
Formally, we generalise the model to a disjoint set of M input views (i.e. groups of features) and G
input groups (i.e. groups of samples). The data is factorised according to the following model:
Ymg = Zg(W
m)T + ϵmg (5.16)
where Zg ∈ RNg×K are a set of G matrices that contain the factor values for the g-th group and
Wm ∈ RDm×K are a set of M matrices that define the feature weights for the m-th view. ϵmg ∈ RDm
captures the residuals, or the noise for each feature in each group. Notice that if G = 1 then the
model simplifies to the MOFA framework presented in Chapter 3.
It is important to get the intuition for the multi-group formulation right. In the factor analysis
setting, the aim is not to capture differential changes in mean levels between the groups but rather
to exploit the covariation patterns of the features to identify which sources of variability (i.e. latent
Factors) are consistently found across multiple groups and which ones are exclusively found within
a single group. This is symmetric to the interpretation of the multi-view framework in MOFA v1:
the absolute levels of the features are not compared across views, only the covariation patterns are
of interest. To achieve this, the features are centered per view and also per group before fitting the
model. Figure 5.3 summarises the MOFA+ pipeline.
As in MOFA v1, the linearity assumptions leads to an interpretable latent space that be visualised
and employed for a range of downstream analyses, including clustering, inference of non-linear
differentiation trajectories, denoising and feature selection, among others. The most important
extension is the generalisation of the variance decomposition analysis, where a value of variance
explained per view and group is obtained for every factor. For example, imagine that Factor 1
in Figure 5.3b corresponds to cell cycle variation, the variance decomposition analysis indicates
that cell cycle is a driver of cell-to-cell heterogeneity largely in views 2 and 3, but with only minor
influence in view 1. Also, this effect is manifested in groups 1 and 2, but not in group 3. This simple
visualisation provides a very intuitive approach to understand variability in complex experimental
designs where observations are structured into multiple views and multiple groups of cells.
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Figure 5.3: Multi-Omics Factor Analysis v2 (MOFA+) provides an unsupervised
framework for the integration of multi-group and multi-view (single-cell) data.
(a) Model overview: the input data consists of multiple datasets structured into M views and G
groups. Views consist of non-overlapping sets of features that often represent different assays. Anal-
ogously, groups consist of non-overlapping sets of samples that often represent different conditions
or experiments. Missing values are allowed in the input data. MOFA+ exploits the covariation
between the features to learn a low-dimensional representation of the data (Z) defined by K latent
factors that capture the global sources of variability. The weights (W) provide a measure of feature
importance. Model inference is performed using (GPU-accelerated) stochastic variational inference.
(b) The trained MOFA+ model can be queried for a range of downstream analyses: variance
decomposition, inspection of feature weights, visualisation of factors and other applications such as
clustering, inference of non-linear differentiation trajectories, denoising and feature selection.
5.2.1 Model priors and likelihood
Prior on the weights
This remains the same as in MOFA v1. We adopt a two-level sparsity prior with an Automatic




dk) = N (ŵmdk | 0, 1/αmk )Ber(smdk | θmk ) (5.17)
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with the corresponding conjugate priors for θ and α:
p(θmk ) = Beta
(
θmk | aθ0, bθ0
)
(5.18)
p(αmk ) = G (αmk | aα0 , bα0 ) (5.19)
As discussed in Chapter 3, the aim of the ARD prior is to encourage sparse associations between
factors and views, such that the weight vector wm:,k is shrunk to zero if the factor k does not explain
any variation in view m. The aim of the spike-and-slab prior is to push individual weights to zero
to yield a more interpretable solution.
Prior on the factors
In MOFA v1 we adopted an isotropic Gaussian prior which assumes an unstructured latent space a
priori :
p(znk) = N (znk | 0, 1) (5.20)
This is the assumption that we want to break. Following the same logic as for the weights, the
integration of multiple groups of samples requires a flexible prior distribution that defines the
existence of non-overlapping groups, such that the model encourages sparse linkages between factors
and groups. To formalise this intuition we simply need to extrapolate the sparsity prior from the
weights to the factors:
p(ẑgnk, s
g
nk) = N (ẑ
g

























where g is the index of the sample groups.
Prior on the noise
The variable ϵ captures the residuals, or the noise, which is assumed to be normally distributed and
heteroskedastic. In MOFA v2 we generalise the noise to have an estimate per feature and per group.
This is important to capture the case where some features may be highly variable in one group but
not variable in other groups.
p(ϵmg ) = N
(












In addition, as in MOFA v1, non-Gaussian noise models can also be defined, but unless otherwise
stated, we will always assume Gaussian residuals.
Graphical model
In summary, the updated model formulation introduces symmetric two-level sparsity priors in both




















Figure 5.4: Graphical model for MOFA+.
The white circles represent hidden variables that are inferred by the model, whereas the grey circles
represent the observed variables. There are a total of five plates, each one representing a dimension
of the model: M for the number of views, G for the number of groups, K for the number of factors,
Dm for the number of features in the m-th view and Ng for the number of samples in the g-th
group.
Guidelines on the definition of views and groups
• Views: views typically correspond to different assays, but there is flexibility in their definition
and the user can explore different definitions of views. For example, one could divide the
RNA expression data into three views corresponding to mRNA, rRNA and miRNA. Similarly,
one can quantify DNA methylation and chromatin accessibility data over different genomic
context (enhancers, promoters, etc.).
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• Groups: groups are generally motivated by the experimental design, but the user can also
explore data-driven formulations. There is no right or wrong definition of groups, depending
on the hypothesis that is sought to explore some definitions will be more useful than others.
Model selection
As discussed in Section 3.2.3, the inference procedure depends on the parameter initialisation. When
using random initialisation, the Factors can vary between different model instances and a model
selection step is advised. I realised that this was not a user-friendly solution and it requires a lot of
computational resources when applying the model to large datasets. To simplify model training in
MOFA+ we initialise the Factors using the principal components from the concatenated data set.
In practice, we observe faster convergence times and better ELBO estimates when initialising with






















Figure 5.5: Comparison of PCA and Random initialisation in MOFA.
Data was simulated from the generative model with the following dimensions: M = 2 modalities,
G = 2 groups, D = 1000 features, N = 1000 samples and K = 10 factors. The dashed lines mark
the iteration at which the model converged.
5.2.2 A note on the implementation
The core of MOFA+ is implemented in Python, and the downstream analysis and visualisations
are implemented in R. GPU acceleration is implemented using CuPy [222], an open-source matrix
library accelerated with NVIDIA CUDA. To facilitate adoption of the method, we deployed MOFA+





We validated the new features of MOFA+ using simulated data drawn from its generative model.
5.3.1 Stochastic variational inference
We simulated data with varying sample sizes, with the other dimensions fixed to M = 3 views,
G = 3 groups, D = 1000 features (per view), and K = 25 factors.
We trained a set of models with (deterministic) variational inference (VI) and a set of models with
stochastic variational inference (SVI). Overall, we observe that SVI yields Evidence Lower Bounds
that are comparable to those obtained from VI across a range of batch sizes, learning rates and
forgetting rates (Figure 5.6). In terms of speed, GPU-accelerated SVI inference is up to ≈ 20x
faster than VI, with speed differences becoming more pronounced with increasing number of cells
(Figure 5.7). For completeness, we also compared the convergence time estimates for SVI when
using CPU versus GPU. We observe that for large sample sizes there is a speed improvement even
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Figure 5.6: Validation of stochastic variational inference using simulated data.
(a) Line plots display the iteration number of the inference (x-axis) and the Evidence Lower Bound
on the y-axis. Panels correspond to different values of batch sizes (10%, 25%, 50% of the data) and
initial learning rates (0.05, 0.25, 0.5, 0.75). Colours correspond to different forgetting rates (0.05,
0.25, 0.5, 0.75, 1.0). The dashed horizontal line indicates the ELBO achieved using VI.
(b) Bar plots display the forgetting rate (x-axis) and the total variance explained (%) in the y-axis.
Panels correspond to different values of batch sizes (10%, 25%, 50% of the data) and initial learning
rates (0.05, 0.25, 0.5, 0.75). The dashed line indicates the variance explained achieved using
standard VI.
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Figure 5.7: Evaluation of convergence speed for stochastic variational inference using
simulated data.
Bar plots show the time elapsed for training MOFA+ models usign SVI. Colours represent different
batch sizes (10%, 25% or 50%). The dashed line indicates the training time for standard VI. CPU
models were trained using a single E5-2680v3. GPU models were trained an Nvidia GTX 1080Ti
(second column).
5.3.2 Multi-group inference
We evaluated whether the new model formulation improves the detection of factors with differential
activity across groups and views. We simulated data with the following parameters: M = 2 views,
G = 2 groups, D = 1000 features, N = 1000 samples and K = 10 factors. Differential factor
activities are incorporated in the simulation process by turning some factors off in random sets of
views and groups (Figure 5.8, see ground truth). The task is to recover the true factor activity
structure given a random initialisation. We compared three models: Bayesian Factor Analysis (no
sparsity priors), MOFA v1 (only view-wise sparsity prior) and MOFA+ (view-wise and group-wise
sparsity prior). Indeed, we observe that when having factors that explain varying amounts of
variance across groups and across views, MOFA+ was able to more accurately reconstruct the true
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Figure 5.8: Recovering complex factor activity patterns using simulated data.
Representative example of the resulting variance explained patterns. The first row of heatmaps
correspond to view 0 and the second row to view 1. In each heatmap, the first column corresponds
to group 0 and the second column to group 1. Rows correspond to the inferred factors. The colour
scale displays the percentage of variance explained by a given factor in a given view and group.
The heatmaps displayed in columns one to three show the solutions yielded by different models
(Bayesian Factor Analysis; MOFA; MOFA+). The ground truth is shown in the right panel.
5.4 Applications
5.4.1 Integration of a heterogeneous time-course single-cell RNA-
seq dataset
To demonstrate the novel multi-group integration framework, we considered a time course scRNA-
seq dataset comprising 16,152 cells that were isolated from a total of 8 mouse embryos from
developmental stages E6.5, E7.0 and E7.25 (two biological replicates per stage), encompassing
post-implantation and early gastrulation [232]. This data set, which has been introduced in Chapter
4, consists of a single view but with a clear group structure where cells belongs to different biological
replicates at different developmental time points. Different embryos are expected to contain similar
subpopulations of cells but also some differences due to developmental progression. As a proof of
principle, we used MOFA+ to disentangle stage-specific transcriptional signatures from signatures
that are shared across all stages. Although in principle one could employ the MOFA+ factors for
clustering and cell type annotation, here we adopted the cell type definitions described in [232].
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MOFA+ identified 7 Factors that explained at least 1% of variance in a group and all together
captured between 35% and 55% of the total transcriptional heterogeneity per embryo (Figure 5.9).
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Figure 5.9: MOFA+ applied to gastrulation scRNA-seq atlas: variance decomposition
analysis
(a) Heatmap displays the variance explained (%) for each factor (rows) in each group (mouse
embryos at a specific developmental stage, columns).
(b) Cumulative variance explained (per group, y-axis) versus factor number (x-axis). Asterisks
indicate the factors that are selected for downstream analysis (minimum of 1% variance explained
in at least one group).
Characterisation of individual factors
Some factors recover the existence of post-implantation developmental cell types, including extra-
embryonic (ExE) tissue (Factor 1 and Factor 2), and the emergence of mesoderm cells from the
primitive streak (Factor 4). Consistently, the top weights for these factors are enriched for lineage-
specific gene expression markers, including Ttr and Apoa1 for ExE endoderm (Figure 5.10); Rhox5
and Bex3 for ExE ectoderm (Figure 5.11); Mesp1 and Phlda2 for nascent mesoderm (Figure 5.13).
Other factors captured technical variation due to metabolic stress that affects all batches in a similar
fashion (Factor 3, Figure 5.12).
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bEpiblastExE ectodermExE endoderm Mesoderm Primitive Streak
Figure 5.10: Characterisation of Factor 1 as extra-embryonic (ExE) endoderm forma-
tion.
(a) Beeswarm plot of Factor values for each group. Cells are grouped and coloured by cell type.
(b) Plot of gene weights. Highlighted are the top five genes with largest weight (in absolute values)
(c) Beeswarm plot of Factor values for each group. Cells are coloured by the expression of the two
genes with largest weight (in absolute values).
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ExE endoderm Mesoderm Primitive Streak
Figure 5.11: Characterisation of Factor 2 as extra-embryonic (ExE) ectoderm forma-
tion.
(a) Beeswarm plot of Factor values for each group. Cells are grouped and coloured by cell type.
(b) Plot of gene weights. Highlighted are the top five genes with largest weight (in absolute values)
(c) Beeswarm plot of Factor values for each group. Cells are coloured by the expression of the two
genes with largest weight (in absolute values).
133
a














































Figure 5.12: Characterisation of Factor 3 as cell-to-cell differences in metabolic activ-
ity.
(a) Beeswarm plot of Factor values for each group. Cells are grouped and coloured by cell type.
(b) Plot of gene weights. Highlighted are the top seven genes with largest weight (in absolute
values)
(c) Gene set enrichment analysis applied to the gene weights using the Reactome gene sets [87].
Significance is assessed via a parametric. Resulting p-values were adjusted for multiple testing
using the Benjamini-Hochberg procedure.
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Figure 5.13: Characterisation of Factor 4 as mesoderm commitment.
(a) Beeswarm plot of Factor values for each group. Cells are grouped and coloured by cell type.
(b) Plot of gene weights. Highlighted are the top five genes with largest weight (in absolute values)
(c) Beeswarm plot of Factor values for each group. Cells are coloured by the expression of the two
genes with largest weight (in absolute values).
Interestingly, Factors displayed different signatures of activity (variance explained values) across
developmental stages. For example, Factors 1 and 2 remain constant across the developmental
progression (Figure 5.9), indicating that commitment to ExE ectoderm and ExE endoderm fate
occurs early in the embryo and the proportion of this cell type remains relatively constant. In
contrast, the activity of Factor 4 increases with developmental progression, consistent with a higher
proportion of cells committing to mesoderm after ingression through the primitive streak.
In conclusion, this application shows how MOFA+ can identify biologically relevant structure in
multi-group scRNA-seq datasets.
5.4.2 Identification of molecular signatures of lineage commitment
during mammalian embryogenesis
As a second application, I considered the multi-omic atlas of mouse gastrulation introduced in
Chapter 4, where scNMT-seq was used to profile RNA expression, DNA methylation and chromatin
accessibility in 1,828 cells at multiple stages of development [14]. The main difference with respect
to the MOFA analysis presented in Chapter 4 (Section 4.2.5) is that MOFA+ can employ the
multi-group functionality to perform a simultaneous analysis across multiple stages, instead of
focusing only on stage E7.5.
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Data processing
As input to the model we quantified DNA methylation and chromatin accessibility values over two
sets of regulatory elements: gene promoters and enhancer elements (distal H3K27ac sites). RNA
expression was quantified over protein-coding genes. More details on the feature quantification
and data processing steps are described in Chapter 4. We defined separate views for the RNA
expression and for each combination of genomic context and epigenetic readout. Cells were grouped
according to their developmental stage (E5.5, E6.5 and E7.5), reflecting the underlying experimental
design [14] (Figure 5.14). Note that the CpG methylation (endogenous DNA methylation) and GpC
methylation (proxy for chromatin accessibility) readouts result in very sparse matrices that are








































Figure 5.14: Overview of the scNMT-seq mouse gastrulation data set used as input
for MOFA+.
(a) Structure of the input data in terms of views (y-axis) versus samples (x-axis). Each panel
corresponds to a different group (embryonic stage). Grey bars represent missing views.
(b) Structure of the missing values in the data. For each cell and view, the colour displays the
fraction of missing values.
Model overview
In this data set MOFA+ identified 8 largely orthogonal factors with a minimum variance explained
of 1% in the RNA expression (in at least one group, Figure 5.15). The model explains little amounts
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of variance in chromatin accessibility, both for promoters (≈15%) and enhancers (≈18%), mostly
driven by Factors 1 and 2. In contrast, the model explains larger amounts of variation in DNA
methylation (≈23% for promoters and ≈59% for enhancers). However, as in chromatin accessibility,
this variation is mostly driven by the first two Factors. Finally, for RNA expression there is a
steady increase in the variance explained per Factor, suggesting that the (small) sources of variation











































































Factor 9* * * * * * * * *
Figure 5.15: MOFA+ application to the scNMT-seq gastrulation data set: model
overview.
(a) Cumulative variance explained (per view, y-axis) versus factor number (x-axis). Asterisks
indicate the factors that are selected for downstream analysis (minimum of 1% variance explained
in the RNA expression). Note that the variance estimates shown here are the sum across all groups.
(b) Pearson correlation coefficients between selected factors. In MOFA+ there are no orthogonality
constraints, but the factors are expected to be largely uncorrelated.
Characterisation of the MOFA+ Factors
Factor 1 captured the formation of ExE endoderm, a cell type that is present across all stages
(Figure 5.16a), in agreement with our previous results using the independently generated scRNA-seq
atlas of mouse gastrulation (Figure 5.10). This Factor is associated to widespread changes across
al molecular layers, most notably DNA methylation (up to 15% variance explained). For both
promoters and enhances, the distribution of weights for DNA methylation are skewed towards
negative values. This suggests that most features are uniformly affected by this Factor, such that
lower methylation levels are observed in ExE endoderm cells. This is consistent with previous studies
that have shown that ExE endoderm cells are characterised by a state of global demethylation[336,
14]. The weights for chromatin accessibility are not skewed towards one direction, indicating that
accessibility changes are not uniform and the state of global demethylation in ExE endoderm cells
is not necessarily associated with a (globally) more open chromatin state.
The next two factors, Factor 2 and Factor 3, captured the molecular variation associated with the
formation of the primary germ layers at E7.5: mesoderm (Factor 2, Figure 5.16b), and embryonic
endoderm (Factor 3, not shown). As with Factor 1, MOFA+ connects transcriptome variation to
changes in DNA methylation and chromatin accessibility, but only at stage E7.5, when the germ
layers are known to emerge. Nevertheless, there is a striking difference between Factor 1 and Factor
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2. The variance decomposition analysis and the distribution of weights indicate that the epigenetic
dynamics are mostly driven by enhancer elements. This is consistent with our results from Chapter
4 where we showed that little coordinated variation is observed in promoters, even for genes that
show strong differential expression between germ layers.

























































































































Figure 5.16: MOFA+ integrates multi-modal scNMT-seq experiments to reveal epi-
genetic signatures associated with lineage commitment during mammalian embryoge-
nesis.
Characterisation of (a) Factor 1 as ExE endoderm formation and (b) Factor 2 as Mesoderm com-
mitment. Top left plot shows the percentage of variance explained by the factor across the different
views (rows) and groups (embryonic stages, as columns). Bottom left plot shows the distribution of
factor values for each stage, coloured by cell type assignment. Histograms display the distribution
of DNA methylation and chromatin accessibility weights for promoters and enhancer elements.
As suggested by the variance decomposition analysis (Figure 5.15), the remaining MOFA+ Factors
explain significantly less variance than Factors 1 and 2, and they are mostly driven by RNA
expression alone (Figure 5.15). Their aetiology can be identified by the inspection of gene weights
and by gene set enrichment analysis. For simplicity, I will only display the characterisation of Factor



































































Figure 5.17: Characterisation of Factor 6 as cell cycle variation.
(a) Variance explained by Factor 6 in each group (embryonic stage, columns) and view (rows).
(b) Distribution of Factor 6 values per group (embryonic stage, x-axis), with cells coloured by the
inferred cell cycle state using cyclone.
(c) Gene set enrichment analysis applied to the Factor 6 weights.
(d) Cumulative distribution of RNA weights for Factor 6. The top genes with the highest (absolute)
weight are labelled.
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5.5 Conclusions, limitations and open perspectives
In this Chapter I introduced a generalisation of the MOFA model for the principled analysis of
large-scale structured datasets. Although we have emphasised single-cell applications, the model
remains applicable to bulk datasets. MOFA+ solves some of the limitations of the MOFA model
presented in Chapter 3, but a significant number of challenges remain unsolved and could be
addressed in future research:
• Linearity: this is arguably the major limitation of MOFA. Although it is critical for obtaining
interpretable feature weights, this results in a significant loss of explanatory power. Deep
generative models have proven successful in modelling complex observations. Their principle
is the use of non-linear maps via neural networks to encode the parameters of probability
distributions. Among this class of methods, variational autoencoders provide a rigorous and
scalable non-linear generalisation of factor models [3].
• Improving the stochastic inference scheme: a common extension of stochastic gradient
descent is the addition of a momentum term, which has been widely adopted in the training
of artificial neural networks [334, 239]. The idea is to take account of past updates when
calculating the present step, using for example a moving average calculation. This has been
shown to improve the stability of gradients vectors, thus leading to a faster convergence.
• Modelling dependencies between groups: often groups are not independent and have
some type of structure among themselves. A clear example are time course experiments.
Explicit modelling of these dependencies, when known, could help on model inference and
interpretation.
• Modelling continuous dependencies between samples and/or features: in the MOFA
framework the views and the groups correspond to discrete and non-overlapping sets. An
interesting improvement would be to model continuous dependencies using Gaussian Process
priors [53]. A clear application for this is spatial transcriptomics, where one could build a
covariance matrix using spatial distances which can then be imposed in the prior distribution
of the latent factors (recall that in MOFA and MOFA+ the prior distribution for the factors
assumes independence between samples). This would improve the detection of sources of




The last few years have seen an explosion of single-cell sequencing technologies, which have provided
new directions and opportunities for the study of biological complexity. The ultimate goal of
single-cell sequencing is to move from descriptive snapshots to comprehensive multi-modal roadmaps
of biological processes mapped across time and space. Unifying molecular variation across these two
will be at the forefront of scientific research.
The first stones on this path have been laid. Experimental designs that include single-cell genomics
technologies have now become ubiquitious, and the computational pipelines are gradually becoming
standarised. In addition, multi-modal measurements have been successfully collected in single cells,
although this remains in pilot stages and at the time of this writing very few commercial platforms
are available, thus limiting its widespread use by the community.
In this Chapter we discuss current and future perspectives of experimental and computational
methods that will lay the foundations for an unprecedented and exciting era for studying biological
complexity using single-cell multi-omics.
6.1 Experimental perspectives
6.1.1 Recording space
The dissociation and pooling of cells from their native location, with the consequent loss of
information of their spatial coordinates, is one of the biggest limitations of current single-cell
technologies. The positioning and the interaction of cells in their native tissue is essential to
understand biological function, as complex tissues arise following organized events in space and
time [193]. Pioneering work in single-molecule fluorescence in situ hybridization demonstrated that
mRNA molecules can be measured, but quantifying multiple genes at the same time has been a
major challenge, mostly hindered by physical limitations on the optical resolution and the high
density of transcripts within each cell [83]. Remarkbly, recent technological breakthroughts have
scaled these assays to transcriptome-wide measurements while maintaining high accuracy. One of
these methods, seqFISH [182, 83], employs a multiplexed strategy to overcome the diffraction limit
where multiple rounds of sequential probe hybridization and imaging are applied. Although most of
the spatially-resolved methods have been focused on transcriptomics, epigenomic measurements
have also been successfully recorded by adapting the ATAC-seq protocol [301], thus paving the way




In the timespan of a few days, a mammalian embryo expands from a handful of cells to millions
of them, experiencing in the process a set of cell fate commitments that will eventually generate
a myriad of specialised cell types. Besides knowing the spatial location of cells, recording the
timing and the hierarchy of the events at high-resolution is an essential step to understand complex
biological dynamics. Static single-cell experiments can provide useful snapshots that can be used to
reconstruct dynamic differentiation processes [323], but the past story of the cells remains elusive.
A fundamental biological principle is that each cell originates from another existing cell. Thus, each
adult cell has an associated cell lineage tree that unambiguously defines its past history and can
potentially be recorded by tracking the progeny of single cells. Historically, imaging-based techniques
have been used to perform lineage tracing in a low-throughput manner by employing fluorescent
protein markers. However, classical fluorescence-based experiments are limited when it comes to both
temporal and molecular resolution. The current generation of lineage tracing techniques introduce
inheritable genetic marks that can be read in terminal cells through next-generation sequencing
[24, 141, 200]. For example, one can induce double-stranded breaks using CRISPR-Cas9 at target
genomic sites, which after repair results in random genomic insertions and deletions (indels) that
become inherited in different hierarchical combinations by the progeny cells [24, 141, 200]. Notably,
this strategy can be combined with single-cell sequencing for the simultaneous quantification of
clonal history (applying phylogenetic methods on the indel profiles) and cell type identity (applying
clustering methods on the gene expression profiles). This strategy was employed to map cell fates
in several model organisms, including adult zebrafish [5] and mouse embryos [54].
One of the most exciting opportunities that will soon become a reality is combining lineage
tracing technologies with single-cell multi-modal readouts. An ideal system would measure multiple
biological layers in situ and would recover each cell’s past history at the same time [200]. In the
context of this thesis, the genomic modality of scNMT-seq could be employed to track not only
CRISPR-Cas9-induced indels but also naturally occurring mitochondrial mutations. The latter in
particular would be critical to identify clones in complex human tissues, where genetic manipulation
is not an option [183].
In conclusion, multi-modal lineage tracing would be a major step towards the ultimate goal
of constructing dynamic models of cell fate commitment and to understand how they become
dysregulated in disease. Notably, each of these tools is already available, but combining them in
coassays will be one of the big challenges ahead.
Recording the future
scRNA-seq offers transcriptome-wide snapshots of the present status of each cell. However, simulta-
neously measuring some property of its future state would provide extremely valuable information
to understand cell fate decisions.
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A milestone of scRNA-seq analysis was achieved with the inference of RNA velocity in single cells
[160]. This method leverages the small quantity of intronic reads that are present in the sequencing
library to calculate a relative ratio of unspliced (intronic) and spliced (exonic) mRNAs to infer
gene expression kinetics. In turn, by pooling information across multiple genes and under some
assumptions one can estimate the nascent transcriptional state for each cell. Interestingly, similar
information can be obtained from spatial transcriptomics data. However, instead of identifying
intronic reads, which are lowly abundant due to polyA selection, one can exploit the subcellular
resolution of the molecules to distinguish between nuclear (unspliced) and cytoplasmic (spliced)
reads [330].
RNA velocity is appealing because it can be applied to most conventional scRNA-seq protocols.
However, intronic coverage is sparse, particularly for droplet-based assays, thus limiting the reliability
of the method in some datasets [278]. Moreover, the inference of gene expression kinetics is restricted
to genes that undergo splicing events. Alternative strategies to record the future state of individual
cells are aimed at directly monitoring newly synthesised RNA. For example, NASC-seq [115] relies
on chemical modifications of the nascent RNA that can be read out by sequencing at much greater
sensitivity and better temporal resolution than RNA velocity estimates.
6.2 Computational perspectives
None of the biological insights offered by multi-modal assays would be possible without concomitant
development of computational methods. Each new data modality presents distinct challenges, from
low level processing, quality control and normalisation through to downstream challenges such as
quantifying sources of biological variability and using these to generate testable biological hypotheses.
Additionally, in the context of single-cell multi-omics datasets there exist specific challenges that
need to be overcome, as discussed in Section 1.3.2. Here I outline some challenges that need to be
addressed in order to optimally leverage the power of single-cell multi-omics.
6.2.1 Mechanistic insights
One of the most promising aspects of multi-modal sequencing is the opportunity to move from
descriptive snapshot to a more mechanistic understanding of gene regulation. By incorporating prior
knowledge about the hierarchical relationship between molecular layers, we envision that multi-modal
assays will play an important role in identifying causal chains of events in gene regulatory networks.
However, to construct such mechanistic models it will be essential to combine multi-modal readouts
with perturbations assays.
Single-cell perturbation studies using the CRISPR technology is one of most exciting experiments
that single-cell genomics has brougth us [78, 71, 128, 4]. In the first step, cells are infected with
a pool of lentiviral constructs that contain guide RNAs that target (typically by inactivation)
specific genes. Notably, increasing the multiplicity of infection can be used to target multiple genes
at once and thus study epistatic effects. After stimulation or differentiation, cells are sequenced
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using single-cell methodologies. The unique combination of barcodes within each cell enables the
computational identification of the gene(s) targeted. Remarkably, this strategy of pooling guides
and cells together and later deconvoluting them enables this protocol to be done in a massively
parallel fashion.
While most of the perturbation studies have been focused on RNA expression, the profiling of
epigenomic layers is receiving increased interest [259]. Yet, to my knowledge, no multi-modal
single-cell CRISPR screening has performed to date. This is a matter of time, as all the ingredients
are already available, and I envision that this will become the state-of-the-art for the characterisation
of gene regulatory networks.
6.2.2 Benchmarking of methods
Benchmarking of methods has been extensively performed on horizontal data integration strategies,
particularly in the context of batch correction [185, 309]. However, benchmarking vertical and
diagonal integration strategies is notorously difficult, as the ground truth is rarely known. In the
context of MOFA, for example, it is difficult to assess the quality of the output. There are useful
quality control metrics, such as the number of factors or the total variance explained, but it is not
clear how to assess whether the latent Factors are a reliable representation of biological variation or
whether they are just arbitrary (but useful) mathematical representations.
In this context, having gold-standard truth datasets will prove essential to benchmark integrative
methods. Here, we discuss two existing biological systems that are well suited to benchmark data
integration tasks. The first one is Peripheral Blood Mononuclear Cells (PBMCs), which is the de
facto dataset to validate single-cell technologies developed by 10x Genomics, owing to its simplicity
and well-characterised subpopulations of cells. Multiple assays have been profiled on PBMCs across
multiple human donors and different species, including scRNA-seq, scATAC-seq, CITE-seq and
[T/B]-cell receptor sequencing. Moreover, some horizontal and vertical integration strategies have
already been successfully applied [291].
The second biological system is mammalian embryonic development, a significantly more complex
system with branching differentiation trajectories and where the regulation between molecular layers
is less well understood when compared to somatic cell types. In addition, unlike PBMCs, the solid
tissue enables the integration of molecular readouts with spatial context information. A large variety
of single-cell technologies have been applied to mouse embryonic development, including scRNA-seq
[232, 207, 270, 100, 220], scATAC-seq [233], scNMT-seq [14] and even spatial measurements [229,
37].
As the Human Cell Atlas project [249] matures, we expect many more biological systems to be
suitable datasets for benchmarking data integration strategies, not only across data modalities but
also across individuals and even across different species.
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6.2.3 Mosaic integration
A major challenge in the next few years will be to integrate independent experiments with the goal
of building self-consistent multi-modal datasets of biological processes. However, given how difficult
it is to simultaneously capture multiple molecular layers in an efficient and scalable manner, this
task will require computational integration of independent uni-modal and multi-modal experiments
from the same biological system. There is an urgent need to develop a unifying integrative strategy
that selectively exploits cells and features as common coordinate frameworks to perform transfer
learning of molecular signatures across experiments (Figure 6.1). I coin the term mosaic integration
for this combination of vertical, horizontal and diagonal integration tasks. Undeniably, this task
will not be solved by linear matrix factorisation frameworks such as MOFA, and it will require
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Figure 6.1: Mosaic integration The aim is to integrate a complex experimental design that
consists of uni-modal and multi-modal datasets by selectively exploiting cells and features as
common coordinate frameworks. The output would be a self-consistent data set where all missing
data modalities have been imputed across all experimental conditions.
6.2.4 Software infrastructure
Open-source software, data sharing platforms and reproducible analysis pipelines are essential
elements in computational biology. Generic frameworks that can contain increasingly large complex
experimental designs from single-cell genomics are urgently needed. Popular tools for scRNA-seq
analysis such as SingleCellExperiment, Seurat and Scanpy are continuously being extended to handle
novel multi-modal assays. There are however important challenges that need to be overcome.
The first one is data standarisation and interoperabiliy between platforms. Conversion between
R-based objects is relatively easy, but connecting Python and R is still a significant challenge that
involves tedious configurations [6].
Second, the large scale of single-cell genomics requires optimisation of memory usage. Just to give a
sense of how important this is, one of datasets released by 10x Genomics contains transcriptome-wide
measurements for 1.3 million cells from the mouse brain 1. Storing this data set in an ordinary
1https://support.10xgenomics.com/single-cell-gene-expression/datasets/1.3.0/1M_neurons
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integer matrix requires more than 100 GB of memory. Clearly, the conventional approach of loading
the entire data set to memory on a conventional laptop becomes prohibitive. One of the most
efficient approaches to handle vast amounts of data is to use on-disk operations, where common
array operations are performed using a block processing mechanism, thus preventing the entire
object from being loaded into memory at once. This is a strategy that we implemented for the
downstream analysis in MOFA+ by adapting the DelayedArray framework [116], albeit the matrix
operations during model training require loading the entire data set in memory.
Finally, we need a centralised data sharing platform where curated landmark datasets are made
available with common data structures alongside reproducible analysis vignettes. This would be
of immense help to both beginners and method developers alike to cope with the vast amounts of
invaluable data that single-cell genomics promises to generate in the future.
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6.3 Thesis summmary
In this Thesis I have described the work I performed throughout my PhD where I sought to develop
and apply computational strategies for data integration in the context of single-cell multi-omics.
First, I worked together with experimental collaborators to devise scNMT-seq, an experimental
protocol for the genome-wide profiling of RNA expression, DNA methylation and chromatin
accessibility in single cells. I developed the entire computational analysis pipeline and after
validating the quality of the readouts I demonstrated how scNMT-seq can be used to study
coordinated epigenetic and transcriptomic heterogeneity along a simple differentiation process.
Second, motivated by the need to discover biologically meaningful insights from such complex data
I developed Multi-Omics Factor Analysis (MOFA), a statistical framework for the integration of
multi-omics datasets. Briefly, MOFA is a statistically rigorous generalisation of Principal Component
Analysis for multi-view data. It provides a systematic approach to explore, in an unsupervised
manner, the underlying sources of sample heterogeneity in a multi-omics data set. Owing to its
linear formulation, interpretability is an essential property of this model that permits a series of
useful downstream analyses. Before applying MOFA to single-cell datasets, we benchmarked it using
a large multi-omics cohort of chronic lymphocytic leukaemia patients and demonstrated how MOFA
can be used to capture multiple dimensions of disease heterogeneity, enhance data interpretation
and build predictive models for clinical outcomes.
Third, I aimed to leverage the experimental and computational frameworks described above to
study embryonic development and specifically germ layer commitment. Together with experimental
collaborators we employed scNMT-seq to simultaneously profile mRNA expression, DNA methylation
and chromatin accessibility for more than 1000 cells, spanning four time points between the exit
from pluripotency and primary germ layer specification. This data set represents the first multi-
omics roadmap of mouse gastrulation at single-cell resolution, which enabled us to perform an
integrative study that revealed novel insights into the dynamics of the epigenome during gastrulation.
Notably, we show that cells committed to mesoderm and endoderm undergo widespread epigenetic
rearrangements, driven by demethylation in enhancer marks and by concerted changes in chromatin
accessibility. In contrast, the epigenetic landscape of ectodermal cells remains in a default state,
resembling earlier stage epiblast cells. This work provides a comprehensive insight into the molecular
logic for a hierarchical emergence of the primary germ layers, revealing underlying molecular
constituents of Waddington’s landscape.
Finally, after having benchmarked MOFA using high-quality bulk multi-omics and relatively small
single-cell genomics dat asets, I developed a second version of the software aimed at the scalable
analysis of datasets with thousands of samples and more complex experimental designs. Key
methodological improvements included a fast stochastic variational inference framework and a




Mathematical derivations of MOFA+
A.1 Deriving the variational inference algorithm
The theoretical foundations for the variational inference scheme are described in Section 3.1.4. Just
to brief, we need to define a variational distribution of a factorised form and subsequently look for
the member of this family that most closely resembles the true posterior using the KL divergence























































However, inspired by [304], we did not adopt a fully factorised distribution as ŵmk and s
m
k can hardly
be assumed to be independent.
To derive the variational updates we can proceed in two ways, as described in Section 3.1.4. One
option is to use exploit the mean-field assumption and use calculus of variations to find the optimal
distribution q(X) that maximises the lower bound L(X)[31, 214]. The alternative and possibly
easier approach is to define a parametric form for the distribution q(X) with some parameters
Θ to be of the same form as the corresponding prior distribution p(X). Then, one can find the
gradients with respect to the parameters to obtain the coordinate ascent optimisation scheme. In
our derivations we followed the first approach, but because we used conjugate priors the second one
should converge to the same result.
Below we give the explicit update equations for every hidden variable in the MOFA+ model which
are applied at each iteration of the variational inference algorithm.
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A.2 Variational update equations
Factors For every group g, sample n and factor k:
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Feature weights For every view m, feature d and factor k:
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q(ŵmkd|smkd = 0) = N (ŵmkd|0, 1/αmk )
q(ŵmkd|smkd = 1) = N
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ARD prior on the weights For every view m and factor k:
Prior distribution p(αmk ):
p(αmk ) = G (αmk | aα0 , bα0 )
Variational distribution q(αmk ):
q(αmk ) = G
(
















Sparsity parameter of the weights For every view m and factor k:
Prior distribution:
p(θmk ) = Beta
(
θmk | aθ0, bθ0
)
Variational distribution:
q(θmk ) = Beta
(















Noise (Gaussian) For every view m, group g and feature d:
Prior distribution p(τ gmd ):
p(τ gmd ) = G
(




Variational distribution q(τ gmd ):
q(τ gmd ) = G
(































A.3 Evidence Lower Bound
Although computing the ELBO is not necessary in order to estimate the posterior distribution of
the parameters, it is used to monitor the convergence of the algorithm. As shown in Equation (3.2),
the ELBO can be decomposed into a sum of two terms: (1) the expected log likelihood under the
current estimate of the posterior distribution of the parameters and (2) the KL divergence between
the prior and the variational distributions of the parameters:
L = Eq(X) ln p(Y |X)−KL (q(X)||p(X)) (A.24)
Log likelihood term Assuming a Gaussian likelihood:


































KL divergence terms Note that KL (q(X)||p(X)) = Eq(q(X))− Eq(p(X)).
Below, we will write the analytical form for these two expectations.
Weights































































(1− ⟨smkd⟩) ln(1− ⟨smkd⟩)− ⟨smkd⟩ ln⟨smkd⟩
(A.27)
Factors

































































































k − 1)⟨lnαk⟩ − b̂αk ⟨αk⟩ − ln Γ(âαk )
) (A.30)
Sparsity parameter of the weights








(a0 − 1)× ⟨ln(πmd,k)⟩+ (b0 − 1)⟨ln(1− πmd,k)⟩ − ln(B(a0, b0))
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(amk,d − 1)× ⟨ln(πmd,k)⟩+ (bmk,d − 1)⟨ln(1− πmd,k)⟩ − ln(B(amk,d, bmk,d))
)
(A.31)
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) (A.32)
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Sparsity parameter of the Factors
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Characterisation of MOFA factors in the






























































Figure B.1: Characterisation of MOFA Factor 3 as antero-posterior axial patterning
and mesoderm maturation.
(a) Beeswarm plot of Factor 3 values, grouped and coloured by cell type. The mesoderm cells are
subclassified into nascent and mature mesoderm.
(b) RNA expression weights for Factor 3. Genes with large positive weights increase expression in
the positive factor values (more anterior), whereas genes with negative weights increase expression
in the negative factor values (more posterior).
(c) Same beeswarm plots as in (a), coloured by the relative RNA expression of genes with the
highest positive (top) or negative (bottom) weight.
(d) Gene set enrichment analysis of the gene weights of Factor 3. Shown are the top most significant
pathways from MSigDB C2 [292, 17].
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Figure B.2: Characterisation of MOFA Factor 4 as notochord formation.
(a) Beeswarm plot of Factor 4 values, grouped and coloured by cell type. The endoderm cells are
subclassified into notochord (dark green) and not notochord (green) (see Figure S2).
(b) RNA expression weights for Factor 4. Genes with large positive weights increase expression in
the positive factor values (endoderm cells), whereas genes with negative weights increase expression
in the negative factor values (notochord cells).
(c) Same beeswarm plots as in (a), coloured by the relative RNA expression of genes with the























































Figure B.3: Characterisation of MOFA Factor 5 as mesoderm patterning.
(a) Beeswarm plot of Factor 5 values, grouped and coloured by cell type.
(b) RNA expression weights for Factor 5. A higher absolute value indicates higher feature importance.
(c) Same beeswarm plots as in (a), coloured by the relative RNA expression of genes with the
highest weight on this factor.
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Figure B.4: Characterisation of MOFA Factor 6 as cell cycle.
(a) Beeswarm plot of Factor 6 values, grouped by cell type and coloured by infered cell cycle state
using cyclone[269].
(b) RNA expression weights for Factor 6. Genes with large positive weights increase expression in
the positive factor values (G1/S phase), whereas genes with negative weights increase expression in
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